
<html lang="en"     class="pb-page"  data-request-id="944086b5-b346-49ce-a6cb-82b63528d0ce"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-12;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c00026;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Metabolism and Bioactivation: It’s Time to Expect the Unexpected" /></meta><meta name="dc.Creator" content="James P.  Driscoll" /></meta><meta name="dc.Creator" content="Corinne M.  Sadlowski" /></meta><meta name="dc.Creator" content="Nina R.  Shah" /></meta><meta name="dc.Creator" content="Antonio  Feula" /></meta><meta name="dc.Description" content="Improvements in in vitro ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-indu..." /></meta><meta name="Description" content="Improvements in in vitro ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-indu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 8, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00026" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00026" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00026" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00026" /></link>
        
    
    

<title>Metabolism and Bioactivation: It’s Time to Expect the Unexpected | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00026" /></meta><meta property="og:title" content="Metabolism and Bioactivation: It’s Time to Expect the Unexpected" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0017.jpeg" /></meta><meta property="og:description" content="Improvements in in vitro ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-induced liver injury (DILI). Assessing a new chemical entity’s potential for liver toxicity is an important consideration for the likely success of new drug candidates. Reactive intermediates produced during drug metabolism have been implicated as a cause of DILI, and their formation has been correlated to the addition of a black box warning on a drug label. In this work, we will present contemporary examples of the bioactivation of atypical structures usually regarded as benign and often used by medicinal chemists when attempting to avoid bioactivation. Medicinal chemistry strategies used to derisk bioactivation will be discussed, and an emphasis will be placed on the necessity of a multidisciplinary approach." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Improvements in in vitro ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-induced liver injury (DILI). Assessing a new chemical entity’s potential for liver toxicity is an important consideration for the likely success of new drug candidates. Reactive intermediates produced during drug metabolism have been implicated as a cause of DILI, and their formation has been correlated to the addition of a black box warning on a drug label. In this work, we will present contemporary examples of the bioactivation of atypical structures usually regarded as benign and often used by medicinal chemists when attempting to avoid bioactivation. Medicinal chemistry strategies used to derisk bioactivation will be discussed, and an emphasis will be placed on the necessity of a multidisciplinary approach." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0017.jpeg" /></meta><meta name="twitter:title" content="Metabolism and Bioactivation: It’s Time to Expect the Unexpected" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00026"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00026">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00026&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00026&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00026&amp;href=/doi/10.1021/acs.jmedchem.0c00026" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 6303-6314</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00917" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01877" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Metabolism and Bioactivation: It’s Time to Expect the Unexpected</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">James P. Driscoll</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James P. Driscoll</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MyoKardia, Inc., 333 Allerton Avenue, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#711b15031802121e1d1d311c081e1a10031518105f121e1c"><span class="__cf_email__" data-cfemail="2e444a5c475d4d4142426e435741454f5c4a474f004d4143">[email protected]</span></a>. Phone: 650-741-0928.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+P.++Driscoll">James P. Driscoll</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3736-1673" title="Orcid link">http://orcid.org/0000-0002-3736-1673</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Corinne M. Sadlowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Corinne M. Sadlowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MyoKardia, Inc., 333 Allerton Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Corinne+M.++Sadlowski">Corinne M. Sadlowski</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nina R. Shah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nina R. Shah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MyoKardia, Inc., 333 Allerton Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nina+R.++Shah">Nina R. Shah</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Antonio Feula</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Feula</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MyoKardia, Inc., 333 Allerton Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Feula">Antonio Feula</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00026&amp;href=/doi/10.1021%2Facs.jmedchem.0c00026" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 6303–6314</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 January 2020</li><li><span class="item_label"><b>Published</b> online</span>8 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00026" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00026</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6303%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJames%2BP.%2BDriscoll%252C%2BCorinne%2BM.%2BSadlowski%252C%2BNina%2BR.%2BShah%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D12%26contentID%3Dacs.jmedchem.0c00026%26title%3DMetabolism%2Band%2BBioactivation%253A%2BIt%25E2%2580%2599s%2BTime%2Bto%2BExpect%2Bthe%2BUnexpected%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6314%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00026"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6699</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00026" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Metabolism and Bioactivation: It’s Time to Expect the Unexpected&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;P. Driscoll&quot;},{&quot;first_name&quot;:&quot;Corinne&quot;,&quot;last_name&quot;:&quot;M. Sadlowski&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;R. Shah&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Feula&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6303-6314&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00026&quot;},&quot;abstract&quot;:&quot;Improvements in in vitro ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-induced liver injury (DILI). Assessing a new chemical entity’s potential for liver toxicity is an important consideration for the likely success of new drug candidates. Reactive intermediates produced during drug metabolism have been implicated as a cause of DILI, and their formation has been correlated to the addition of a black box warning on a drug label. In this work, we will present contemporary examples of the bioactivation of atypical structures usually regarded as benign and often used by medicinal chemists when attempting to avoid bioactivation. Medicinal chemistry strategies used to derisk bioactivation will be discussed, and an emphasis will be placed on the necessity of a multidisciplinary approach.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00026&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00026" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00026&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00026" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00026&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00026" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00026&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00026&amp;href=/doi/10.1021/acs.jmedchem.0c00026" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00026" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00026" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00026%26sid%3Dliteratum%253Aachs%26pmid%3D32267691%26genre%3Darticle%26aulast%3DDriscoll%26date%3D2020%26atitle%3DMetabolism%2Band%2BBioactivation%253A%2BIt%25E2%2580%2599s%2BTime%2Bto%2BExpect%2Bthe%2BUnexpected%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D12%26spage%3D6303%26epage%3D6314%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292236" title="Aldehydes">Aldehydes</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292082" title="Bioactivation">Bioactivation</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/12" title="Go to Volume 63, Issue 12"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/jmcmar.2020.63.issue-12/20200625/jmcmar.2020.63.issue-12.largecover.jpg" alt="Go to Volume 63, Issue 12"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Improvements in <i>in vitro</i> ADME tools and pharmacokinetic prediction models have helped to shift attrition rates in early clinical trials from poor exposure to drug safety concerns, such as drug-induced liver injury (DILI). Assessing a new chemical entity’s potential for liver toxicity is an important consideration for the likely success of new drug candidates. Reactive intermediates produced during drug metabolism have been implicated as a cause of DILI, and their formation has been correlated to the addition of a black box warning on a drug label. In this work, we will present contemporary examples of the bioactivation of atypical structures usually regarded as benign and often used by medicinal chemists when attempting to avoid bioactivation. Medicinal chemistry strategies used to derisk bioactivation will be discussed, and an emphasis will be placed on the necessity of a multidisciplinary approach.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/12"><issue-title>Drug Metabolism and Toxicology</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">After this paper was published ASAP on April 21, 2020, corrections were made to the compound numbering in the second paragraph of the Cyclopropyl Group section. Also, a reference was added to the reference list. The revised version was reposted April 30, 2020.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drug induced liver injury has become the main cause of attrition in clinical trials and often is the reason for regulatory agencies to add black box warnings to drug labels. There has been an increased emphasis on identifying earlier means to predicting and overcoming drug induced liver injury, thus providing the opportunity to circumvent the potential liability during the drug discovery phase. The latest literature and review articles have focused on prediction models, which span from simple models<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> based on physical and chemical properties to more complex models<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> with multipronged approaches. Simple approaches like the rule of two<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> or empirically determining reactive metabolite (RM) formation can have a high predictive value and low false negatives, as outlined by Chan and Bennet (2017).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p last">The bioactivation of structural alerts (SA) has been discussed at length in recent literature because understanding bioactivation is an important predictive strategy.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Unfortunately, bioactivation beyond established SA has not been examined in depth. Herein, a focus will be placed on the bioactivation of functional moieties that are generally considered acceptable, such as the pyrazole, imidazole, cyclopropyl, ethylurea, azetidine, and aliphatic groups. We will survey both the top selling and most prescribed drugs on the market<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> for such structural entities and provide examples that, under the right circumstances, are bioactivated to generate reactive metabolites. We will highlight both the mechanisms by which RMs are formed and the trapping experiments performed with nucleophiles or reaction with endogenous protein to identify bioactivation pathways.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Aromatic Bioactivation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Medicinal chemists and metabolism scientists have studied the bioactivation of aromatic groups for many decades. In fact, the enzymatic systems in the liver that deactivate aromatic quinones, quinone amines, and quinone methides have been recently reviewed by Bolton and Dunlap.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For example, a simple aromatic group can be hydroxylated followed by a two-electron oxidative step to form <i>ortho</i> and <i>para</i> quinones, which are reactive as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Below are a few examples of aromatic groups that can sometimes be bioactivated independent of the quinone pathway.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0001.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactivation of aromatic rings.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Aminopyrazole</h3><div class="NLM_p">The aminopyrazole motif is a popular building block employed in many drug discovery programs due to its favorable physiochemical properties and synthetic tractability. Considered a bioisostere of aniline, the aminopyrazole scaffold is a heteroanalog that is more capable of progressing in a medicinal chemistry campaign because it avoids many of the DILI risks associated with aniline-containing candidates. Specifically, the pyrazole core is less susceptible to oxidative metabolism than other five-membered heterocycles, presumably due to the extra heteroatom within the ring compared to thiophenes or pyrroles that contain only one electronegative heteroatom. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> gives some examples of approved drugs that contain aminopyrazoles. The fact that there are currently no aminopyrazole containing FDA-approved drugs that have been known to cause DILI, combined with the prevalence and relative chemical stability of this moiety, would suggest an assumption of safety; nonetheless, there has been emerging evidence that not all aminopyrazoles are created equally, and recently, RM formation has been discovered. Aminopyrazole motifs exist in preclinical and clinical programs spanning therapies aimed to treat leishmaniasis, cancer chemotherapy, Alzheimer’s disease, and other ailments, and thus further discussion of this motif should be given due consideration.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0002.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. FDA Approved drugs containing an aminopyrazole moiety in the form of a sulphonamide <b>1</b>, urea <b>2</b>, indazole <b>3</b>, and a fused pyrimidine <b>4</b>. Only the anticancer drug entrectinib contains an unsubstituted pyrazole nitrogen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ryan and co-workers have uncovered the bioactivation of 3- and 4-aminopyrazoles with a glutathione trapping agent in the presence of human liver microsomes.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(9)</a> They investigated a series of pyrimidine-substituted aminopyrazoles <b>5</b> and reported thioether adduct formation <b>8</b> regardless of electron-withdrawing or electron-donating substituents present on the pyrimidine <b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). When the pyrazole-NH is substituted with a methyl group <b>5a</b>–<b>d</b>, glutathione conjugates are not detected. The authors propose a mechanism that is consistent with these findings. When the amino group is a secondary amine, P450 oxidation can occur to generate a pyrazolohydroxyamine (intermediate <b>6</b>). In the case of the unsubstituted pyrazole, this intermediate can undergo elimination of water to produce a reactive iminopyrazole <b>7</b>. However, N-substituted pyrazoles are unable to generate an iminopyrazole <b>7</b> because there is no hydrogen available for abstraction and it is unlikely that direct N-oxidation occurs on the pyrazole N–H since the ring is quite electron poor. This strategy would be ideal if a particular structure–activity relationship (SAR) effort could tolerate the loss of a H-bond donor, yet substituents at that position would likely create limitations to a drug discovery effort. An alternative bioactivation pathway could include two electron oxidation of <b>5</b> to form intermediate <b>7</b>. Other aminopyrazole substituents, either on the amino side or the pyrazole nitrogen, have not been investigated, and their substitution could play a role in the bioactivation of a compound. Interestingly, out of four FDA-approved compounds that contain an amine at the 3 or 4 position of a pyrazole ring, only one (entrectinib <b>3</b>), a metastatic non-small-cell lung cancer treatment, is N-unsubstituted at the pyrrole nitrogen. There are 57 other clinical candidates reported that are not approved, and 29 of these contain an N-unsubstituted pyrazole (tozasertib, barasertib, danusertib, etc.). Though the work of Ryan et al. is context-specific, this important discovery of bioactivation on a seemingly innocuous aminopyrazole motif suggests a watchful eye should be given to monitor for potentially similar bioactivation patterns when an unsubstituted pyrazole nitrogen is employed.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Bioactivation of Aminopyrazole Containing Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pyrimidine</h3><div class="NLM_p">Replacing the carbon atoms in aromatic rings with nitrogens can dramatically affect the physiochemical properties of compounds in comparison to the carbon-based phenyl system.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(10)</a> Specifically, pyrimidine can be a useful building block in medicinal chemistry and has been utilized to increase binding affinity, intramolecular interactions, and target selectivity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(10)</a> Pyrimidine has also been shown to decrease the bioactivation potential by destabilizing quinone-like intermediates <b>10</b> and <b>11</b>, such as in the case of the pyrimidine-containing buspirone <b>12</b> compared to the aniline-containing nefazodone <b>13</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(11)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Bioactivation Pathway for Nefazodone and the Lack of Bioactivation of Buspirone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The bioactivation of fluoropyrimidine is a rare occurrence and is contrary to documented cases that show that adding fluorine and nitrogen to aromatic rings can slow P450 metabolism.<a onclick="showRef(event, 'ref9 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref11 ref12">(10,12,13)</a> Some fluoropyrimidine-containing compounds were being developed as BACE1 inhibitors <b>14</b> for the treatment of Alzheimer’s disease.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(14)</a> The molecules investigated were found to have time-dependent inhibition (TDI) of CYP 3A4, a predominant P450 enzyme, indicating an increased potential for drug–drug interactions in the clinic.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(15)</a> With further assessment into the mechanisms of CYP-mediated TDI, the authors identified that the fluoropyrimidine motif in <b>14</b> was responsible for CYP 3A4 inhibition. Metabolite identification studies were conducted, and metabolite <b>18</b> was discovered, corresponding to the mass of the parent compound with loss of fluorine and the addition of a hydroxyl group. When glutathione (GSH) was added to human liver microsome incubations, the same oxidative defluorination was detected along with the addition of GSH <b>17</b>, suggesting the oxidative defluorination proceeds through a reactive intermediate pathway. The proposed mechanism of bioactivation starts with the epoxidation of the double bond <b>15</b> in the pyrimidine ring, forming a reactive intermediate. The GSH adducts could then be formed by direct nucleophilic attack of the thiol by GSH causing ring-opening of the epoxide and loss of fluorine. Alternatively, a reactive quinone imine intermediate <b>16</b> could explain the oxidative defluorination metabolite. Changing the fluoropyrimidine <b>14a</b> to a fluoropyridine <b>14b</b> reduced the IC<sub>50</sub> from 1.2 μM to 6.4 μM, while removing the nitrogen from the ring altogether (<b>14c</b>) showed no evidence of CYP 3A4 TDI up to 30 μM (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Bioactivation Pathway of Fluoropyrimidine</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Imidazole</h3><div class="NLM_p">Imidazole is an amphoteric heterocycle present in important biological building blocks such as histidine or histamine and is a ubiquitous building block in medicinal chemistry. It is found in six compounds on the market including the anthelmintic agents mebendazole and albendazole. In most compounds, the imidazole core is fused to a benzene ring and the free aminoimidazole motif is only found in one currently approved drug, benznidazole, for the treatment of Chagas disease.</div><div class="NLM_p">An interesting bioactivation pathway involving an imidazole was found during the discovery of inhibitors of the microsomal prostaglandin E synthase-1 enzyme (mPGES-1) for the treatment of osteoarthritis pain.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(16)</a> Two compounds (LY3031207 <b>19</b> and LY3023703 <b>20</b>) entered into the clinic but failed due to a significant increase in alanine aminotransferase (ALT) serum levels (a signature of liver toxicity) and hypersensitivity in a multiple ascending dose study.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(17)</a> Both compounds contain a 2-aminoimidazole moiety, which was found to undergo bioactivation.</div><div class="NLM_p">The proposed bioactivation pathway for LY3031207 originates with the P450 oxidation of <b>21</b> across the 4–5 double bond of the 2-aminoimidazole, which disrupts the aromaticity to form an epoxide intermediate (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). This intermediate (<b>22</b>) can rearomatize to generate hydroxylated metabolite <b>23</b>, or diol <b>24</b> can form through the addition of water. The epoxide is also susceptible to nucleophilic attack by GSH <b>25</b> followed by loss of water in the process of rearomatization to <b>27</b>. The diastereometric diol <b>24</b> can undergo ring scission analogous to the aminothiazole activation of sudoxicam<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(18)</a> with the loss of a glyoxal moiety, resulting in an acylguanidine metabolite <b>26</b> found in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The formation and detection of the acylguanidine metabolite were used as evidence that the epoxide intermediate was formed during further medicinal chemistry efforts.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Bioactivation Pathway for the Aminoimidazole in LY3031207 and LY3023703</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Metabolite identification experiments were performed on <i>in vivo</i> (rat, dog, and human plasma and human urine) and <i>in vitro</i> samples (hepatocytes and liver microsomes fortified with glutathione). Metabolite <b>23</b> was found across all species in hepatocytes and plasma as well as in human urine samples. Thioether adducts <b>27</b> were only found in HLM with GSH and in human urine. A compound corresponding to compound <b>25</b> was found in HLM with GSH. The acylguanidine metabolite <b>26</b> was found in dog hepatocytes and in plasma of rat, dog, and human as well as human urine.</div><div class="NLM_p">From a medicinal chemistry perspective, substitution on the imidazole did not change the bioactivation potential of these compounds. The bioactivation pathway for another substituted 2-aminoimidazole containing compound (LY3023703 <b>28</b>) was similar to that of LY3031207 with some potentially competing pathways. It is possible that oxidation of the methylated aminoimidazole <b>29</b> produces an imine methide metabolite <b>30</b> by hydrogen atom abstraction, followed by single electron oxidation (proposed by Rettie et al.) leading to glutathione adduct <b>31</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(19)</a></div><div class="NLM_p last">This example provides further evidence to the argument that reactive metabolites should be considered before starting expensive clinical trials, since the researchers knew these particular compounds formed RM but permitted the compound to enter the clinic. Though predicting DILI is not an easy task, it is important to check for reactive metabolites iteratively throughout the discovery process. As this example illustrates, discovery of the reactive metabolites was essential for informing clinicians on the need to dose-adjust to prevent adverse events.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Aliphatic Bioactivation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aliphatic groups exist on most drugs and have the potential to be hydroxylated by P450 enzymes. During the enzymatic reaction, the first step is hydrogen atom abstraction that generates a radical, enabling oxygen rebound to produce a hydroxylated metabolite. However, several examples exist in the literature where the P450-generated radical can escape the oxygen rebound step and bind to the inside of a binding pocket and cause inactivation of the enzyme (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(20,21)</a> In both of these mechanisms, it is suggested that bioactivation is achieved through a carbon-centered radical (<b>33a</b>, <b>37</b>, <b>38</b>) intermediate en route to the hydroxylated product. In the case of tacrine <b>32</b>, the 1-OH product <b>35</b> did not cause inactivation of the enzyme when a synthetic standard was incubated with HLM, suggesting the carbon-centered radical <b>33a</b>, carbocation <b>33b</b>, or perhaps the quinoline-imine <b>34</b> is the culprit in the inactivation process. In the case of phencyclidine, when a <i>para</i>-ketone substituent <b>40</b> was added to the cyclohexane ring of phencyclidine <b>36</b> to protect from oxidation, less inactivation of CYP2B6 was observed. It should be noted that multiple mechanisms of phencyclidine have been proposed<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(22−24)</a> including iminium formation and formation of a quinone methide intermediate, which could be the reason the keto group did not abolish TDI completely. Given this evidence, the bioactivation of aliphatic groups is possible if the carbon-centered radical can escape the oxygen rebound step in the binding pocket of CYP P450 enzymes.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Radical Formation during Aliphatic Hydroxylation by P450s</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cyclopropyl Group</h3><div class="NLM_p">The cyclopropyl ring has been extensively used as a motif to improve drug-like properties and is often employed in medicinal chemistry as a tool to achieve desirable ADME properties. Due to its characteristic ring strain, the cyclopropyl group has enhanced π character of its C–C bonds with both shorter and stronger C–H bonds, making hydrogen atom abstraction more energetically difficult compared to a methyl group. Furthermore, the cyclopropyl ring features a more pronounced three-dimensional character which results in disruption of planarity. Because of this enhanced three-dimensional and π character, cyclopropane-containing compounds can have improved properties ranging from higher aqueous solubility, bioavailability, and increased metabolic stability.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(25)</a> This motif is currently found in 60 FDA-approved drugs, ranging from small molecules to cyclic peptides. Of these, 23 have cyclopropyl rings directly bound to a nitrogen (see <b>41</b> and <b>44</b> as examples) and six are directly bound to the sulfur of a sulfonamide group (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a><b>42</b> for examples). According to DrugBank.com, there are 104 cyclopropyl-containing compounds at various stages in clinical trials with 81 at the preclinical stage. Of the top 200 best-selling drugs approved by the FDA, eight contained a cyclopropyl ring, clarifying that this synthon has demonstrated significant biological activity across various human diseases.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. FDA-approved drugs containing a cyclopropyl ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The bioactivation of cyclopropylamines has been well understood to proceed through a single electron transfer from the nitrogen resulting in the formation of a double bond or through hydrogen atom transfer at the α-carbon of the cyclopropyl group, deemed to be the possible mechanisms.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(26)</a> The mechanism of bioactivation described here proceeds through a different process since the α-carbon is substituted. Zhuo and co-workers employed the cyclopropyl group during the optimization of a series of hepatitis C virus NS5B inhibitors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(27)</a> The authors found that the cyclopropyl group <b>45</b> was being bioactivated by P450 enzymes (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). High resolution mass spectrometry and NMR spectroscopy were used to identify the site of metabolic activation, and it was confirmed that the cyclopropyl was oxidized by P450. Hydrogen abstraction of the cyclopropyl ring <b>45</b> mediated by P450 was hypothesized to be the first step of its bioactivation. The radical formed was proposed to rearrange to ring opened propenyl radicals <b>47</b> and <b>48</b>; these radicals could then react with inbound hydroxy radicals to produce the allylic alcohols <b>49</b> and <b>50</b>, primed for nucleophilic attack by glutathione <b>51</b> and <b>52</b> as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The authors also propose that the tertiary alcohol <b>50</b> may undergo elimination of a water molecule to form a carbonyl imine intermediate <b>53</b> which undergoes reductive conjugation with GSH to form <b>54</b> and <b>55</b>. Changing the cyclopropyl to a <i>gem</i>-dimethyl alleviated the bioactivation by making only small changes to the core of the molecule, maintaining potency. These molecules were devoid of reactive metabolite formation.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Bioactivation of the Cyclopropyl Group in HCV NS5B Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Azetidine</h3><div class="NLM_p">The azetidine ring has a long history in the medicinal chemistry design world, most notably within β-lactams found in antibiotic drugs. Azetidines also exist in the Janus kinase inhibitors, cobimetinib and baricitinib, and a lactam version also exists in the cholesterol lowering medication ezetimibe. Recently, Obach et al. investigated the use of azetidine as an isostere for piperidine in a 5HT-4 partial agonist series, in which the piperidine moiety was bioactivated to an iminium intermediate, causing internal cyclization.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(28)</a> During their investigation it was found that computationally the energy required for α-carbon hydrogen atom abstraction was significantly higher for azetidine <b>58</b> than for piperidine <b>56</b> or pyrrolidine <b>57</b> analogues as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The α-carbon hydrogen abstraction can lead to potentially reactive iminium metabolites. Given this favorable property, it is expected that azetidines are likely to appear in more medicinal chemistry efforts to reduce metabolic clearance and give favorable pharmacokinetic properties.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0004.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Use of azetidine as a more stable isostere of piperidine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During efforts to develop a sphingosine-1-phosphate-1 receptor agonist for organ transplant immunosuppression, a radiolabeled advanced candidate (MRL-A) <b>59</b>, containing an azetidine ring, was dosed to rats in a bile duct cannulated study.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(29)</a> During the metabolite identification process, evidence for the formation of reactive metabolites was found through covalent adduction to liver proteins. After digestion of liver proteins with nonspecific protease, the authors observed a lysine adduct <b>63</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). With the use of high resolution mass spectrometry and <sup>1</sup>H and <sup>13</sup>C NMR, the structure was determined to be a product of a ring-opened azetidine in a multistep process outlined in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. The authors proposed hemiaminal formation <b>60</b> followed by ring opening <b>61</b>. An additional desaturation step by P450 leads to intermediate <b>62</b>, an α,β unsaturated aldehyde, where lysine can then attack to form the imine <b>63</b>.</div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. P450 Based Bioactivation of the Azetidine in MRL-A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, a glutathione adduct was detected, confirmed by the high-resolution mass spectrum fragmentation pattern, which indicated addition of glutathione to the ring-opened azetidine <b>66</b>. The authors propose the aldehyde <b>61</b> will be reduced to the alcohol intermediate <b>64</b> which can be dehydrated yielding an α,β unsaturated carboxylic acid <b>65</b>. This intermediate is a good Michael acceptor and can produce the glutathione adduct <b>66</b>. Alternatively, a mechanism that involves coenzyme A and this carboxylic acid intermediate (a known structural alert) is discussed elsewhere.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(30)</a></div><div class="NLM_p">The azetidine-containing AZD1979 <b>67</b> is being developed as a melanin-concentrating hormone receptor 1 antagonist designed for the treatment of obesity, containing a spiro-moiety with an azetidine ring and an oxetane ring.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(31)</a> When radiolabeled [C<sup>14</sup>]-AZD-1979 was incubated with human liver S9 fraction in the presence of aminobenztriazole, a pan P450 inhibitor, seven metabolites were identified by liquid chromatography with radiometric detection. One metabolite (<b>59</b>) was characterized by high resolution mass spectrometry to be the <i>m</i>/<i>z</i> of AZD1979 with the addition of 307.0706 Da, consistent with the addition of glutathione. Three of the other metabolites were characterized as glutathione degradation products; cysteineglycinyl, cysteinyl, and the mercapturic acid-conjugated metabolites (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). Further investigations revealed that glutathione-<i>S</i>-tranferases (GSTs) were involved in the formation of the adduct by using chemical inhibitors and recombinant enzymes.</div><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Biotransformation of an Azetidine Ring by Glutathione Transferase</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The NADPH-independent formation of GSH adducts is an important finding for the safety profile of AZD1979. If the conjugation by GST is rapid, then the compound could facilitate the depletion of intracellular GSH and potentially lead to the loss of hepatic protection. Given these two examples of azetidine metabolism, it is important to work closely with metabolism scientists to ensure there are no surprises.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Ethylurea</h3><div class="NLM_p">Urea derivatives have played a useful role in drug discovery due to their strong hydrogen bonding potential with proteins and other targets. This feature makes them strong candidates for antibacterial, anticancer, and anticonvulsive drug therapies.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(35)</a> In general, linear methyl- and ethylureas are a topic of investigation because of their antiviral or antibacterial properties; however, they are usually more stable when incorporated into the backbone of a molecule due to their minimal hydrolysis compared to amide bonds. To the best of our knowledge, only two ethylureas (lisuride and celiprolol, both diethyl substituted) and two methylureas (ritonavir amd cariprazine, both monosubstituted) have been FDA-approved. Most FDA-approved compounds containing a urea are unsubstituted or cyclized within a ring system, or one nitrogen is part of a sulfonamide moiety. This could be due to the fact that ethylureas have been identified as potential culprits in RM formation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(33)</a> In previous work, ethyl- and methylureas have been considered mutagenic, which could be a reason they are utilized to a lesser extent as substituents in drug scaffolds.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(32)</a> Another possible explanation for the lack of unsubstituted ethylurea being used in drugs scaffolds is the potential to solvate with water by hydrogen bonds and cause poor membrane permeability.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(34)</a></div><div class="NLM_p">In a series of antibacterial benzimidazole ureas, Grillot et al. found their lead compound <b>70</b> was covalently binding to liver proteins <i>in vivo</i> and <i>in vitro</i>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(33)</a> They uncovered a −2 amu metabolite on the ethylurea motif and proposed that an aliphatic carbon on the ethylurea underwent α-hydroxylation <b>71</b> as shown in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>. Consequently, the hydroxylated metabolite loses water and forms an imine intermediate <b>72</b>. This mechanism is mediated by CYP3A4, CYP1A2, and CYP2D6. After attempting to replace the ethylurea with several isosteres unsuccessfully, the authors planned a metabolic shift strategy by adding metabolic “soft spots” or easily metabolized groups (1-pyrazole <b>75</b> and 2-tetrahydrofuran <b>74</b>) as substituents to the benzimidazole. From a medicinal chemistry perspective, both substituents maintain the necessary intramolecular forces for ligand preorganization and planarity, two properties that increased the binding affinity of the compounds. Both substituents also exhibit lower clogP values, a favorable property due to the correlation between high clogP values and increased toxicity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(35)</a></div><figure id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Proposed Bioactivation Pathway of Ethylurea</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Dealkylation to Problematic Aldehydes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dealkylation reactions occur when hydroxylation by P450 ensues α to a heteroatom (O, N, S of <b>76</b>), usually resulting in smaller, more easily excretable metabolites. The instability of a hemiaminal, hemiacetyl, or sulfur and oxygen bound to the same carbon <b>77</b> will cause the heteroatom–carbon bond to break (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>) resulting in XH <b>78</b> and an aldehyde. This aldehyde <b>79</b> is usually further metabolized to the benign alcohol <b>81</b> or a carboxylic acid <b>80</b>, though there are cases where aldehyde formation turns out to be toxic.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(38)</a> The local chemical environment of the aldehyde resulting from this mechanism plays an important role in its resulting reactivity.</div><figure id="sch10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Dealkylation Reaction by P450 Resulting in Aldehyde Formation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As an example, terbinafine <b>82</b> was found to undergo N-dealkylation to produce a reactive aldehyde <b>83</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(37)</a> The authors noted this unsaturated aldehyde is a Michael acceptor and reacted with GSH by either a 1,4- <b>84</b> or 1,6-addition <b>85</b> to form two adducts (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>). The case of terbinafine may be extreme with the formation of the Michael acceptor as a byproduct of the dealkylation, and similar results were found with other α,β-unsaturated carbonyl derivatives with varying side groups.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(38)</a> Their work found that short chain aldehydes and longer alkanals were hard electrophiles (see compound <b>86</b> as an example), and amino acid residues such as lysine <b>87</b> could be biological targets resulting in Schiff base products <b>88</b>. The carbon–carbon double bond in α,β-unsaturated carbonyl derivatives such as alkenals and α-oxoaldehydes are softer electrophiles (see <b>89</b> as an example compound) and will likely target cysteine <b>90</b> residues leading to Michael addition product <b>91</b> (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>). When the reactivity of aldehydes resulting from N-dealkylation reactions was assessed through computational methods, the authors suggested a novel explanation for the hepatoxicity of several FDA-approved drugs including indinavir, piperacillin, verapamil, and ziprasidone.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(36)</a> According to the computational model, the aldehydes formed from the dealkylation reaction of these compounds were more reactive than the parent and all the other reported metabolites (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>).</div><figure id="sch11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Bioactivation of the Reactive Aldehyde Formed from Terbinafine N-Dealkylation (A) and Reactivity of Alkanals and Alkenals with Lysine and Cysteine (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Formation of Aldehydes from Drugs Associated with Hepatotoxicity</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The examples presented herein aim to highlight the importance of working closely with metabolism scientists during the initial drug discovery process, since no compound or moiety can be assumed to be benign or “safe.” Time-dependent inhibition experiments are crucial to determine if reactive metabolites are formed, while well thought-out metabolite identification experiments can help to identify the substructures responsible for RM formation. This close relationship between chemist and metabolism scientists will prove invaluable and should serve to decrease the potential for DILI in the clinic. Nevertheless, the avoidance of structural alerts in drug design is still warranted and medicinal chemistry approaches to evade bioactivation have been nicely outlined.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(39)</a> This review summarized several presumed moieties that, given their chemical context, were bioactivated and led to <i>in vivo</i> or <i>in vitro</i> complications. It should be noted that even if a compound is bioactivated to a reactive intermediate and the compound binds to liver protein, it does not necessarily mean the compound will be toxic, and oftentimes covalent binding studies alone cannot distinguish toxic from nontoxic drugs.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(40)</a> Prediction methods for determining if covalent binding will have an effect and cause idiosyncratic adverse drug reactions have improved, and daily covalent binding burden should be taken into account.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(41)</a> For the medicinal chemist and DMPK scientist, a strong alliance should be formed to evaluate presumably safe functional groups within their specified molecular context so that the most effective and least harmful therapies make it to the clinic. We do not however recommend these motifs to be included as structural alerts since the bioactivation seems to be rare; however, we do recommend checking for bioactivation on lead compounds advancing along the drug discovery pipeline. With this in mind, we have no doubt that the development of small molecule drugs with improved safety profiles will continue to improve as long as we continue to expect the unexpected for the sake of making safer drugs.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1"><span class="title" id="d72303252e812">Author Contributions</span><p class="last">The manuscript was written through contributions of all authors. J.P.D conceptualized manuscript and performed writing. All authors have given approval to the final version of the manuscript.</p></div><div class="NLM_notes" id="notes-2"><p class="first last">The authors declare the following competing financial interest(s): J.P.D., C.M.S., A.F., and N.R.S. were employed by MyoKardia, Inc. at the time this manuscript was written.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00026" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James P. Driscoll</span> - <span class="hlFld-Affiliation affiliation">MyoKardia, Inc., 333 Allerton Avenue, South
San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3736-1673" title="Orcid link">http://orcid.org/0000-0002-3736-1673</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89e3edfbe0faeae6e5e5c9e4f0e6e2e8fbede0e8a7eae6e4"><span class="__cf_email__" data-cfemail="85efe1f7ecf6e6eae9e9c5e8fceaeee4f7e1ece4abe6eae8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corinne M. Sadlowski</span> - <span class="hlFld-Affiliation affiliation">MyoKardia, Inc., 333 Allerton Avenue, South
San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina R. Shah</span> - <span class="hlFld-Affiliation affiliation">MyoKardia, Inc., 333 Allerton Avenue, South
San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Feula</span> - <span class="hlFld-Affiliation affiliation">MyoKardia, Inc., 333 Allerton Avenue, South
San Francisco, California 94080, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. J.P.D conceptualized manuscript and performed writing. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare the following competing financial interest(s): J.P.D., C.M.S., A.F., and N.R.S. were employed by MyoKardia, Inc. at the time this manuscript was written.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="17" class="article__inlineFigure"><h2 class="fig-label">James P. Driscoll</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=BIO-d7e912-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>James P. Driscoll</b> is an accomplished Senior Scientist and Project Team Leader in the Drug Metabolism and Pharmacokinetics department at MyoKardia, Inc, a clinical stage biopharmaceutical company focused on genetic heart disease. He has over 17 years of industry experience with Pfizer, Genentech, and Theravance and has coauthored over 20 publications spanning topics from medicinal chemistry to mechanistic ADME. His expertise includes reactive metabolite identification, drug metabolism, and drug design. His responsibilities include driving early stage projects forward by identifying structure–activity relationships, avoiding off-target toxicity, interrogating potential new targets in drug discovery, and leading a team focused on <i>in vitro</i> compound optimization. James received his B.S. in Human Biology from the State University of New York at Albany.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Corinne M. Sadlowski</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=BIO-d7e920-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Corinne M. Sadlowski</b> received her undergraduate degree from the University of New Hampshire and her Ph.D. in Organic Chemistry from the University of Vermont, where she worked on the total synthesis of indole alkaloids. Dr. Sadlowski then moved to the University of California, Berkeley for a postdoctoral fellowship, where her research focused on the synthesis of new antibiotic agents and drug delivery vehicles for improving gene therapies. Corinne currently works as a medicinal chemist on targeted therapies in heart disease at MyoKardia, Inc.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Nina R. Shah</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=BIO-d7e925-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nina R. Shah</b> is currently a member of the Drug Metabolism and Pharmacokinetics department at MyoKardia, Inc. She leads the <i>in vitro</i> suite of ADME assays, including metabolic stability, competitive CYP inhibition, and plasma protein binding. Nina’s research interests include the use of traditional ADME techniques, combined with analytical instrumentation, to study the intersection of biotransformation, bioactivation, and drug-induced liver injury (DILI). She routinely experiments with reactive metabolite trapping, metabolite identification, and structure–activity/toxicity relationships to understand the mechanisms of drugs known to cause idiosyncratic adverse drug reactions. Nina received her B.S. in Biochemistry from California Polytechnic State University in San Luis Obispo, CA, where she researched the role of actinomycetes in the production of antibiotics.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Antonio Feula</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=BIO-d7e933-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Antonio Feula</b> received his M.S. in Organic and Biomolecular Chemistry from Sapienza University of Rome and went on to complete his Ph.D. in Organic Chemistry at the University of Birmingham where he worked on the synthesis of azetidines and pyrrolidines. He then performed his postdoctoral studies at the University of Reading in collaboration with the University of Oxford working on the synthesis and characterization of self-healable polyurethanes and organic synthesis of self-immolative systems for the disclosure of reactive electrophilic alkylating agents. Following his postdoc, Antonio spent a short time at Merck in their Process Chemistry Department and then moved on to Orthobond where he worked on surface chemistry. He is now part of the Medicinal Chemistry department as a scientist at MyoKardia, Inc.</p></figure></div><div class="ack" id="ACK-d7e944-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Sheerin Shahi-Latham for editorial comment and review of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">RM</td><td class="NLM_def"><p class="first last">reactive metabolite</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenosine diphosphate reduced</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">LC–MS-UV</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry ultraviolet detection</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">Evaluation of DILI Predictive Hypotheses in Early Drug Development</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Knu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=1017-1029&issue=4&author=R.+Chanauthor=L.+Z.+Benet&title=Evaluation+of+DILI+Predictive+Hypotheses+in+Early+Drug+Development&doi=10.1021%2Facs.chemrestox.7b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of DILI Predictive Hypotheses in Early Drug Development</span></div><div class="casAuthors">Chan, Rosa; Benet, Leslie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals.  DILI has been shown to be dependent on both daily dose and extent of hepatic metab.  Yet, early in drug development daily dose is unknown.  Here, we perform a comprehensive anal. of the published hypotheses that attempt to predict DILI, including a new anal. of the Biopharmaceutics Drug Disposition Classification System (BDDCS) in evaluating the severity of DILI warnings in drug labels approved by the FDA and the withdrawal status due to adverse drug reactions (ADRs).  Our anal. confirms that higher doses ≥50 mg/day lead to increased DILI potential, but this property alone is not sufficient to predict the DILI potential.  We evaluate prior attempts to categorize DILI such as Rule of 2, BSEP inhibition, and measures of key mechanisms of toxicity compared to BDDCS classification.  Our results show that BDDCS Class 2 drugs exhibit the highest DILI severity and that all of the published methodologies evaluated here, except when daily dose is known, do not yield markedly better predictions than BDDCS.  The assertion that extensive metabolized compds. are at higher risk of developing DILI is confirmed but can be enhanced by differentiating BDDCS Class 2 from Class 1 drugs.  We do not propose that the BDDCS classification, which does not require knowledge of the clin. dose, is sufficiently predictive/accurate of DILI potential for new mol. entities but suggest that comparison of proposed DILI prediction methodologies with BDDCS classification is a useful tool to evaluate the potential reliability of newly proposed algorithms.  Conclusion: The most successful approaches to predict DILI potential all include a measure of dose, yet there is a quantifiable uncertainty assocd. with the predicted dose early in drug development.  Here, we compare the possibility of predicting DILI potential using the BDDCS classification vs. previously published methods and note that many hypothesized predictive DILI metrics do no better than just avoiding BDDCS Class 2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwMFj2kgoGErVg90H21EOLACvtfcHk0liwY90MzT0EBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Knu7s%253D&md5=27c6448357f8e7c862a7d8cfc7d033aa</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00025%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DEvaluation%2520of%2520DILI%2520Predictive%2520Hypotheses%2520in%2520Early%2520Drug%2520Development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26issue%3D4%26spage%3D1017%26epage%3D1029%26doi%3D10.1021%2Facs.chemrestox.7b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span> <span> </span><span class="NLM_article-title">Moving Beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) Towards Contrasting Relative Risk Potential</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.9b00262</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.9b00262" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslyqs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2020&pages=223-238&author=M.+D.+Aleoauthor=F.+Shahauthor=S.+Allenauthor=H.+A.+Bartonauthor=C.+Costalesauthor=S.+Lazzaroauthor=L.+Leungauthor=A.+Nilsonauthor=R.+S.+Obachauthor=A.+D.+Rodriguesauthor=Y.+Will&title=Moving+Beyond+Binary+Predictions+of+Human+Drug-Induced+Liver+Injury+%28DILI%29+Towards+Contrasting+Relative+Risk+Potential&doi=10.1021%2Facs.chemrestox.9b00262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential</span></div><div class="casAuthors">Aleo, Michael D.; Shah, Falgun; Allen, Scott; Barton, Hugh A.; Costales, Chester; Lazzaro, Sarah; Leung, Louis; Nilson, Andrea; Obach, R. Scott; Rodrigues, A. David; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-238</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatic risk matrix (HRM) was developed and used to differentiate lead clin. and back-up drug candidates against competitor/marketed drugs within the same pharmaceutical class for their potential to cause human drug-induced liver injury (DILI).  The hybrid HRM scoring system blends physicochem. properties (Rule of Two Model: dose and lipophilicity or Partition Model: dose, ionization state, lipophilicity, and carbon bond satn.) with common toxicity mechanisms (cytotoxicity, mitochondrial dysfunction, and bile salt export pump (BSEP) inhibition) that promote DILI.  HRM scores are based on bracketed safety margins (<1, 1-10, 10-100, and >100x of clin. Cmax,total. Based on well-established clin. safety experience of marketed/withdrawn drug candidates, the background anal. consists of 200 drugs from the Liver Toxicity Knowledge Base annotated as Most-DILI- (79), Less-DILI- (56), No-DILI- (47) and Ambiguous-DILI-concern (18) drugs.  Scores were generated for over 21 internal and 7 external drug candidates discontinued for unacceptable incidence/magnitude of liver transaminase elevations during clin. trials or withdrawn for liver injury severity.  Both hybrid scoring systems identified 70-80% Most-DILI-concern drugs, but more importantly stratified successful/unsuccessful drug candidates for liver safety (incidence/severity of transaminase elevations and approved drug labels).  Incorporating other mechanisms (reactive metabolite and cytotoxic metabolite generation and hepatic efflux transport inhibition, other than BSEP) to the HRM had minimal beneficial impact in DILI prediction/stratification.  As is, the hybrid scoring system was positioned for portfolio assessments to contrast DILI risk potential of small mol. drug candidates in early clin. development.  This stratified approach for DILI prediction aided decisions regarding drug candidate progression, back-up selection, clin. dose selection, and due diligence assessments in favor of compds. with less implied clin. hepatotoxicity risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxpXYcWnTspbVg90H21EOLACvtfcHk0lg2YhVNZFtE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslyqs7nM&md5=00852b0e8f03e7813e90f6f29c507d0e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.9b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.9b00262%26sid%3Dliteratum%253Aachs%26aulast%3DAleo%26aufirst%3DM.%2BD.%26aulast%3DShah%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DLazzaro%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DNilson%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DMoving%2520Beyond%2520Binary%2520Predictions%2520of%2520Human%2520Drug-Induced%2520Liver%2520Injury%2520%2528DILI%2529%2520Towards%2520Contrasting%2520Relative%2520Risk%2520Potential%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2020%26volume%3D33%26spage%3D223%26epage%3D238%26doi%3D10.1021%2Facs.chemrestox.9b00262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span> <span> </span><span class="NLM_article-title">High Lipophilicity and High Daily Dose of Oral Medications Are Associated with Significant Risk for Drug-Induced Liver Injury</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1002/hep.26208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1002%2Fhep.26208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=23258593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=388-396&issue=1&author=M.+Chenauthor=J.+Borlakauthor=W.+Tong&title=High+Lipophilicity+and+High+Daily+Dose+of+Oral+Medications+Are+Associated+with+Significant+Risk+for+Drug-Induced+Liver+Injury&doi=10.1002%2Fhep.26208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span></div><div class="casAuthors">Chen, Minjun; Borlak, Juergen; Tong, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals from the market.  Although there is evidence that dosages of ≥100 mg/day are assocd. with increased risk for hepatotoxicity, many drugs are safe at such dosages.  There is an unmet need to predict risk for DILI more reliably, and lipophilicity might be a contributing factor.  We analyzed the combined factors of daily dose and lipophilicity for 164 US Food and Drug Administration-approved oral medications and obsd. high risk for hepatotoxicity (odds ratio [OR], 14.05; P < 0.001) for drugs given at dosages ≥100 mg/day and octanol-water partition coeff. (logP) ≥3.  This defined the "rule-of-two.".  Similar results were obtained for an independent set of 179 oral medications with 85% of the rule-of-two positives being assocd. with hepatotoxicity (OR, 3.89; P < 0.01).  Using the World Health Organization's Anatomical Therapeutic Chem. classification system, the rule-of-two performed best in predicting DILI in seven therapeutic categories.  Among 15 rule-of-two positives, 14 were withdrawn from hepatotoxic drugs, and one was over-the-counter medication labeled for liver injury.  We addnl. examd. drug pairs that have similar chem. structures and act on the same mol. target but differ in their potential for DILI.  Again, the rule-of-two predicted hepatotoxicity reliably.  Finally, the rule-of-two was applied to clin. case studies to identify hepatotoxic drugs in complex comedication regimes to further demonstrate its use.  Conclusion: Apart from dose, lipophilicity contributes significantly to risk for hepatotoxicity.  Applying the rule-of-two is an appropriate means of estg. risk for DILI compared with dose alone. (HEPATOl. 2013).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EE02L_JCdLVg90H21EOLACvtfcHk0lg2YhVNZFtE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM&md5=a88e02ff29653bdeee53b59a4da46d06</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fhep.26208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DW.%26atitle%3DHigh%2520Lipophilicity%2520and%2520High%2520Daily%2520Dose%2520of%2520Oral%2520Medications%2520Are%2520Associated%2520with%2520Significant%2520Risk%2520for%2520Drug-Induced%2520Liver%2520Injury%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26issue%3D1%26spage%3D388%26epage%3D396%26doi%3D10.1002%2Fhep.26208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Limban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuţă, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiriţă, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negreş, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsene, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goumenou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakitsios, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsakis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarigiannis, D. A.</span></span> <span> </span><span class="NLM_article-title">The Use of Structural Alerts to Avoid the Toxicity of Pharmaceuticals</span>. <i>Toxicology Reports</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1016/j.toxrep.2018.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1016%2Fj.toxrep.2018.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=30258789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=943-953&author=C.+Limbanauthor=D.+C.+Nu%C5%A3%C4%83author=C.+Chiri%C5%A3%C4%83author=S.+Negre%C5%9Fauthor=A.+L.+Arseneauthor=M.+Goumenouauthor=S.+P.+Karakitsiosauthor=A.+M.+Tsatsakisauthor=D.+A.+Sarigiannis&title=The+Use+of+Structural+Alerts+to+Avoid+the+Toxicity+of+Pharmaceuticals&doi=10.1016%2Fj.toxrep.2018.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The use of structural alerts to avoid the toxicity of pharmaceuticals</span></div><div class="casAuthors">Limban, Carmen; Nuta, Diana C.; Chirita, Cornel; Negres, Simona; Arsene, Andreea L.; Goumenou, Marina; Karakitsios, Spyros P.; Tsatsakis, Aristidis M.; Sarigiannis, Dimosthenis A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">943-953</span>CODEN:
                <span class="NLM_cas:coden">TROEF9</span>;
        ISSN:<span class="NLM_cas:issn">2214-7500</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In order to identify compds. with potential toxicity problems, particular attention is paid to structural alerts, which are high chem. reactivity mol. fragments or fragments that can be transformed via bioactivation by human enzymes into fragments with high chem. reactivity.  The concept has been introduced in order to reduce the likelihood that future candidate substances as pharmaceuticals will have undesirable toxic effects.  A significant proportion (∼78-86%) of drugs characterized by residual toxicity contain structural alerts; there is also evidence indicating the formation of active metabolites as a causal factor for the toxicity of 62-69% of these mols.  On the other hand, the pharmacol. action of certain drugs depends on the formation of reactive metabolites.  Detailed assessment of the potential for the formation of active metabolites is recommended to characterize a biol. active compd.  Although many prescribed drugs frequently contain structural alerts and form reactive metabolites, the vast majority of these drugs are administered in low daily doses.  Avoiding structural alerts has become almost a norm in new drug design.  An in-depth review of the biochem. reactivity of these structural alerts for new drug candidates is crit. from a safety point of view and is currently being monitored in the discovery of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo166eMQmr1e7Vg90H21EOLACvtfcHk0lg2YhVNZFtE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrnN&md5=28743dd8412732377d245375a4da3dc6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.toxrep.2018.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxrep.2018.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DLimban%26aufirst%3DC.%26aulast%3DNu%25C5%25A3%25C4%2583%26aufirst%3DD.%2BC.%26aulast%3DChiri%25C5%25A3%25C4%2583%26aufirst%3DC.%26aulast%3DNegre%25C5%259F%26aufirst%3DS.%26aulast%3DArsene%26aufirst%3DA.%2BL.%26aulast%3DGoumenou%26aufirst%3DM.%26aulast%3DKarakitsios%26aufirst%3DS.%2BP.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26aulast%3DSarigiannis%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Use%2520of%2520Structural%2520Alerts%2520to%2520Avoid%2520the%2520Toxicity%2520of%2520Pharmaceuticals%26jtitle%3DToxicology%2520Reports%26date%3D2018%26volume%3D5%26spage%3D943%26epage%3D953%26doi%3D10.1016%2Fj.toxrep.2018.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claesson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minidis, A.</span></span> <span> </span><span class="NLM_article-title">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1Wkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=389-411&issue=6&author=A.+Claessonauthor=A.+Minidis&title=Systematic+Approach+to+Organizing+Structural+Alerts+for+Reactive+Metabolite+Formation+from+Potential+Drugs&doi=10.1021%2Facs.chemrestox.8b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs</span></div><div class="casAuthors">Claesson, Alf; Minidis, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">389-411</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Reactive metabolites are widely accepted as playing a pivotal role in causing idiosyncratic adverse drug reactions (IDR).  However, much is unknown about the biol. mechanisms of IDR although the initiating event in most cases is an attachment of a reactive intermediate to macromols. leading to immune mediated responses.  Reactive metabolites are also involved in many mutagenesis/ carcinogenesis events by reacting with DNA.  Drug designers thus have all reasons to make large efforts to avoid making test compds. having a liability to generate reactive metabolites.  In this Perspective the authors argue for using structural alerts (SA) as the most straightforward way to link forecasting about chem. hazards of planned test compds. to the accumulated knowledge base.  Although many SAs have been widely recognized and reviewed previously, there are also a lot of observations that have no readily discernable chem. interpretation.  For drug designers to benefit from all published data, the knowledge has to be organized in a way that is readily searchable starting with a query structure.  The authors propose that an increased no. of structural alerts with more details should be applied to obtain improved decision support.  The assocn. of selected SAs with ref. drugs, whose proposed or hypothesized activation mechanisms build the knowledge base, should be readily available in a format comprising of small summaries with included hyperlinks for quick access to the original literature, as outlined in the TOC illustration.  Since some structural alerts are present in drugs that do not cause idiosyncratic adverse reactions or drug-drug interactions, it is important to elaborate on the reasons for this discrepancy as much as possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TRDGoBo8FLVg90H21EOLACvtfcHk0lgkO24GJP8Omw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1Wkurw%253D&md5=8822e32efecbf62c90d62ba5dacfda63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00046%26sid%3Dliteratum%253Aachs%26aulast%3DClaesson%26aufirst%3DA.%26aulast%3DMinidis%26aufirst%3DA.%26atitle%3DSystematic%2520Approach%2520to%2520Organizing%2520Structural%2520Alerts%2520for%2520Reactive%2520Metabolite%2520Formation%2520from%2520Potential%2520Drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D6%26spage%3D389%26epage%3D411%26doi%3D10.1021%2Facs.chemrestox.8b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallqvist, A.</span></span> <span> </span><span class="NLM_article-title">Data-Driven Identification of Structural Alerts for Mitigating the Risk of Drug-Induced Human Liver Injuries</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/s13321-015-0053-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1186%2Fs13321-015-0053-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVakur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=4&issue=1&author=R.+Liuauthor=X.+Yuauthor=A.+Wallqvist&title=Data-Driven+Identification+of+Structural+Alerts+for+Mitigating+the+Risk+of+Drug-Induced+Human+Liver+Injuries&doi=10.1186%2Fs13321-015-0053-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries</span></div><div class="casAuthors">Liu, Ruifeng; Yu, Xueping; Wallqvist, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4/1-4/8</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: The use of structural alerts to de-prioritize compds. with undesirable features as drug candidates has been gaining in popularity.  Hundreds of mol. structural moieties have been proposed as structural alerts.  An emerging issue is that strict application of these alerts will result in a significant redn. of the chem. space for new drug discovery, as more than half of the oral drugs on the market match at least one of the alerts.  To mitigate this issue, we propose to apply a rigorous statistical anal. to derive/validate structural alerts before use.  Method: To derive human liver toxicity structural alerts, we retrieved all small-mol. entries from LiverTox, a U.S.  National Institutes of Health online resource for information on human liver injuries induced by prescription and over-the-counter drugs and dietary supplements.  We classified the compds. into hepatotoxic, nonhepatotoxic, and possible hepatotoxic classes, and performed detailed statistical analyses to identify mol. structural fragments highly enriched in the hepatotoxic class beyond random distribution as structural alerts for human liver injuries.  Results: We identified 12 mol. fragments present in multiple marketed drugs that one can consider as common "drug-like" fragments, yet they are strongly assocd. with drug-induced human liver injuries.  Thus, these fragments may be considered as robust hepatotoxicity structural alerts suitable for use in drug discovery screening programs.  Conclusions: The use of structural alerts has contributed to the identification of many compds. with potential toxicity issues in modern drug discovery.  However, with a large no. of structural alerts published to date without proper validation, application of these alerts may restrict the chem. space and prevent discovery of valuable drugs.  To mitigate this issue, we showed how to use statistical analyses to develop a small, robust, and broadly applicable set of structural alerts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGSOZp-sLIIbVg90H21EOLACvtfcHk0lgkO24GJP8Omw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVakur0%253D&md5=468b141b02779bfdb9a74e8a203ca24f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13321-015-0053-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-015-0053-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWallqvist%26aufirst%3DA.%26atitle%3DData-Driven%2520Identification%2520of%2520Structural%2520Alerts%2520for%2520Mitigating%2520the%2520Risk%2520of%2520Drug-Induced%2520Human%2520Liver%2520Injuries%26jtitle%3DJ.%2520Cheminf.%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D4%26doi%3D10.1186%2Fs13321-015-0053-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkata, K. C. N.</span></span> <span> </span><span class="NLM_article-title">Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice</span>. <i>Pharmacy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">43</span>, <span class="refDoi"> DOI: 10.3390/pharmacy6020043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.3390%2Fpharmacy6020043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=43&issue=2&author=A.+V.+Fuentesauthor=M.+D.+Pinedaauthor=K.+C.+N.+Venkata&title=Comprehension+of+Top+200+Prescribed+Drugs+in+the+US+as+a+Resource+for+Pharmacy+Teaching%2C+Training+and+Practice&doi=10.3390%2Fpharmacy6020043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fpharmacy6020043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmacy6020043%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes%26aufirst%3DA.%2BV.%26aulast%3DPineda%26aufirst%3DM.%2BD.%26aulast%3DVenkata%26aufirst%3DK.%2BC.%2BN.%26atitle%3DComprehension%2520of%2520Top%2520200%2520Prescribed%2520Drugs%2520in%2520the%2520US%2520as%2520a%2520Resource%2520for%2520Pharmacy%2520Teaching%252C%2520Training%2520and%2520Practice%26jtitle%3DPharmacy%26date%3D2018%26volume%3D6%26issue%3D2%26spage%3D43%26doi%3D10.3390%2Fpharmacy6020043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlap, T.</span></span> <span> </span><span class="NLM_article-title">Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=13-37&issue=1&author=J.+L.+Boltonauthor=T.+Dunlap&title=Formation+and+Biological+Targets+of+Quinones%3A+Cytotoxic+versus+Cytoprotective+Effects&doi=10.1021%2Facs.chemrestox.6b00256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects</span></div><div class="casAuthors">Bolton, Judy L.; Dunlap, Tareisha</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-37</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Quinones represent a class of toxicol. intermediates, which can create a variety of hazardous effects in vivo including, acute cytotoxicity, immunotoxicity, and carcinogenesis.  In contrast, quinones can induce cytoprotection through induction of detoxification enzymes, anti-inflammatory activities, and modification of redox status.  The mechanisms by which quinones cause these effects can be quite complex.  The various biol. targets of quinones depend on their rate and site of formation and their reactivity.  Quinones are formed through a variety of mechanisms from simple oxidn. of catechols/hydroquinones catalyzed by a variety of oxidative enzymes and metal ions to more complex mechanisms involving initial P 450-catalyzed hydroxylation reactions followed by two-electron oxidn.  Quinones are Michael acceptors and modification of cellular processes could occur through alkylation of crucial cellular proteins and/or DNA.  Alternatively, quinones are highly redox active mols. which can redox cycle with their semiquinone radical anions leading to formation of reactive oxygen species (ROS) including superoxide, hydrogen peroxide, and ultimately the hydroxyl radical.  Prodn. of ROS can alter redox balance within cells through the formation of oxidized cellular macromols. including lipids, proteins, and DNA.  This perspective explores the varied biol. targets of quinones including GSH, NADPH, protein sulfhydryls [heat shock proteins, P 450, cyclooxygenase-2 (COX-2), glutathione S-transferase (GST), NAD(P)H:quinone oxidoreductase 1, (NQO1), kelch-like ECH-assocd. protein 1 (Keap1), IκB kinase (IKK), arylhydrocarbon receptor (AhR)], and DNA.  The evidence strongly suggests that the numerous mechanisms of quinone modulations (i.e., alkylation vs. oxidative stress) can be correlated with the known pathol./cytoprotection of the parent compd.(s) that is best described by an inverse U-shaped dose-response curve.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSxHXZNZr3cbVg90H21EOLACvtfcHk0lgkO24GJP8Omw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtb7P&md5=a8dfdbd1e5b6d7bc016a97aca34e6c5a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00256%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DJ.%2BL.%26aulast%3DDunlap%26aufirst%3DT.%26atitle%3DFormation%2520and%2520Biological%2520Targets%2520of%2520Quinones%253A%2520Cytotoxic%2520versus%2520Cytoprotective%2520Effects%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26issue%3D1%26spage%3D13%26epage%3D37%26doi%3D10.1021%2Facs.chemrestox.6b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foitzik, R.</span></span> <span> </span><span class="NLM_article-title">Evidence for the <i>in Vitro</i> Bioactivation of Aminopyrazole Derivatives: Trapping Reactive Aminopyrazole Intermediates Using Glutathione Ethyl Ester in Human Liver Microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1747</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWitb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=1747-1752&issue=9&author=E.+Ryanauthor=B.+Morrowauthor=C.+Hemleyauthor=J.+Pinsonauthor=S.+Charmanauthor=F.+Chiuauthor=R.+Foitzik&title=Evidence+for+the+in+Vitro+Bioactivation+of+Aminopyrazole+Derivatives%3A+Trapping+Reactive+Aminopyrazole+Intermediates+Using+Glutathione+Ethyl+Ester+in+Human+Liver+Microsomes&doi=10.1021%2Facs.chemrestox.5b00202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the in Vitro Bioactivation of Aminopyrazole Derivatives: Trapping Reactive Aminopyrazole Intermediates Using Glutathione Ethyl Ester in Human Liver Microsomes</span></div><div class="casAuthors">Ryan, Eileen; Morrow, Benjamin J.; Hemley, Catherine F.; Pinson, Jo-Anne; Charman, Susan A.; Chiu, Francis C. K.; Foitzik, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1747-1752</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced toxicity is a leading cause of drug withdrawal from clin. development and clin. use and represents a major impediment to the development of new drugs.  The mechanisms underlying drug-induced toxicities are varied; however, metabolic bioactivation to form reactive metabolites has been identified as a major contributor.  These electrophilic species can covalently modify important biol. macromols. and thereby increase the risk of adverse drug reactions or idiosyncratic toxicity.  Consequently, screening compds. for their propensity to form reactive metabolites has become an integral part of drug discovery programs.  This screening process typically involves identification of structural alerts as well as the generation of reactive metabolites in vitro in subcellular hepatic fractions, followed by trapping the reactive species with nucleophiles and characterization via LC-MS.  This article presents evidence for the bioactivation of a series of aminopyrazole derivs. via LC-MS detection of glutathione Et ester-trapped reactive intermediates formed in human liver microsomal incubations.  These results indicate that the aminopyrazole motif, within specific contexts, may be considered a new structural alert for the potential formation of reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLgkp20tGk7Vg90H21EOLACvtfcHk0ljKpBsdJVeJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWitb7J&md5=fde6656778dfcd6dfb6d14cc5e3a2b9c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00202%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DMorrow%26aufirst%3DB.%26aulast%3DHemley%26aufirst%3DC.%26aulast%3DPinson%26aufirst%3DJ.%26aulast%3DCharman%26aufirst%3DS.%26aulast%3DChiu%26aufirst%3DF.%26aulast%3DFoitzik%26aufirst%3DR.%26atitle%3DEvidence%2520for%2520the%2520in%2520Vitro%2520Bioactivation%2520of%2520Aminopyrazole%2520Derivatives%253A%2520Trapping%2520Reactive%2520Aminopyrazole%2520Intermediates%2520Using%2520Glutathione%2520Ethyl%2520Ester%2520in%2520Human%2520Liver%2520Microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D9%26spage%3D1747%26epage%3D1752%26doi%3D10.1021%2Facs.chemrestox.5b00202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&issue=9&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+Necessary+Nitrogen+Atom%3A+A+Versatile+High-Impact+Design+Element+for+Multiparameter+Optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0ljKpBsdJVeJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520Necessary%2520Nitrogen%2520Atom%253A%2520A%2520Versatile%2520High-Impact%2520Design%2520Element%2520for%2520Multiparameter%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lame, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soglia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendsch, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.C. A.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of the Nontricyclic Antidepressant Nefazodone to a Reactive Quinone-Imine Species in Human Liver Microsomes and Recombinant Cytochrome P450 3A4</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.104.001735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15523046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=243-253&issue=2&author=A.+S.+Kalgutkarauthor=A.+D.+N.+Vazauthor=M.+E.+Lameauthor=K.+R.+Henneauthor=J.+Sogliaauthor=S.+X.+Zhaoauthor=Y.+A.+Abramovauthor=F.+Lombardoauthor=C.+Collinauthor=Z.+S.+Hendschauthor=C.+E.C.+A.+Hop&title=Bioactivation+of+the+Nontricyclic+Antidepressant+Nefazodone+to+a+Reactive+Quinone-Imine+Species+in+Human+Liver+Microsomes+and+Recombinant+Cytochrome+P450+3A4&doi=10.1124%2Fdmd.104.001735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4</span></div><div class="casAuthors">Kalgutkar, Amit S.; Vaz, Alfin D. N.; Lame, Mary E.; Henne, Kirk R.; Soglia, John; Zhao, Sabrina X.; Abramov, Yuri A.; Lombardo, Franco; Collin, Claire; Hendsch, Zachary S.; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The therapeutic benefits of the antidepressant nefazodone have been hampered by several cases of acute hepatotoxicity/liver failure.  Although the mechanism of hepatotoxicity remains unknown, it is possible that reactive metabolites of nefazodone play a causative role.  Studies were initiated to det. whether nefazodone undergoes bioactivation in human liver microsomes to electrophilic intermediates.  Following incubation of nefazodone with microsomes or recombinant P 4503A4 in the presence of sulfhydryl nucleophiles, conjugates derived from the addn. of thiol to a monohydroxylated nefazodone metabolite were obsd.  Product ion spectra suggested that hydroxylation and sulfhydryl conjugation occurred on the 3-chlorophenylpiperazine-ring, consistent with a bioactivation pathway involving initial formation of p-hydroxynefazodone, followed by its two-electron oxidn. to the reactive quinone-imine intermediate.  The formation of novel N-dearylated nefazodone metabolites was also discernible in these incubations, and 2-chloro-1,4-benzoquinone, a byproduct of N-dearylation, was trapped with glutathione to afford the corresponding hydroquinone-sulfhydryl adduct.  Nefazodone also displayed NADPH-, time-, and concn.-dependent inactivation of P 450 3A4 activity, suggesting that reactive metabolites derived from nefazodone bioactivation are capable of covalently modifying P 4503A4.  A causative role for 2-chloro-1,4-benzoquinone and/or the quinone-imine intermediate(s) in nefazodone hepatotoxicity is speculated.  Although the antianxiety agent buspirone, which contains a pyrimidine ring in place of the 3-chlorophenyl-ring, also generated p-hydroxybuspirone in liver microsomes, no sulfhydryl conjugates of this metabolite were obsd.  This finding is consistent with the proposal that two-electron oxidn. of p-hydroxybuspirone to the corresponding quinone-imine is less favorable due to differences in the protonation state at physiol. pH and due to weaker resonance stabilization of the oxidn. products as predicted from ab initio measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm8ZzhHTzKarVg90H21EOLACvtfcHk0lgPXKcTrB0RbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cjsbc%253D&md5=7f6d27921d2236e202256ad0035fedce</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001735%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DSoglia%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DCollin%26aufirst%3DC.%26aulast%3DHendsch%26aufirst%3DZ.%2BS.%26aulast%3DHop%26aufirst%3DC.%2BE.C.%2BA.%26atitle%3DBioactivation%2520of%2520the%2520Nontricyclic%2520Antidepressant%2520Nefazodone%2520to%2520a%2520Reactive%2520Quinone-Imine%2520Species%2520in%2520Human%2520Liver%2520Microsomes%2520and%2520Recombinant%2520Cytochrome%2520P450%25203A4%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26issue%3D2%26spage%3D243%26epage%3D253%26doi%3D10.1124%2Fdmd.104.001735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&issue=13&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lgPXKcTrB0RbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagzoog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmowitch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczesniak, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, G. A.</span></span> <span> </span><span class="NLM_article-title">Application of Fluorine- And Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of CB1 Receptor Positive Allosteric Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01142</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1WktrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=542-568&author=S.+Garaiauthor=P.+M.+Kulkarniauthor=P.+C.+Schafferauthor=L.+Leoauthor=A.+L.+Brandtauthor=A.+Zagzoogauthor=T.+Blackauthor=X.+Linauthor=D.+P.+Hurstauthor=D.+R.+Janeroauthor=M.+E.+Aboodauthor=A.+Zimmowitchauthor=A.+Straikerauthor=R.+G.+Pertweeauthor=M.+Kellyauthor=A.+M.+Szczesniakauthor=E.+M.+Denovan-Wrightauthor=K.+Mackieauthor=A.+G.+Hohmannauthor=P.+H.+Reggioauthor=R.+B.+Laprairieauthor=G.+A.+Thakur&title=Application+of+Fluorine-+And+Nitrogen-Walk+Approaches%3A+Defining+the+Structural+and+Functional+Diversity+of+2-Phenylindole+Class+of+CB1+Receptor+Positive+Allosteric+Modulators&doi=10.1021%2Facs.jmedchem.9b01142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators</span></div><div class="casAuthors">Garai, Sumanta; Kulkarni, Pushkar M.; Schaffer, Peter C.; Leo, Luciana M.; Brandt, Asher L.; Zagzoog, Ayat; Black, Tallan; Lin, Xiaoyan; Hurst, Dow P.; Janero, David R.; Abood, Mary E.; Zimmowitch, Anaelle; Straiker, Alex; Pertwee, Roger G.; Kelly, Melanie; Szczesniak, Anna-Maria; Denovan-Wright, Eileen M.; Mackie, Ken; Hohmann, Andrea G.; Reggio, Patricia H.; Laprairie, Robert B.; Thakur, Ganesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">542-568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cannabinoid 1 receptor (CB1R) allosteric ligands hold far-reaching therapeutic promise.  We report application of fluoro- and nitrogen-walk approaches to enhance the drug-like properties of GAT211, a prototype CB1R allosteric agonist-pos. allosteric modulator (ago-PAM).  Several analogs exhibited improved functional potency (cAMP, arrestin2), metabolic stability, and aq. soly.  Two key analogs, GAT591 (6r) and GAT593 (6s), exhibited augmented allosteric-agonist and PAM activities in neuronal cultures, improved metabolic stability, and enhanced orthosteric agonist binding (CP55,940).  Both also exhibited good analgesic potency in the CFA inflammatory-pain model with longer duration of action over GAT211 while devoid of adverse cannabimimetic effects.  Another analog, GAT592 (9j), exhibited moderate ago-PAM potency and improved aq. soly. with therapeutic redn. of intraocular pressure in murine glaucoma models.  The SAR findings and the enhanced allosteric activity in this class of allosteric modulators were accounted for in our recently developed computational model for CB1R allosteric activation and pos. allosteric modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOfHY8Dr6ugbVg90H21EOLACvtfcHk0lgPXKcTrB0RbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktrbF&md5=42e8edb208751b040c3f6d7481381834</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01142%26sid%3Dliteratum%253Aachs%26aulast%3DGarai%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DP.%2BM.%26aulast%3DSchaffer%26aufirst%3DP.%2BC.%26aulast%3DLeo%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DA.%2BL.%26aulast%3DZagzoog%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DZimmowitch%26aufirst%3DA.%26aulast%3DStraiker%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DSzczesniak%26aufirst%3DA.%2BM.%26aulast%3DDenovan-Wright%26aufirst%3DE.%2BM.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DThakur%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520Fluorine-%2520And%2520Nitrogen-Walk%2520Approaches%253A%2520Defining%2520the%2520Structural%2520and%2520Functional%2520Diversity%2520of%25202-Phenylindole%2520Class%2520of%2520CB1%2520Receptor%2520Positive%2520Allosteric%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D542%26epage%3D568%26doi%3D10.1021%2Facs.jmedchem.9b01142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamanda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span> <span> </span><span class="NLM_article-title">Overcoming Time Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10708</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2rtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10700-10708&issue=23&author=M.+Mandalauthor=K.+Mitraauthor=D.+Grotzauthor=X.+Linauthor=J.+Palamandaauthor=P.+Kumariauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Chenauthor=K.+Coxauthor=L.+Favreauauthor=L.+Hydeauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=E.+Parkerauthor=D.+Rindgenauthor=E.+Shererauthor=H.+Wangauthor=Z.+Zhuauthor=A.+W.+Stamfordauthor=J.+N.+Cumming&title=Overcoming+Time+Dependent+Inhibition+%28TDI%29+of+Cytochrome+P450+3A4+%28CYP3A4%29+Resulting+from+Bioactivation+of+a+Fluoropyrimidine+Moiety&doi=10.1021%2Facs.jmedchem.8b01326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety</span></div><div class="casAuthors">Mandal, Mihirbaran; Mitra, Kaushik; Grotz, Diane; Lin, Xinjie; Palamanda, Jairam; Kumari, Pramila; Buevich, Alexei; Caldwell, John P.; Chen, Xia; Cox, Kathleen; Favreau, Leonard; Hyde, Lynn; Kennedy, Matthew E.; Kuvelkar, Reshma; Liu, Xiaoxiang; Mazzola, Robert D.; Parker, Eric; Rindgen, Diane; Sherer, Edward; Wang, Hongwu; Zhu, Zhaoning; Stamford, Andrew W.; Cumming, Jared N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10700-10708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein the authors describe structure-activity relationship (SAR) and metabolite identification (Met-ID) studies that provided insight into the origin of time-dependent inhibition (TDI) of cytochrome P 450 3A4 (CYP3A4) by compd. I.  Collectively, these efforts revealed that bioactivation of the fluoropyrimidine moiety of I led to reactive metabolite formation via oxidative defluorination and was responsible for the obsd. TDI.  The authors discovered that substitution at both the 4- and 6-positions of the 5-fluoropyrimidine of I was necessary to ameliorate this TDI as exemplified by compd. II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1gkRc8EoJSLVg90H21EOLACvtfcHk0lhSI3aZYQKccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2rtbfM&md5=09c862a66c3b078e0886696a6c2cd489</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01326%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DKumari%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DSherer%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DOvercoming%2520Time%2520Dependent%2520Inhibition%2520%2528TDI%2529%2520of%2520Cytochrome%2520P450%25203A4%2520%2528CYP3A4%2529%2520Resulting%2520from%2520Bioactivation%2520of%2520a%2520Fluoropyrimidine%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D23%26spage%3D10700%26epage%3D10708%26doi%3D10.1021%2Facs.jmedchem.8b01326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.106.012633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=17093004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=246-255&issue=2&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnan&title=Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+Enzymes+and+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.106.012633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to use vitro inactivation kinetic parameters in scaling to in vivo drug-drug interactions (DDIs) for mechanism-based inactivators of human cytochrome P 450 (P 450) enzymes was examd. using eight human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, in vivo P 450 enzyme degrdn. rate consts. estd. from clin. pharmacokinetic data, and fraction of the affected drug cleared by the inhibited enzyme) to predict increases in exposure to drugs, and the predictions were compared with in vivo DDIs gathered from clin. studies reported in the scientific literature.  In general, the use of unbound systemic Cmax as the inactivator concn. in vivo yielded the most accurate predictions of DDI with a mean -fold error of 1.64.  Abbreviated in vitro approaches to identifying mechanism-based inactivators were developed.  Testing potential inactivators at a single concn. (IC25) in a 30-min preincubation with human liver microsomes in the absence and presence of NADPH followed by assessment of P 450 marker activities readily identified those compds. known to be mechanism-based inactivators and represents an approach that can be used with greater throughput.  Measurement of decreases in IC50 occurring with a 30-min preincubation with liver microsomes and NADPH was also useful in identifying mechanism-based inactivators, and the IC50 measured after such a preincubation was highly correlated with the kinact/K1 ratio measured after a full characterization of inactivation.  Overall, these findings support the conclusion that P 450 in vitro inactivation data are valuable in predicting clin. DDIs that can occur via this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPRf5ZGrW6LVg90H21EOLACvtfcHk0lhSI3aZYQKccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D&md5=71733cfafba3b2c9cc6b47a46e7b3f40</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012633%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26atitle%3DMechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520and%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D246%26epage%3D255%26doi%3D10.1124%2Fdmd.106.012633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuklish, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czeskis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luffer-Atlas, D.</span></span> <span> </span><span class="NLM_article-title">Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2051</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01806</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2041-2051&author=B.+H.+Normanauthor=M.+J.+Fisherauthor=M.+A.+Schifflerauthor=S.+L.+Kuklishauthor=N.+E.+Hughesauthor=B.+A.+Czeskisauthor=K.+C.+Cassidyauthor=T.+L.+Abrahamauthor=J.+J.+Albertsauthor=D.+Luffer-Atlas&title=Identification+and+Mitigation+of+Reactive+Metabolites+of+2-Aminoimidazole-Containing+Microsomal+Prostaglandin+E+Synthase-1+Inhibitors+Terminated+Due+to+Clinical+Drug-Induced+Liver+Injury&doi=10.1021%2Facs.jmedchem.7b01806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury</span></div><div class="casAuthors">Norman, Bryan H.; Fisher, Matthew J.; Schiffler, Matthew A.; Kuklish, Steven L.; Hughes, Norman E.; Czeskis, Boris A.; Cassidy, Kenneth C.; Abraham, Trent L.; Alberts, Jeffrey J.; Luffer-Atlas, Debra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2041-2051</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two 2-aminoimidazole-based inhibitors, LY3031207 (1) and LY3023703 (2), of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme were found to cause drug-induced liver injury (DILI) in humans.  We studied imidazole ring substitutions to successfully mitigate reactive metabolite (RM) formation.  These studies support the conclusion that RM formation may play a role in the observations of DILI and the consideration of 2-aminoimidazoles as structure alerts, due to the high likelihood of bioactivation to generate RMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYz_L4vs5v2LVg90H21EOLACvtfcHk0lhSI3aZYQKccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gtbY%253D&md5=e4e9f4fac1cae1af730b997dcf663d21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01806%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DM.%2BJ.%26aulast%3DSchiffler%26aufirst%3DM.%2BA.%26aulast%3DKuklish%26aufirst%3DS.%2BL.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DCzeskis%26aufirst%3DB.%2BA.%26aulast%3DCassidy%26aufirst%3DK.%2BC.%26aulast%3DAbraham%26aufirst%3DT.%2BL.%26aulast%3DAlberts%26aufirst%3DJ.%2BJ.%26aulast%3DLuffer-Atlas%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520Mitigation%2520of%2520Reactive%2520Metabolites%2520of%25202-Aminoimidazole-Containing%2520Microsomal%2520Prostaglandin%2520E%2520Synthase-1%2520Inhibitors%2520Terminated%2520Due%2520to%2520Clinical%2520Drug-Induced%2520Liver%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2041%26epage%3D2051%26doi%3D10.1021%2Facs.jmedchem.7b01806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNearney, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landschulz, W.</span></span> <span> </span><span class="NLM_article-title">Dose-dependent Acute Liver Injury with Hypersensitivity Features in Humans Due to a Novel Microsomal Prostaglandin E Synthase 1 Inhibitor</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1111/bcp.13423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1111%2Fbcp.13423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=28865237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Shug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=179-188&issue=1&author=Y.+Jinauthor=A.+Regevauthor=J.+Kamauthor=K.+Phippsauthor=C.+Smithauthor=J.+Henckauthor=K.+Campanaleauthor=L.+Huauthor=D.+G.+Hallauthor=X.+Y.+Yangauthor=M.+Nakanoauthor=T.+A.+McNearneyauthor=J.+Uetrechtauthor=W.+Landschulz&title=Dose-dependent+Acute+Liver+Injury+with+Hypersensitivity+Features+in+Humans+Due+to+a+Novel+Microsomal+Prostaglandin+E+Synthase+1+Inhibitor&doi=10.1111%2Fbcp.13423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor</span></div><div class="casAuthors">Jin, Yan; Regev, Arie; Kam, Jeanelle; Phipps, Krista; Smith, Claire; Henck, Judith; Campanale, Kristina; Hu, Leijun; Hall, D. Greg; Yang, Xiao Yan; Nakano, Masako; McNearney, Terry Ann; Uetrecht, Jack; Landschulz, William</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : LY3031207, a novel microsomal prostaglandin E synthase 1 inhibitor, was evaluated in a multiple ascending dose study after nonclin. toxicol. studies and a single ascending dose study demonstrated an acceptable toxicity, safety and tolerability profile.  Methods : Healthy subjects were randomized to receive LY3031207 (25, 75 and 275 mg), placebo or celecoxib (400 mg) once daily for 28 days.  The safety, tolerability and pharmacokinetic and pharmacodynamic profiles of LY3031207 were evaluated.  Results : The study was terminated when two subjects experienced drug-induced liver injury (DILI) after they had received 225 mg LY3031207 for 19 days.  Liver biopsy from these subjects revealed acute liver injury with eosinophilic infiltration.  Four addnl. DILI cases were identified after LY3031207 dosing had been stopped.  All six DILI cases shared unique presentations of hepatocellular injury with hypersensitivity features and demonstrated a steep dose-dependent trend.  Prompt discontinuation of the study drug and supportive medical care resulted in full recovery.  Metabolites from metabolic activation of the imidazole ring were obsd. in plasma and urine samples from all subjects randomized to LY3031207 dosing.  Conclusions : This study emphasized the importance of careful safety monitoring and serious adverse events management in phase I trials.  Metabolic activation of the imidazole ring may be involved in the development of hepatotoxicity of LY3031207.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTg0xW88KU4LVg90H21EOLACvtfcHk0lgGB7dRrqOXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Shug%253D%253D&md5=d57e0853ca828b7f02b613aea72497f1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13423%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DKam%26aufirst%3DJ.%26aulast%3DPhipps%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHenck%26aufirst%3DJ.%26aulast%3DCampanale%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DYang%26aufirst%3DX.%2BY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DMcNearney%26aufirst%3DT.%2BA.%26aulast%3DUetrecht%26aufirst%3DJ.%26aulast%3DLandschulz%26aufirst%3DW.%26atitle%3DDose-dependent%2520Acute%2520Liver%2520Injury%2520with%2520Hypersensitivity%2520Features%2520in%2520Humans%2520Due%2520to%2520a%2520Novel%2520Microsomal%2520Prostaglandin%2520E%2520Synthase%25201%2520Inhibitor%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26issue%3D1%26spage%3D179%26epage%3D188%26doi%3D10.1111%2Fbcp.13423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twomey, T. M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Sudoxicam by the Rat, Dog, and Monkey</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=13979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaE2sXhsFShtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=75-81&issue=1&author=D.+C.+Hobbsauthor=T.+M.+Twomey&title=Metabolism+of+Sudoxicam+by+the+Rat%2C+Dog%2C+and+Monkey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of sudoxicam by the rat, dog, and monkey</span></div><div class="casAuthors">Hobbs, Donald C.; Twomey, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">Sudoxicam (N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)(I) [34042-85-8] was prepd. in radiolabeled form and administered to rats, dogs, and monkeys.  Urine contained approx. 60,25, and 49% of the label given to rats, dogs, and monkeys, resp; the remainder was cleared via feces.  In addn. to some unchanged drug, urine from all species examd. contained 2 major metabolites.  These were identified from their mass spectra as the thiohydantoic acid and thiourea resulting from scission of the thiazole ring of sudoxicam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1k7yqZN80LVg90H21EOLACvtfcHk0lgGB7dRrqOXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhsFShtbo%253D&md5=d7dad8fd060eed7a5c53a67d0e114de0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DD.%2BC.%26aulast%3DTwomey%26aufirst%3DT.%2BM.%26atitle%3DMetabolism%2520of%2520Sudoxicam%2520by%2520the%2520Rat%252C%2520Dog%252C%2520and%2520Monkey%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1977%26volume%3D5%26issue%3D1%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rettie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rettenmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howald, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450--Catalyzed Formation of Delta 4-VPA, a Toxic Metabolite of Valproic Acid</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>235</i></span> (<span class="NLM_issue">4791</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1126/science.3101178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1126%2Fscience.3101178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=3101178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=890-893&issue=4791&author=A.+Rettieauthor=A.+Rettenmeierauthor=W.+Howaldauthor=T.+Baillie&title=Cytochrome+P-450%2D%2DCatalyzed+Formation+of+Delta+4-VPA%2C+a+Toxic+Metabolite+of+Valproic+Acid&doi=10.1126%2Fscience.3101178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P-450-catalyzed formation of Δ4-VPA, a toxic metabolite of valproic acid</span></div><div class="casAuthors">Rettie, Allan E.; Rettenmeier, Albert W.; Howald, William N.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">4791</span>),
    <span class="NLM_cas:pages">890-3</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Liver damage induced by the antiepileptic drug valproic acid (VPA)  [99-66-1] is believed to be mediated by an unsatd. metabolite of the drug 2-n-propyl-4-pentenoic acid (Δ4-VPA)  [1575-72-0].  In studies of the biol. origin of this hepatotoxic compd., it was found that liver microsomes from phenobarbital-treated rats catalyzed the desatn. of VPA to Δ4-VPA.  Indirect evidence suggested that cytochrome P 450  [9035-51-2] was the responsible enzyme, a conclusion that was verified by studies with a purified and reconstituted form of the hemoprotein, which catalyzed the oxidn. of VPA to 4-  [60113-82-8] and 5-hydroxyvalproic acid  [53660-23-4] and to Δ4-VPA.  Desatn. of a nonactivated alkyl substituent represents a novel metabolic function of cytochrome P 450 and probably proceeds via the conversion of substrate to a transient free radical intermediate, which partitions between recombination (alc. formation) and elimination (olefin prodn.) pathways.  These findings have broad implications with resp. to the metabolic generation of olefins and may explain the increased hepatotoxic potential of VPA when it is administered in combination with potent enzyme-inducing anticonvulsants such as phenobarbital.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgCTIRwDQwlrVg90H21EOLACvtfcHk0lgGB7dRrqOXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyqsbo%253D&md5=fbbc8f1d52faf24d9d333b3c1d6b0ff6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.3101178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3101178%26sid%3Dliteratum%253Aachs%26aulast%3DRettie%26aufirst%3DA.%26aulast%3DRettenmeier%26aufirst%3DA.%26aulast%3DHowald%26aufirst%3DW.%26aulast%3DBaillie%26aufirst%3DT.%26atitle%3DCytochrome%2520P-450--Catalyzed%2520Formation%2520of%2520Delta%25204-VPA%252C%2520a%2520Toxic%2520Metabolite%2520of%2520Valproic%2520Acid%26jtitle%3DScience%26date%3D1987%26volume%3D235%26issue%3D4791%26spage%3D890%26epage%3D893%26doi%3D10.1126%2Fscience.3101178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawchuk, R. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Murine Cytochrome P4501A by Tacrine: In Vitro Studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.8.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.32.8.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15258105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFCjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=805-812&issue=8&author=J.+Z.+Pengauthor=R.+P.+Remmelauthor=R.+J.+Sawchuk&title=Inhibition+of+Murine+Cytochrome+P4501A+by+Tacrine%3A+In+Vitro+Studies&doi=10.1124%2Fdmd.32.8.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of murine cytochrome P4501A by tacrine: In vitro studies</span></div><div class="casAuthors">Peng, Joanna Z.; Remmel, Rory P.; Sawchuk, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Tacrine, a cholinesterase inhibitor, was approved for the treatment of Alzheimer's disease.  Oxidative metab. of tacrine occurs by CYP1A-catalyzed hydroxylation.  In rats, it was obsd. that the area under the curve (AUC) of the second oral dose was consistently higher than the AUC after the first oral dose, which was not due to the accumulation of the drug in the plasma from the first dose.  This finding suggested inhibition of the enzyme during metab. or inhibition by a metabolite.  The inhibitory mechanism was studied in liver and intestinal microsomes prepd. from 3-methylcholanthrene-treated rats and with recombinant CYP1A1 and CYP1A2.  Preincubation of CYP1A2 with tacrine and NADPH revealed a time-dependent inhibition of 7-ethoxyresorufin O-deethylation with a Ki of 1.94 μM and a kinact of 0.091 min-1.  No time-dependent inhibition was obsd. with CYP1A1 or with 1-hydroxytacrine or 2-hydroxytacrine.  Tacrine metab. catalyzed by CYP1A was also carried out, and the partition ratio was estd. to be 22.  A modified Michaelis-Menten equation involving mechanism-based inhibition was derived and used to analyze the data.  Reasonable parameter fits were obtained indicating that this equation is suitable to describe metab. data when the substrate is a mechanism-based inhibitor of the enzyme.  The probable inactivation mechanism involves either hydrogen atom abstraction to produce a carbon-centered radical intermediate at the benzylic position or insertion of OH+ into a C-H bond with subsequent loss of water to produce a carbocation.  Rapid rearrangement of the carbocation or radical and subsequent covalent binding of the tacrine moiety would result in enzyme inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3VeF_ZysNdLVg90H21EOLACvtfcHk0lgyv3R4KU0rqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFCjt7g%253D&md5=b38e964963873741583ac7d72dc2f15f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.8.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.8.805%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%2BZ.%26aulast%3DRemmel%26aufirst%3DR.%2BP.%26aulast%3DSawchuk%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520Murine%2520Cytochrome%2520P4501A%2520by%2520Tacrine%253A%2520In%2520Vitro%2520Studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D8%26spage%3D805%26epage%3D812%26doi%3D10.1124%2Fdmd.32.8.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jushchyshyn, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahlstrom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienkers, L. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inactivation of Human Cytochrome P450 2B6 by Phencyclidine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.010579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.106.010579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=16782764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1523-1529&issue=9&author=M.+I.+Jushchyshynauthor=J.+L.+Wahlstromauthor=P.+F.+Hollenbergauthor=L.+C.+Wienkers&title=Mechanism+of+Inactivation+of+Human+Cytochrome+P450+2B6+by+Phencyclidine&doi=10.1124%2Fdmd.106.010579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine</span></div><div class="casAuthors">Jushchyshyn, Monica I.; Wahlstrom, Jan L.; Hollenberg, Paul F.; Wienkers, Larry C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1523-1529</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mechanism behind the obsd. inactivation of human P 450 2B6 by phencyclidine (PCP) has been evaluated over the past 2 decades.  The scope of the current investigation was to contribute to the fundamental knowledge of PCP oxidn. and perhaps the mechanism behind P 450 inactivation.  To study the chem. of PCP oxidn., we subjected PCP to the Fenton reagent.  Under Fenton chem. conditions, oxidn. on all three PCP rings was obsd. by liq. chromatog./tandem mass spectrometry (LC-MS/MS).  When PCP was incubated with the Fenton system in the presence of glutathione (GSH), three GSH-PCP conjugates were identified.  Subsequent LC-MS/MS anal. of these conjugates revealed two species that had GSH attached to the cyclohexane ring of PCP and a third conjugate in which GSH was adducted to the piperidine ring.  When PCP was incubated across a panel of P 450 enzymes, several enzymes, including P450s 2D6 and 3A4, were able to catalyze the formation of the PCP iminium ion, whereas P450s 2B6 and 2C19 were exclusively able to hydroxylate secondary carbons on the cyclohexane ring of PCP.  Subsequent mechanistic expts. revealed that only P450s 2B6 and 2C19 demonstrated loss of catalytic activity after preincubation with 10 μM PCP.  Finally, investigation of P 450 2B6 inactivation using structural analogs of PCP revealed that blocking the para-carbon atom on the cyclohexane ring of PCP from oxidn. protected the P 450 2B6 from inactivation, which suggests that a reactive intermediate generated during the hydroxylation of the cyclohexane ring may be linked to the mechanism of inactivation of P 450 2B6 by PCP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH7JJJ7v_R7LVg90H21EOLACvtfcHk0lgyv3R4KU0rqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sks7c%253D&md5=567d10c98dc393cb65d8f365f1752ddd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.010579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.010579%26sid%3Dliteratum%253Aachs%26aulast%3DJushchyshyn%26aufirst%3DM.%2BI.%26aulast%3DWahlstrom%26aufirst%3DJ.%2BL.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26aulast%3DWienkers%26aufirst%3DL.%2BC.%26atitle%3DMechanism%2520of%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%25202B6%2520by%2520Phencyclidine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26issue%3D9%26spage%3D1523%26epage%3D1529%26doi%3D10.1124%2Fdmd.106.010579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jushchyshyn, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">The Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Phencyclidine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.1.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.31.1.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=12485952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtV2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=46-52&issue=1&author=M.+I.+Jushchyshynauthor=U.+M.+Kentauthor=P.+F.+Hollenberg&title=The+Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+2B6+by+Phencyclidine&doi=10.1124%2Fdmd.31.1.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine</span></div><div class="casAuthors">Jushchyshyn, Monica I.; Kent, Ute M.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phencyclidine (PCP) was analyzed for its ability to inactivate human cytochrome P 450 (P 450) 2B6.  PCP inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of P 450 2B6 in a concn.-, time-, and NADPH-dependent manner and exhibited pseudo-first order kinetics.  The K1 was 10 μM, kinact was 0.01 min-1, which corresponds to a t1/2 of 31 min.  The partition ratio was approx. 45.  Spectral anal. of the heme moiety demonstrated that the heme was not modified during inactivation.  Extensive dialysis of the PCP-inactivated P 450 2B6 did not cause a return in catalytic activity demonstrating PCP inactivation was irreversible.  Including 7-ethoxycoumarin, an alternate substrate, protected 2B6 from inactivation by PCP indicating competition of the two substrates for the active site.  Exogenous nucleophiles such as glutathione (GSH) and cyanide could not protect P 450 2B6 from PCP inactivation demonstrating that the reactive intermediate remained within the P 450 active site.  High performance liq. chromatog. anal. of P 450 2B6 inactivated in the presence of 3H-labeled PCP showed that PCP binding was specific for the P 450 and not to other proteins in the reaction mixt.  The stoichiometry of binding of PCP to P 450 2B6 was demonstrated using 3H-labeled PCP.  In the absence of GSH, the stoichiometry was 5.5:1 (PCP/P 450).  In the presence of GSH, the stoichiometry was 1:1.  This stoichiometry was further supported using electrospray ionization-liq. chromatog.-mass spectrometry to analyze PCP-inactivated P 450 2B1, 2B4, and 2B6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJuvzxADO6brVg90H21EOLACvtfcHk0lgyv3R4KU0rqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtV2msw%253D%253D&md5=d31ba5b0d4f91c2b8df2f9410101d104</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.1.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.1.46%26sid%3Dliteratum%253Aachs%26aulast%3DJushchyshyn%26aufirst%3DM.%2BI.%26aulast%3DKent%26aufirst%3DU.%2BM.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DThe%2520Mechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%25202B6%2520by%2520Phencyclidine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D46%26epage%3D52%26doi%3D10.1124%2Fdmd.31.1.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Phencyclidine. The Role of Iminium Ion Formation in Covalent Binding to Rabbit Microsomal Protein</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=6130925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaL3sXms1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1982&pages=690-695&issue=6&author=D.+Wardauthor=A.+Trevorauthor=A.+Kalirauthor=J.+Adamsauthor=T.+Baillieauthor=N.+Castagnoli&title=Metabolism+of+Phencyclidine.+The+Role+of+Iminium+Ion+Formation+in+Covalent+Binding+to+Rabbit+Microsomal+Protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of phencyclidine.  The role of iminium ion formation in covalent binding to rabbit microsomal protein</span></div><div class="casAuthors">Ward, D. P.; Trevor, A. J.; Kalir, A.; Adams, J. D.; Baillie, T. A.; Castagnoli, N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">690-5</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">Incubation of phencyclidine (PCP)(I)  [77-10-1] with rabbit liver microsomes and Na14CN resulted in the metabolically dependent formation of a 14C-labeled cyano adduct of the drug.  After isolation by high-pressure liq. chromatog. (HPLC), this compd. was identified as the α-aminonitrile [1-(1-phenylcyclohexyl)-2-cyanopiperidine  [81262-67-1]] deriv. of PCP by use of chem.-ionization and gas-chromatog. coupled electron-impact mass spectrometry.  Synthetic α-aminonitrile exhibited identical chem. properties and comigrated in HPLC and gas liq. chromatog. with the metab.-derived cyano adduct.  Mol. identification of the adduct formed by cyanide trapping provided evidence for the formation of an iminium ion during PCP metab.  Quant. estn. by HPLC demonstrated that the α-aminonitrile accounted for ∼50% of the PCP metabolized in 30 min by hepatic microsomes in vitro.  Metab.-dependent covalent binding of [3H]PCP to rabbit liver microsomal proteins was inhibited by cyanide ion in a concn.-dependent manner with an IC50 of 57 μM.  The concns. of cyanide ion used in these expts. did not significantly inhibit the metab. of PCP.  Thus, iminium ion formation may represent an important intermediary step in the metab. of PCP and such a reactive electrophilic species may be capable of covalent interactions with nucleophilic groupings on microsomal macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUpdYxDdRr_LVg90H21EOLACvtfcHk0ljn4SyrIq3sXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXms1Gkug%253D%253D&md5=323e11acbf22c1021b2bde6096f9c272</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DD.%26aulast%3DTrevor%26aufirst%3DA.%26aulast%3DKalir%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DT.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DMetabolism%2520of%2520Phencyclidine.%2520The%2520Role%2520of%2520Iminium%2520Ion%2520Formation%2520in%2520Covalent%2520Binding%2520to%2520Rabbit%2520Microsomal%2520Protein%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1982%26volume%3D10%26issue%3D6%26spage%3D690%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkowski, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of Phencyclidine in Rat and Human Liver Microsomes and Recombinant P450 2B Enzymes: Evidence for the Formation of a Novel Quinone Methide Intermediate</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1021/tx700145k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700145k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1488-1497&issue=10&author=J.+P.+Driscollauthor=K.+Korneckiauthor=J.+P.+Wolkowskiauthor=L.+Chupakauthor=A.+S.+Kalgutkarauthor=J.+P.+O%E2%80%99Donnell&title=Bioactivation+of+Phencyclidine+in+Rat+and+Human+Liver+Microsomes+and+Recombinant+P450+2B+Enzymes%3A+Evidence+for+the+Formation+of+a+Novel+Quinone+Methide+Intermediate&doi=10.1021%2Ftx700145k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of Phencyclidine in Rat and Human Liver Microsomes and Recombinant P450 2B Enzymes: Evidence for the Formation of a Novel Quinone Methide Intermediate</span></div><div class="casAuthors">Driscoll, James P.; Kornecki, Katherine; Wolkowski, Joanna P.; Chupak, Lou; Kalgutkar, Amit S.; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1488-1497</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypothesis that the psychol. side effects assocd. with the anesthetic phencyclidine (PCP) may be caused by irreversible binding of PCP or its reactive metabolite(s) to crit. macromols. in the brain has resulted in numerous in vitro studies aimed at characterizing pathways of PCP bioactivation.  The studies described herein extend the current knowledge of PCP metab. and provide details on a previously unknown metabolic activation pathway of PCP.  Following incubations with NADPH- and GSH-supplemented human and rat liver microsomes and recombinant P 450 2B enzymes, two sulfhydryl conjugates with MH+ ions at 547 and 482 Da, resp., were detected by LC/MS/MS.  Shebley et al. have also obsd. the GSH conjugate 1 with MH+ at 547 Da in PCP incubations with rat P 450 2B1 and rabbit P 450 2B4 isoforms fortified with NADPH and GSH.  The mol. wt. of 1 is consistent with a bioactivation pathway involving Michael addn. of the sulfhydryl nucleophile to the putative 2,3-dihydropyridinium metabolite of PCP obtained via a four-electron oxidn. of the piperidine ring in the parent compd.  The mass spectrum of the novel GSH adduct 2 with an MH+ ion at 482 Da was suggestive of a unique PCP bioactivation pathway involving initial ortho- or para-hydroxylation of the Ph ring in PCP followed by spontaneous decompn. to piperidine and an electrophilic quinone methide intermediate, which upon reaction with GSH yielded adduct 2.  The LC retention times and mass spectral properties of enzymically generated 2 were identical to those of a ref. std. obtained via reaction of GSH with synthetic p-hydroxyPCP in phosphate buffer (pH 7.4, 37°). 1H NMR and 13C-distortionless enhancement by polarization transfer (DEPT) NMR spectral studies on synthetically generated 2 suggested that the structural integrity of the p-hydroxyphenyl and cyclohexyl rings likely was preserved and that the site of GSH addn. was the benzylic carbon joining the two scaffolds.  The formation of 2 in human microsomes was reduced upon addn. of the dual P 450 2C19/P 450 2B6 inhibitor (+)-N-3-benzylnirvanol.  Consistent with this finding, both recombinant P 450 2B6 and P 450 2C19 catalyzed PCP bioactivation to 2.  In the absence of GSH, synthetic p-hydroxyPCP underwent rapid decompn. (t1/2 ∼ 5.2 min) to afford p-hydroxyphenylcyclohexanol and p-hydroxyphenylcyclohexene, presumably via the quinone methide intermediate.  Overall, our findings on the facile degrdn. of synthetic p-hydroxyPCP to yield an electrophilic quinone methide intermediate capable of reacting with nucleophiles, including GSH and water, suggest an inherent instability of the putative phenolic PCP metabolite.  Thus, if formed enzymically in vivo, p-hydroxyPCP may not require further metab. to liberate the quinone methide, which can then react with macromols.  To our knowledge, this is the first report of a quinone methide reactive intermediate obtained in human-liver microsomal metab. of PCP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSZWcMYbznCbVg90H21EOLACvtfcHk0ljn4SyrIq3sXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsr3K&md5=379142481a787f68c038111370d0314b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx700145k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700145k%26sid%3Dliteratum%253Aachs%26aulast%3DDriscoll%26aufirst%3DJ.%2BP.%26aulast%3DKornecki%26aufirst%3DK.%26aulast%3DWolkowski%26aufirst%3DJ.%2BP.%26aulast%3DChupak%26aufirst%3DL.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBioactivation%2520of%2520Phencyclidine%2520in%2520Rat%2520and%2520Human%2520Liver%2520Microsomes%2520and%2520Recombinant%2520P450%25202B%2520Enzymes%253A%2520Evidence%2520for%2520the%2520Formation%2520of%2520a%2520Novel%2520Quinone%2520Methide%2520Intermediate%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26issue%3D10%26spage%3D1488%26epage%3D1497%26doi%3D10.1021%2Ftx700145k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “Cyclopropyl Fragment” Is a Versatile Player That Frequently Appears in Preclinical/Clinical Drug Molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&issue=19&author=T.+T.+Talele&title=The+%E2%80%9CCyclopropyl+Fragment%E2%80%9D+Is+a+Versatile+Player+That+Frequently+Appears+in+Preclinical%2FClinical+Drug+Molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0ljn4SyrIq3sXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259CCyclopropyl%2520Fragment%25E2%2580%259D%2520Is%2520a%2520Versatile%2520Player%2520That%2520Frequently%2520Appears%2520in%2520Preclinical%252FClinical%2520Drug%2520Molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S. P.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&issue=3&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+Comprehensive+Listing+of+Bioactivation+Pathways+of+Organic+Functional+Groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lhMsITASTMIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520Comprehensive%2520Listing%2520of%2520Bioactivation%2520Pathways%2520of%2520Organic%2520Functional%2520Groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26issue%3D3%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of Cyclopropyl Rings by P450: An Observation Encountered during the Optimisation of a Series of Hepatitis C Virus NS5B Inhibitors</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1409915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1080%2F00498254.2017.1409915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=29182424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKgsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=1215-1226&issue=12&author=X.+Zhuoauthor=Y.-Z.+Wangauthor=K.-S.+Yeungauthor=J.+Zhuauthor=X.+S.+Huangauthor=K.+E.+Parcellaauthor=K.+J.+Eastmanauthor=J.+F.+Kadowauthor=N.+A.+Meanwellauthor=Y.-Z.+Shuauthor=B.+M.+Johnson&title=Bioactivation+of+Cyclopropyl+Rings+by+P450%3A+An+Observation+Encountered+during+the+Optimisation+of+a+Series+of+Hepatitis+C+Virus+NS5B+Inhibitors&doi=10.1080%2F00498254.2017.1409915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimization of a series of hepatitis C virus NS5B inhibitors</span></div><div class="casAuthors">Zhuo, Xiaoliang; Wang, Ying-Zi; Yeung, Kap-Sun; Zhu, Juliang; Huang, Xiaohua Stella; Parcella, Kyle E.; Eastman, Kyle J.; Kadow, John F.; Meanwell, Nicholas A.; Shu, Yue-Zhong; Johnson, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Due to its unique C-C and C-H bonding properties, conformational preferences and relative hydrophilicity, the cyclopropyl ring has been used as a synthetic building block in drug discovery to modulate potency and drug-like properties.  During an effort to discover inhibitors of the hepatitis C virus non-structural protein 5B with improved potency and genotype-coverage profiles, the use of a pyrimidinylcyclopropylbenzamide moiety linked to a C6-substituted benzofuran or azabenzofuran core scaffold was explored in an effort to balance antiviral potency and metabolic stability.  In vitro metab. studies of two compds. from this C6-substituted series revealed an NADPH-dependent bioactivation pathway leading to the formation of multiple glutathione (GSH) conjugates.  Anal. of these conjugates by LC-MS and NMR demonstrated that the cyclopropyl group was the site of bioactivation.  Based on the putative structures and mol. wts. of the cyclopropyl-GSH conjugates, a multi-step mechanism was proposed to explain the formation of these metabolites by P 450.  This mechanism involves hydrogen atom abstraction to form a cyclopropyl radical, followed by a ring opening rearrangement and reaction with GSH.  These findings provided important information to the medicinal chem. team which responded by replacing the cyclopropyl ring with a gem-di-Me group.  Subsequent compds. bearing this feature were shown to avert the bioactivation pathways in question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrolyOdHK2ec7Vg90H21EOLACvtfcHk0lhMsITASTMIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKgsr7K&md5=a24a2385788de07979dcec236988cb9f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1409915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1409915%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-Z.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%2BS.%26aulast%3DParcella%26aufirst%3DK.%2BE.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26atitle%3DBioactivation%2520of%2520Cyclopropyl%2520Rings%2520by%2520P450%253A%2520An%2520Observation%2520Encountered%2520during%2520the%2520Optimisation%2520of%2520a%2520Series%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Inhibitors%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D12%26spage%3D1215%26epage%3D1226%26doi%3D10.1080%2F00498254.2017.1409915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span> <span> </span><span class="NLM_article-title">Strategies toward Optimization of the Metabolism of a Series of Serotonin-4 Partial Agonists: Investigation of Azetidines as Piperidine Isosteres</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.3109/00498254.2016.1152522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.3109%2F00498254.2016.1152522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=26947511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslKhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=1112-1121&issue=12&author=R.+S.+Obachauthor=E.+A.+LaChapelleauthor=M.+A.+Brodneyauthor=M.+Vanase-Frawleyauthor=G.+W.+Kauffmanauthor=A.+Sawant-Basak&title=Strategies+toward+Optimization+of+the+Metabolism+of+a+Series+of+Serotonin-4+Partial+Agonists%3A+Investigation+of+Azetidines+as+Piperidine+Isosteres&doi=10.3109%2F00498254.2016.1152522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres</span></div><div class="casAuthors">Obach, Ronald Scott; LaChapelle, Erik A.; Brodney, Michael A.; Vanase-Frawley, Michelle; Kauffman, Gregory W.; Sawant-Basak, Aarti</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1112-1121</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The first generation 5HT-4 partial agonist, 4-{4-[4-Tetrahydrofuran-3-yloxy-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol, PF-4995274 (TBPT), was metabolized to N-dealkylated (M1) and an unusual, cyclized oxazolidine (M2) metabolites. and demonstrated pharmacol. activity at 5HT receptor subtypes warranting further investigation into their dispositional properties in humans; was a minor component in vitro but was the pre-dominant metabolite identified in human plasma.  To shift metab. away from the piperidine ring of TBPT, a series of heterocyclic replacements were designed, synthesized, and profiled.  Groups including azetidines, pyrrolidines, as well as functionalized piperidines were evaluated with the goal of identifying an alternative group that maintained the desired potency, functional activity, and reduced turnover in human hepatocytes.  Activities of 4-substituted piperidines or pyrrolidine analogs at the pharmacol. target were not significantly altered, but the same metabolic pathways of N-dealkylation and oxazolidine formation were still obsd.  Altering these to bridged ring systems lowered oxazolidine metabolite formation, but not N-dealkylation.  The effort concluded with identification of azetidines as second-generation 5HT4 partial agonists.  These were neither metabolized via N-dealkylation nor converted to cyclized oxazolidine metabolites rather oxidized on the isoxazole ring.  The use of azetidine as a replacement for aliph. aza-heterocyclic rings in drug design to alter drug metab. and pharmacol. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVnMRsLJZpj7Vg90H21EOLACvtfcHk0lhMsITASTMIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslKhur4%253D&md5=109b5893fc34291b627e1127d9807fb4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498254.2016.1152522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2016.1152522%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DLaChapelle%26aufirst%3DE.%2BA.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSawant-Basak%26aufirst%3DA.%26atitle%3DStrategies%2520toward%2520Optimization%2520of%2520the%2520Metabolism%2520of%2520a%2520Series%2520of%2520Serotonin-4%2520Partial%2520Agonists%253A%2520Investigation%2520of%2520Azetidines%2520as%2520Piperidine%2520Isosteres%26jtitle%3DXenobiotica%26date%3D2016%26volume%3D46%26issue%3D12%26spage%3D1112%26epage%3D1121%26doi%3D10.3109%2F00498254.2016.1152522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloysius, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschirret-Guth, R. A.</span></span> <span> </span><span class="NLM_article-title">Metabolic Activation and Major Protein Target of a 1-Benzyl-3-Carboxyazetidine Sphingosine-1-Phosphate-1 Receptor Agonist</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1422</span>, <span class="refDoi"> DOI: 10.1021/tx300017s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300017s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2is78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1412-1422&issue=7&author=H.+Aloysiusauthor=V.+W.+Tongauthor=J.+Yabutauthor=S.+A.+Bradleyauthor=J.+Shangauthor=Y.+Zouauthor=R.+A.+Tschirret-Guth&title=Metabolic+Activation+and+Major+Protein+Target+of+a+1-Benzyl-3-Carboxyazetidine+Sphingosine-1-Phosphate-1+Receptor+Agonist&doi=10.1021%2Ftx300017s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Activation and Major Protein Target of a 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonist</span></div><div class="casAuthors">Aloysius, Herve; Tong, Vincent W.; Yabut, Jocelyn; Bradley, Scott A.; Shang, Jackie; Zou, Yan; Tschirret-Guth, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1412-1422</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-{4-[(4-Phenyl-5-trifluoromethyl-2-thienyl)methoxy]benzyl}azetidine-3-carboxylic acid (MRL-A) is a potent sphingosine-1-phosphate-1 receptor agonist, with potential application as an immunosuppressant in organ transplantation or for the treatment of autoimmune diseases.  When administered orally to rats, radiolabeled MRL-A was found to undergo metab. to several reactive intermediates, and in this study, we have investigated its potential for protein modification in vivo and in vitro.  MRL-A irreversibly modified liver and kidney proteins in vivo, in a dose- and time-dependent manner.  The binding was found to occur selectively to microsomal and mitochondrial subcellular fractions.  Following a nonspecific proteolytic digestion of liver and kidney proteins, a single major amino acid adduct was obsd.  This adduct was characterized with LC/MS/UV and NMR spectroscopy and was the product of an unprecedented metabolic activation of the azetidine moiety leading to the formation of a ring-opened α,β-unsatd. imine conjugated to the ε-amino group of a lysine residue.  The formation of this adduct was not inhibited when rats were pretreated with 1-aminobenzotriazole, indicating that P 450 enzymes were not involved in the metabolic activation of MRL-A.  Rather, our findings suggested that MRL-A underwent bioactivation via a β-oxidn. pathway.  Several other minor adducts were identified from protein hydrolyzates and included lysine, serine, and cysteine conjugates of MRL-A.  These minor adducts were also detected in microsomal incubations fortified with the cofactors for acyl-CoA synthesis and in hepatocytes.  Trypsin digestion of crude liver homogenates from rats treated with radiolabeled MRL-A led to the identification of a single radioactive peptide.  Its sequence, detd. by LC/MS anal., revealed that the target of the major reactive species of MRL-A in vivo is Lys676 of long chain acyl-CoA synthetase-1 (ACSL1).  This lysine residue has been crit. for ACSL1 activity, and its modification has the potential to lead to biol. consequences such as cardiac hypertrophy or thermogenesis dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprOkKn83jQ3bVg90H21EOLACvtfcHk0lhn_r-NhBh35g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2is78%253D&md5=225b32958c3d9be6da1d25b4fdbb89d6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Ftx300017s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300017s%26sid%3Dliteratum%253Aachs%26aulast%3DAloysius%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DV.%2BW.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DBradley%26aufirst%3DS.%2BA.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DTschirret-Guth%26aufirst%3DR.%2BA.%26atitle%3DMetabolic%2520Activation%2520and%2520Major%2520Protein%2520Target%2520of%2520a%25201-Benzyl-3-Carboxyazetidine%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonist%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D7%26spage%3D1412%26epage%3D1422%26doi%3D10.1021%2Ftx300017s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitholtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurva, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">886</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1021/tx500514z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500514z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvF2ht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=886-896&issue=5&author=M.+Darnellauthor=K.+Breitholtzauthor=E.+M.+Isinauthor=U.+Jurvaauthor=L.+Weidolf&title=Significantly+Different+Covalent+Binding+of+Oxidative+Metabolites%2C+Acyl+Glucuronides%2C+and+S-Acyl+CoA+Conjugates+Formed+from+Xenobiotic+Carboxylic+Acids+in+Human+Liver+Microsomes&doi=10.1021%2Ftx500514z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes</span></div><div class="casAuthors">Darnell, Malin; Breitholtz, Katarina; Isin, Emre M.; Jurva, Ulrik; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-896</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Xenobiotic carboxylic acids may be metabolized to oxidative metabolites, acyl glucuronides, and/or S-acyl-CoA thioesters (CoA conjugates) in vitro, e.g., in hepatocytes, and in vivo.  These metabolites can potentially be reactive species and bind covalently to tissue proteins and are generally considered to mediate adverse drug reactions in humans.  Acyl glucuronide metabolites have been the focus of reactive metabolite research for decades, whereas drug-CoA conjugates, which have been shown to be up to 40-70 times more reactive, have been given much less attention.  In an attempt to dissect the contribution of different pathways to covalent binding, we utilized human liver microsomes supplemented with NADPH, uridine 5'-diphosphoglucuronic acid (UDPGA), or CoA to evaluate the reactivity of each metabolite sep.  Seven carboxylic acid drugs were included in this study.  While ibuprofen and tolmetin are still on the market, ibufenac, fenclozic acid, tienilic acid, suprofen, and zomepirac were stopped before their launch or withdrawn.  The reactivities of the CoA conjugates of ibuprofen, ibufenac, fenclozic acid, and tolmetin were higher compared to those of their corresponding oxidative metabolites and acyl glucuronides, as measured by the level of covalent binding to human liver microsomal proteins.  The highest covalent binding was obsd. for ibuprofenyl-CoA and ibufenacyl-CoA, to levels of 1000 and 8600 pmol drug eq/mg protein, resp.  In contrast and in agreement with the proposed P 450-mediated toxicity for these drug mols., the reactivities of oxidative metabolites of suprofen and tienilic acid were higher compared to the reactivities of their conjugated metabolites, with NADPH-dependent covalent binding of 250 pmol drug eq/mg protein for both drugs.  The seven drugs all formed UDPGA-dependent acyl glucuronides, but none of these resulted in covalent binding.  This study shows that, unlike studies with hepatocytes or in vivo, human liver microsomes provide an opportunity to investigate the reactivity of individual metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWKWURekmygLVg90H21EOLACvtfcHk0lhn_r-NhBh35g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvF2ht7k%253D&md5=770a4825095e7651d8271b66c86568a1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx500514z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500514z%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DM.%26aulast%3DBreitholtz%26aufirst%3DK.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DSignificantly%2520Different%2520Covalent%2520Binding%2520of%2520Oxidative%2520Metabolites%252C%2520Acyl%2520Glucuronides%252C%2520and%2520S-Acyl%2520CoA%2520Conjugates%2520Formed%2520from%2520Xenobiotic%2520Carboxylic%2520Acids%2520in%2520Human%2520Liver%2520Microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D5%26spage%3D886%26epage%3D896%26doi%3D10.1021%2Ftx500514z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grönberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Strained Rings: Glutathione S-transferase-Catalyzed Formation of a Glutathione-Conjugated Spiro-azetidine without Prior Bioactivation</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.088658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.119.088658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=31492694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCntb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=1247-1256&issue=11&author=X.+Liauthor=G.+Gr%C3%B6nbergauthor=E.+Bangurauthor=M.+Hayesauthor=N.+Castagnoliauthor=L.+Weidolf&title=Metabolism+of+Strained+Rings%3A+Glutathione+S-transferase-Catalyzed+Formation+of+a+Glutathione-Conjugated+Spiro-azetidine+without+Prior+Bioactivation&doi=10.1124%2Fdmd.119.088658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of strained rings: glutathione S-transferase-catalyzed formation of a glutathione-conjugated spiro-azetidine without prior bioactivation</span></div><div class="casAuthors">Li, Xue-Qing; Groenberg, Gunnar; Bangur, Eva-Henriette; Hayes, Martin A.; Castagnoli, Neal; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1247-1256</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">AZD1979 [(3-(4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone] is a melanin-concg. hormone receptor 1 antagonist designed for the treatment of obesity.  In this study, metabolite profiles of AZD1979 in human hepatocytes revealed a series of glutathione-related metabolites, including the glutathionyl, cysteinyl, cysteinylglycinyl, and mercapturic acid conjugates.  The formation of these metabolites was not inhibited by coincubation with the cytochrome P 450 (P 450) inhibitor 1-aminobenzotriazole.  In efforts to identify the mechanistic features of this pathway, investigations were performed to characterize the structure of the glutathionyl conjugate M12 of AZD1979 and to identify the enzyme system catalyzing its formation.  Studies with various human liver subcellular fractions established that the formation of M12 was NAD(P)H-independent and proceeded in cytosol and S9 fractions but not in microsomal or mitochondrial fractions.  Metabolite M12 was purified from rat liver S9 incubations and its structure elucidated by NMR.  These results establish that M12 is the product of the GST-catalyzed glutathione attack on the carbon atom a to the nitrogen atom of the strained spiro-azetidinyl moiety to give, after ring opening, the corresponding amino-thioether conjugate product, a direct conjugation pathway that occurs without the prior substrate bioactivation by P 450.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrPA57-Kg_vrVg90H21EOLACvtfcHk0lj3ZVgHBaUoOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCntb3O&md5=0c59a3f2baa40d89a84b8a11843e67c0</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.088658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.088658%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGr%25C3%25B6nberg%26aufirst%3DG.%26aulast%3DBangur%26aufirst%3DE.%26aulast%3DHayes%26aufirst%3DM.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DMetabolism%2520of%2520Strained%2520Rings%253A%2520Glutathione%2520S-transferase-Catalyzed%2520Formation%2520of%2520a%2520Glutathione-Conjugated%2520Spiro-azetidine%2520without%2520Prior%2520Bioactivation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D11%26spage%3D1247%26epage%3D1256%26doi%3D10.1124%2Fdmd.119.088658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M. A.</span></span> <span> </span><span class="NLM_article-title">Interactive Mutagenicity of Sodium Nitrite, Dimethylamine, Methylurea and Ethylurea</span>. <i>Mutation Research/Environmental Mutagenesis and Related Subjects</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90073-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1016%2F0165-1161%2875%2990073-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=109-114&issue=2&author=D.+B.+Couchauthor=M.+A.+Friedman&title=Interactive+Mutagenicity+of+Sodium+Nitrite%2C+Dimethylamine%2C+Methylurea+and+Ethylurea&doi=10.1016%2F0165-1161%2875%2990073-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990073-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990073-4%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DD.%2BB.%26aulast%3DFriedman%26aufirst%3DM.%2BA.%26atitle%3DInteractive%2520Mutagenicity%2520of%2520Sodium%2520Nitrite%252C%2520Dimethylamine%252C%2520Methylurea%2520and%2520Ethylurea%26jtitle%3DMutation%2520Research%252FEnvironmental%2520Mutagenesis%2520and%2520Related%2520Subjects%26date%3D1975%26volume%3D31%26issue%3D2%26spage%3D109%26epage%3D114%26doi%3D10.1016%2F0165-1161%2875%2990073-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiran, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzelka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8792</span>– <span class="NLM_lpage">8816</span>, <span class="refDoi"> DOI: 10.1021/jm500563g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&issue=21&author=A.-L.+Grillotauthor=A.+L.+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+Charifson&title=Second-Generation+Antibacterial+Benzimidazole+Ureas%3A+Discovery+of+a+Preclinical+Candidate+with+Reduced+Metabolic+Liability&doi=10.1021%2Fjm500563g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span></div><div class="casAuthors">Grillot, Anne-Laure; Tiran, Arnaud Le; Shannon, Dean; Krueger, Elaine; Liao, Yusheng; O'Dowd, Hardwin; Tang, Qing; Ronkin, Steve; Wang, Tiansheng; Waal, Nathan; Li, Pan; Lauffer, David; Sizensky, Emmanuelle; Tanoury, Jerry; Perola, Emanuele; Grossman, Trudy H.; Doyle, Tim; Hanzelka, Brian; Jones, Steven; Dixit, Vaishali; Ewing, Nigel; Liao, Shengkai; Boucher, Brian; Jacobs, Marc; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8792-8816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 3 is a potent aminobenzimidazole urea with broad-spectrum Gram-pos. antibacterial activity resulting from dual inhibition of bacterial gyrase (GyrB) and topoisomerase IV (ParE), and it demonstrates efficacy in rodent models of bacterial infection.  Preclin. in vitro and in vivo studies showed that compd. 3 covalently labels liver proteins, presumably via formation of a reactive metabolite, and hence presented a potential safety liability.  The urea moiety in compd. 3 was identified as being potentially responsible for reactive metabolite formation, but its replacement resulted in loss of antibacterial activity and/or oral exposure due to poor physicochem. parameters.  To identify second-generation aminobenzimidazole ureas devoid of reactive metabolite formation potential, we implemented a metabolic shift strategy, which focused on shifting metab. away from the urea moiety by introducing metabolic soft spots elsewhere in the mol.  Aminobenzimidazole urea 34, identified through this strategy, exhibits similar antibacterial activity as that of 3 and did not label liver proteins in vivo, indicating reduced/no potential for reactive metabolite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TXw5pd6rXbVg90H21EOLACvtfcHk0lj3ZVgHBaUoOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J&md5=493a19ab7eaa9997f836228e25fe3125</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DTiran%26aufirst%3DA.%2BL.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%26atitle%3DSecond-Generation%2520Antibacterial%2520Benzimidazole%2520Ureas%253A%2520Discovery%2520of%2520a%2520Preclinical%2520Candidate%2520with%2520Reduced%2520Metabolic%2520Liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D21%26spage%3D8792%26epage%3D8816%26doi%3D10.1021%2Fjm500563g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2751</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01541</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1GksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2751-2788&issue=6&author=A.+K.+Ghoshauthor=M.+Brindisi&title=Urea+Derivatives+in+Modern+Drug+Discovery+and+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.9b01541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2751-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The urea functionality is inherent to numerous bioactive compds., including a variety of clin. approved therapies.  Urea-contg. compds. are increasingly used in medicinal chem. and drug design in order to establish key drug-target interactions and also to fine-tune crucial drug-like properties.  In this perspective, physicochem. and conformational properties of urea derivs. are highlighted.  Outlines of traditional reagents and chem. procedures for the prepn. of ureas are provided.  Also, newly developed methodologies mainly aimed at overcoming safety issues assocd. with traditional synthesis are discussed.  Finally, a broad overview of urea-based medicinally relevant compds., ranging from approved drugs to recent medicinal chem. developments is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgk8UhOqJ1gLVg90H21EOLACvtfcHk0lj9ZtPIdJKXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1GksbrF&md5=f888b6af362248abcb16573d8cb69e6d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DUrea%2520Derivatives%2520in%2520Modern%2520Drug%2520Discovery%2520and%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788%26doi%3D10.1021%2Facs.jmedchem.9b01541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+Set+of+Simple%2C+Interpretable+ADMET+Rules+of+Thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lj9ZtPIdJKXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520Set%2520of%2520Simple%252C%2520Interpretable%2520ADMET%2520Rules%2520of%2520Thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamidass, S. J.</span></span> <span> </span><span class="NLM_article-title">Computationally Assessing the Bioactivation of Drugs by N-Dealkylation</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=68-80&issue=2&author=N.+L.+Dangauthor=T.+B.+Hughesauthor=G.+P.+Millerauthor=S.+J.+Swamidass&title=Computationally+Assessing+the+Bioactivation+of+Drugs+by+N-Dealkylation&doi=10.1021%2Facs.chemrestox.7b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Computationally Assessing the Bioactivation of Drugs by N-Dealkylation</span></div><div class="casAuthors">Dang, Na Le; Hughes, Tyler B.; Miller, Grover P.; Swamidass, S. Joshua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-80</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochromes P 450 (CYPs) oxidize alkylated amines commonly found in drugs and other biol. active mols., cleaving them into an amine and an aldehyde.  Metabolic studies usually neglect to report or investigate aldehydes, even though they can be toxic.  It is assumed that they are efficiently detoxified into carboxylic acids and alcs.  Nevertheless, some aldehydes are reactive and escape detoxification pathways to cause adverse events by forming DNA and protein adducts.  Herein, the authors modeled N-dealkylations that produce both amine and aldehyde metabolites and then predicted the reactivity of the aldehyde.  This model used a deep learning approach previously developed by the authors' group to predict other types of drug metab.  In this study, the authors trained the model to predict N-dealkylation by human liver microsomes (HLM), finding that including isoenzyme-specific metab. data alongside HLM data significantly improved results.  The final HLM model accurately predicted the site of N-dealkylation within metabolized substrates (97% top-two and 94% area under the ROC curve).  Next, the authors combined the metab., metabolite structure prediction, and previously published reactivity models into a bioactivation model.  This combined model predicted the structure of the most likely reactive metabolite of a small validation set of drug-like mols. known to be bioactivated by N-dealkylation.  Applying this model to approved and withdrawn medicines, the authors found that aldehyde metabolites produced from N-dealkylation may explain the hepatotoxicity of several drugs: indinavir, piperacillin, verapamil, and ziprasidone.  The authors' results suggest that N-dealkylation may be an under-appreciated bioactivation pathway, esp. in clin. contexts where aldehyde detoxification pathways are inhibited.  Moreover, this is the first report of a bioactivation model constructed by combining a metab. and reactivity model.  These results raise hope that more comprehensive models of bioactivation are possible.  The model developed in this study is available at http://swami.wustl.edu/xenosite/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo9E7gjFvsLVg90H21EOLACvtfcHk0lj9ZtPIdJKXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKns7Y%253D&md5=d26fb0370cf46674a1f828651b2490c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00191%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DN.%2BL.%26aulast%3DHughes%26aufirst%3DT.%2BB.%26aulast%3DMiller%26aufirst%3DG.%2BP.%26aulast%3DSwamidass%26aufirst%3DS.%2BJ.%26atitle%3DComputationally%2520Assessing%2520the%2520Bioactivation%2520of%2520Drugs%2520by%2520N-Dealkylation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D2%26spage%3D68%26epage%3D80%26doi%3D10.1021%2Facs.chemrestox.7b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iverson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J. P.</span></span> <span> </span><span class="NLM_article-title">Identification of a Reactive Metabolite of Terbinafine: Insights into Terbinafine-Induced Hepatotoxicity</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1021/tx0002029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0002029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=175-181&issue=2&author=S.+L.+Iversonauthor=J.+P.+Uetrecht&title=Identification+of+a+Reactive+Metabolite+of+Terbinafine%3A+Insights+into+Terbinafine-Induced+Hepatotoxicity&doi=10.1021%2Ftx0002029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Reactive Metabolite of Terbinafine: Insights into Terbinafine-Induced Hepatotoxicity</span></div><div class="casAuthors">Iverson, Suzanne L.; Uetrecht, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral terbinafine treatment for superficial fungal infections of toe and fingernails is assocd. with a low incidence (1:45000) of hepatobiliary dysfunction.  Due to the rare and unpredictable nature of this adverse drug reaction, the mechanism of toxicity has been hypothesized to be either an uncommon immunol. or metabolically mediated effect. However, there is little evidence to support either mechanism, and toxic metabolites of terbinafine have not been identified.  The authors incubated terbinafine with both rat and human liver microsomal protein in the presence of GSH and were able to trap an allylic aldehyde, 7,7-dimethylhept-2-ene-4-ynal (TBF-A), which corresponds to the N-dealkylation product of terbinafine.  TBF-A was also prepd. synthetically and reacted with excess GSH to yield conjugates with HPLC retention times and mass spectra identical to those generated in the microsomal incubations.  The major GSH conjugate, characterized by 1H NMR, corresponds to addn. of GSH in a 1,6-Michael fashion.  There remains a second electrophilic site on this metabolite, which can bind either to a second mol. of GSH or to cellular proteins via a 1,4-Michael addn. mechanism.  Moreover, the authors demonstrated that the formation of the GSH conjugates was reversible.  The authors speculate that this allylic aldehyde metabolite, formed by liver enzymes and conjugated with GSH, would be transported across the canalicular membrane of hepatocytes and concd. in the bile.  The mono-GSH conjugate, which is still reactive, could bind to hepatobiliary proteins and lead to direct toxicity.  Alternatively, it could modify canalicular proteins and lead to an immune-mediated reaction causing cholestatic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGrZ61XgKfb7Vg90H21EOLACvtfcHk0lj9ZtPIdJKXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKgtr4%253D&md5=a3c239dcafd228dd7bec404053c35dfc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx0002029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0002029%26sid%3Dliteratum%253Aachs%26aulast%3DIverson%26aufirst%3DS.%2BL.%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DIdentification%2520of%2520a%2520Reactive%2520Metabolite%2520of%2520Terbinafine%253A%2520Insights%2520into%2520Terbinafine-Induced%2520Hepatotoxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2001%26volume%3D14%26issue%3D2%26spage%3D175%26epage%3D181%26doi%3D10.1021%2Ftx0002029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoPachin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, T.</span></span> <span> </span><span class="NLM_article-title">Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/tx5001046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx5001046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVensrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=1081-1091&issue=7&author=R.+M.+LoPachinauthor=T.+Gavin&title=Molecular+Mechanisms+of+Aldehyde+Toxicity%3A+A+Chemical+Perspective&doi=10.1021%2Ftx5001046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective</span></div><div class="casAuthors">LoPachin, Richard M.; Gavin, Terrence</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1091</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehydes are electrophilic compds. to which humans are pervasively exposed.  Despite a significant health risk due to exposure, the mechanisms of aldehyde toxicity are poorly understood.  This ambiguity is likely due to the structural diversity of aldehyde derivs. and corresponding differences in chem. reactions and biol. targets.  To gain mechanistic insight, the authors have used parameters based on the hard and soft, acids and bases (HSAB) theory to profile the different aldehyde subclasses with respect to electronic character (softness, hardness), electrophilic reactivity (electrophilic index), and biol. nucleophilic targets.  The authors' analyses indicate that short chain aldehydes and longer chain satd. alkanals are hard electrophiles that cause toxicity by forming adducts with hard biol. nucleophiles, e.g., primary nitrogen groups on lysine residues.  In contrast, α,β-unsatd. carbonyl derivs., alkenals, and the α-oxoaldehydes are soft electrophiles that preferentially react with soft nucleophilic thiolate groups on cysteine residues.  The aldehydes can therefore be grouped into subclasses according to common electronic characteristics (softness/hardness) and mol. mechanisms of toxicity.  As the authors will discuss, the toxic potencies of these subgroups are generally related to corresponding electrophilicities.  For some aldehydes, however, predictions of toxicity based on electrophilicity are less accurate due to inherent physicochem. variables that limit target accessibility, e.g., steric hindrance and soly.  The unsatd. aldehydes are also members of the conjugated type-2 alkene chem. class that includes α,β-unsatd. amide, ketone, and ester derivs.  Type-2 alkenes are electrophiles of varying softness and electrophilicity that share a common mechanism of toxicity.  Therefore, exposure to an environmental mixt. of unsatd. carbonyl derivs. could cause "type-2 alkene toxicity" through additive interactions.  Finally, the authors propose that environmentally derived aldehydes can accelerate diseases by interacting with endogenous aldehydes generated during oxidative stress.  This review provides a basis for understanding aldehyde mechanisms and environmental toxicity through the context of electronic structure, electrophilicity, and nucleophile target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATFAViXVn7rVg90H21EOLACvtfcHk0lir9HF7qrDpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVensrg%253D&md5=e72707796ea59ccaff0283848ebbdf76</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Ftx5001046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx5001046%26sid%3Dliteratum%253Aachs%26aulast%3DLoPachin%26aufirst%3DR.%2BM.%26aulast%3DGavin%26aufirst%3DT.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Aldehyde%2520Toxicity%253A%2520A%2520Chemical%2520Perspective%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26issue%3D7%26spage%3D1081%26epage%3D1091%26doi%3D10.1021%2Ftx5001046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Designing Around Structural Alerts in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+S.+Kalgutkar&title=Designing+Around+Structural+Alerts+in+Drug+Discovery&doi=10.1021%2Facs.jmedchem.9b00917"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00917%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DDesigning%2520Around%2520Structural%2520Alerts%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26doi%3D10.1021%2Facs.jmedchem.9b00917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1021/tx800407w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800407w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=332-340&issue=2&author=J.+N.+Baumanauthor=J.+M.+Kellyauthor=S.+Tripathyauthor=S.+X.+Zhaoauthor=W.+W.+Lamauthor=A.+S.+Kalgutkarauthor=R.+S.+Obach&title=Can+In+Vitro+Metabolism-Dependent+Covalent+Binding+Data+Distinguish+Hepatotoxic+from+Nonhepatotoxic+Drugs%3F+An+Analysis+Using+Human+Hepatocytes+and+Liver+S-9+Fraction&doi=10.1021%2Ftx800407w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction</span></div><div class="casAuthors">Bauman, Jonathon N.; Kelly, Joan M.; Tripathy, Sakambari; Zhao, Sabrina X.; Lam, Wing W.; Kalgutkar, Amit S.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-340</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro covalent binding studies in which xenobiotics are shown to undergo metab.-dependent covalent binding to macromols. have been commonly used to shed light on the biochem. mechanisms of xenobiotic-induced toxicity.  In this paper hepatotoxins and nonhepatotoxins were tested for their proclivity to demonstrate metab.-dependent covalent binding to macromols. in human liver S-9 fraction (9000 g supernatant) or human hepatocytes, as an extension to previous work that used human liver microsomes published in this journal [Obachet al. (2008) Chem. Res. Toxicol.21, 1814-1822].  In the S-9 fraction, seven out of the nine drugs in each category demonstrated some level of metab.-dependent covalent binding.  Inclusion of reduced glutathione, cofactors needed by conjugating enzymes, and other parameters (total daily dose and fraction of total intrinsic clearance comprised by covalent binding) improved the ability of the system to sep. hepatotoxins from nonhepatotoxins to a limited extent.  Covalent binding in human hepatocytes showed that six out of the nine hepatotoxins and four out of eight nonhepatotoxins demonstrated covalent binding.  Taking into account ests. of total daily body burden of covalent binding from the hepatocyte data showed an improvement over other in vitro systems for distinguishing hepatotoxins from nonhepatotoxins; however, this metab. system still displayed some false positives.  Combined with the previous study using liver microsomes, these findings identify the limitations of in vitro covalent binding data for prospective prediction of hepatotoxicity for new drug candidates and highlight the need for a better understanding of the link between drug bioactivation, covalent adduct formation, and toxicity outcomes.  Directly relating covalent binding to hepatotoxicity is likely an oversimplification of the process whereby adduct formation ultimately leads to toxicity.  Understanding underlying complexities (e.g., which macromols. are important covalent binding targets, interindividual differences in susceptibility, etc.) will be essential to any understanding of the problem of metab.-dependent hepatotoxicity and predicting toxicity from in vitro expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTemi_XkByprVg90H21EOLACvtfcHk0lir9HF7qrDpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOnuw%253D%253D&md5=5904378a0deda8e27d73ab0218b03506</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Ftx800407w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800407w%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DTripathy%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DLam%26aufirst%3DW.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DCan%2520In%2520Vitro%2520Metabolism-Dependent%2520Covalent%2520Binding%2520Data%2520Distinguish%2520Hepatotoxic%2520from%2520Nonhepatotoxic%2520Drugs%253F%2520An%2520Analysis%2520Using%2520Human%2520Hepatocytes%2520and%2520Liver%2520S-9%2520Fraction%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26issue%3D2%26spage%3D332%26epage%3D340%26doi%3D10.1021%2Ftx800407w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&issue=8&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+Vitro+Approach+to+Assess+the+Potential+for+Risk+of+Idiosyncratic+Adverse+Reactions+Caused+by+Candidate+Drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0ljl5n2FBlWR2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520Vitro%2520Approach%2520to%2520Assess%2520the%2520Potential%2520for%2520Risk%2520of%2520Idiosyncratic%2520Adverse%2520Reactions%2520Caused%2520by%2520Candidate%2520Drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D8%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref40':['cit40'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref131':['cit131'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Into the Fray! A Beginner's Guide to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (8)
                                     , 1199-1225. <a href="https://doi.org/10.1002/cmdc.202000929" title="DOI URL">https://doi.org/10.1002/cmdc.202000929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000929%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInto%252Bthe%252BFray%252521%252BA%252BBeginner%252527s%252BGuide%252Bto%252BMedicinal%252BChemistry%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D8%26spage%3D1199%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhilesh V.  Dhuria</span>, <span class="hlFld-ContribAuthor ">Bianka  Haro</span>, <span class="hlFld-ContribAuthor ">Amit  Kapadia</span>, <span class="hlFld-ContribAuthor ">Khadjia A.  Lobo</span>, <span class="hlFld-ContribAuthor ">Bernice  Matusow</span>, <span class="hlFld-ContribAuthor ">Mary A.  Schleiff</span>, <span class="hlFld-ContribAuthor ">Christina  Tantoy</span>, <span class="hlFld-ContribAuthor ">Jasleen K.  Sodhi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in predicting CYP-independent metabolism. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2021,</strong> <em>53 </em>
                                    (2)
                                     , 188-206. <a href="https://doi.org/10.1080/03602532.2021.1923728" title="DOI URL">https://doi.org/10.1080/03602532.2021.1923728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2021.1923728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2021.1923728%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DRecent%252Bdevelopments%252Bin%252Bpredicting%252BCYP-independent%252Bmetabolism%26aulast%3DDhuria%26aufirst%3DNikhilesh%2BV.%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D2%26spage%3D188%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches to mitigate the risk of serious adverse reactions in covalent drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 275-287. <a href="https://doi.org/10.1080/17460441.2021.1832079" title="DOI URL">https://doi.org/10.1080/17460441.2021.1832079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1832079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1832079%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bto%252Bmitigate%252Bthe%252Brisk%252Bof%252Bserious%252Badverse%252Breactions%252Bin%252Bcovalent%252Bdrug%252Bdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D275%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Peter  Guengerich</span>. </span><span class="cited-content_cbyCitation_article-title">A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Research</span><span> <strong>2021,</strong> <em>37 </em>
                                    (1)
                                     , 1-23. <a href="https://doi.org/10.1007/s43188-020-00056-z" title="DOI URL">https://doi.org/10.1007/s43188-020-00056-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43188-020-00056-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43188-020-00056-z%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Research%26atitle%3DA%252Bhistory%252Bof%252Bthe%252Broles%252Bof%252Bcytochrome%252BP450%252Benzymes%252Bin%252Bthe%252Btoxicity%252Bof%252Bdrugs%26aulast%3DGuengerich%26aufirst%3DF.%2BPeter%26date%3D2021%26date%3D2020%26volume%3D37%26issue%3D1%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rawan  Alnufaie</span>, <span class="hlFld-ContribAuthor ">Hansa  Raj KC</span>, <span class="hlFld-ContribAuthor ">Nickolas  Alsup</span>, <span class="hlFld-ContribAuthor ">Jedidiah  Whitt</span>, <span class="hlFld-ContribAuthor ">Steven  Andrew Chambers</span>, <span class="hlFld-ContribAuthor ">David  Gilmore</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2758. <a href="https://doi.org/10.3390/molecules25122758" title="DOI URL">https://doi.org/10.3390/molecules25122758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25122758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25122758%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BStudies%252Bof%252BCoumarin-Substituted%252BPyrazole%252BDerivatives%252Bas%252BPotent%252BAnti-Staphylococcus%252Baureus%252BAgents%26aulast%3DAlnufaie%26aufirst%3DRawan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0001.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactivation of aromatic rings.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0002.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. FDA Approved drugs containing an aminopyrazole moiety in the form of a sulphonamide <b>1</b>, urea <b>2</b>, indazole <b>3</b>, and a fused pyrimidine <b>4</b>. Only the anticancer drug entrectinib contains an unsubstituted pyrazole nitrogen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Bioactivation of Aminopyrazole Containing Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Bioactivation Pathway for Nefazodone and the Lack of Bioactivation of Buspirone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Bioactivation Pathway of Fluoropyrimidine</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Bioactivation Pathway for the Aminoimidazole in LY3031207 and LY3023703</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Radical Formation during Aliphatic Hydroxylation by P450s</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. FDA-approved drugs containing a cyclopropyl ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Bioactivation of the Cyclopropyl Group in HCV NS5B Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0004.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Use of azetidine as a more stable isostere of piperidine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. P450 Based Bioactivation of the Azetidine in MRL-A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Biotransformation of an Azetidine Ring by Glutathione Transferase</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Proposed Bioactivation Pathway of Ethylurea</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Dealkylation Reaction by P450 Resulting in Aldehyde Formation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Bioactivation of the Reactive Aldehyde Formed from Terbinafine N-Dealkylation (A) and Reactivity of Alkanals and Alkenals with Lysine and Cysteine (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/medium/jm0c00026_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Formation of Aldehydes from Drugs Associated with Hepatotoxicity</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.0c00026/20200618/images/large/jm0c00026_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00026&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">Evaluation of DILI Predictive Hypotheses in Early Drug Development</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Knu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=1017-1029&issue=4&author=R.+Chanauthor=L.+Z.+Benet&title=Evaluation+of+DILI+Predictive+Hypotheses+in+Early+Drug+Development&doi=10.1021%2Facs.chemrestox.7b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of DILI Predictive Hypotheses in Early Drug Development</span></div><div class="casAuthors">Chan, Rosa; Benet, Leslie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals.  DILI has been shown to be dependent on both daily dose and extent of hepatic metab.  Yet, early in drug development daily dose is unknown.  Here, we perform a comprehensive anal. of the published hypotheses that attempt to predict DILI, including a new anal. of the Biopharmaceutics Drug Disposition Classification System (BDDCS) in evaluating the severity of DILI warnings in drug labels approved by the FDA and the withdrawal status due to adverse drug reactions (ADRs).  Our anal. confirms that higher doses ≥50 mg/day lead to increased DILI potential, but this property alone is not sufficient to predict the DILI potential.  We evaluate prior attempts to categorize DILI such as Rule of 2, BSEP inhibition, and measures of key mechanisms of toxicity compared to BDDCS classification.  Our results show that BDDCS Class 2 drugs exhibit the highest DILI severity and that all of the published methodologies evaluated here, except when daily dose is known, do not yield markedly better predictions than BDDCS.  The assertion that extensive metabolized compds. are at higher risk of developing DILI is confirmed but can be enhanced by differentiating BDDCS Class 2 from Class 1 drugs.  We do not propose that the BDDCS classification, which does not require knowledge of the clin. dose, is sufficiently predictive/accurate of DILI potential for new mol. entities but suggest that comparison of proposed DILI prediction methodologies with BDDCS classification is a useful tool to evaluate the potential reliability of newly proposed algorithms.  Conclusion: The most successful approaches to predict DILI potential all include a measure of dose, yet there is a quantifiable uncertainty assocd. with the predicted dose early in drug development.  Here, we compare the possibility of predicting DILI potential using the BDDCS classification vs. previously published methods and note that many hypothesized predictive DILI metrics do no better than just avoiding BDDCS Class 2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwMFj2kgoGErVg90H21EOLACvtfcHk0li3BGASSkriVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Knu7s%253D&md5=27c6448357f8e7c862a7d8cfc7d033aa</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00025%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DEvaluation%2520of%2520DILI%2520Predictive%2520Hypotheses%2520in%2520Early%2520Drug%2520Development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26issue%3D4%26spage%3D1017%26epage%3D1029%26doi%3D10.1021%2Facs.chemrestox.7b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span> <span> </span><span class="NLM_article-title">Moving Beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) Towards Contrasting Relative Risk Potential</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.9b00262</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.9b00262" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslyqs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2020&pages=223-238&author=M.+D.+Aleoauthor=F.+Shahauthor=S.+Allenauthor=H.+A.+Bartonauthor=C.+Costalesauthor=S.+Lazzaroauthor=L.+Leungauthor=A.+Nilsonauthor=R.+S.+Obachauthor=A.+D.+Rodriguesauthor=Y.+Will&title=Moving+Beyond+Binary+Predictions+of+Human+Drug-Induced+Liver+Injury+%28DILI%29+Towards+Contrasting+Relative+Risk+Potential&doi=10.1021%2Facs.chemrestox.9b00262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential</span></div><div class="casAuthors">Aleo, Michael D.; Shah, Falgun; Allen, Scott; Barton, Hugh A.; Costales, Chester; Lazzaro, Sarah; Leung, Louis; Nilson, Andrea; Obach, R. Scott; Rodrigues, A. David; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-238</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatic risk matrix (HRM) was developed and used to differentiate lead clin. and back-up drug candidates against competitor/marketed drugs within the same pharmaceutical class for their potential to cause human drug-induced liver injury (DILI).  The hybrid HRM scoring system blends physicochem. properties (Rule of Two Model: dose and lipophilicity or Partition Model: dose, ionization state, lipophilicity, and carbon bond satn.) with common toxicity mechanisms (cytotoxicity, mitochondrial dysfunction, and bile salt export pump (BSEP) inhibition) that promote DILI.  HRM scores are based on bracketed safety margins (<1, 1-10, 10-100, and >100x of clin. Cmax,total. Based on well-established clin. safety experience of marketed/withdrawn drug candidates, the background anal. consists of 200 drugs from the Liver Toxicity Knowledge Base annotated as Most-DILI- (79), Less-DILI- (56), No-DILI- (47) and Ambiguous-DILI-concern (18) drugs.  Scores were generated for over 21 internal and 7 external drug candidates discontinued for unacceptable incidence/magnitude of liver transaminase elevations during clin. trials or withdrawn for liver injury severity.  Both hybrid scoring systems identified 70-80% Most-DILI-concern drugs, but more importantly stratified successful/unsuccessful drug candidates for liver safety (incidence/severity of transaminase elevations and approved drug labels).  Incorporating other mechanisms (reactive metabolite and cytotoxic metabolite generation and hepatic efflux transport inhibition, other than BSEP) to the HRM had minimal beneficial impact in DILI prediction/stratification.  As is, the hybrid scoring system was positioned for portfolio assessments to contrast DILI risk potential of small mol. drug candidates in early clin. development.  This stratified approach for DILI prediction aided decisions regarding drug candidate progression, back-up selection, clin. dose selection, and due diligence assessments in favor of compds. with less implied clin. hepatotoxicity risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxpXYcWnTspbVg90H21EOLACvtfcHk0li3BGASSkriVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslyqs7nM&md5=00852b0e8f03e7813e90f6f29c507d0e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.9b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.9b00262%26sid%3Dliteratum%253Aachs%26aulast%3DAleo%26aufirst%3DM.%2BD.%26aulast%3DShah%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DBarton%26aufirst%3DH.%2BA.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DLazzaro%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DNilson%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DMoving%2520Beyond%2520Binary%2520Predictions%2520of%2520Human%2520Drug-Induced%2520Liver%2520Injury%2520%2528DILI%2529%2520Towards%2520Contrasting%2520Relative%2520Risk%2520Potential%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2020%26volume%3D33%26spage%3D223%26epage%3D238%26doi%3D10.1021%2Facs.chemrestox.9b00262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span> <span> </span><span class="NLM_article-title">High Lipophilicity and High Daily Dose of Oral Medications Are Associated with Significant Risk for Drug-Induced Liver Injury</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1002/hep.26208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1002%2Fhep.26208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=23258593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=388-396&issue=1&author=M.+Chenauthor=J.+Borlakauthor=W.+Tong&title=High+Lipophilicity+and+High+Daily+Dose+of+Oral+Medications+Are+Associated+with+Significant+Risk+for+Drug-Induced+Liver+Injury&doi=10.1002%2Fhep.26208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span></div><div class="casAuthors">Chen, Minjun; Borlak, Juergen; Tong, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals from the market.  Although there is evidence that dosages of ≥100 mg/day are assocd. with increased risk for hepatotoxicity, many drugs are safe at such dosages.  There is an unmet need to predict risk for DILI more reliably, and lipophilicity might be a contributing factor.  We analyzed the combined factors of daily dose and lipophilicity for 164 US Food and Drug Administration-approved oral medications and obsd. high risk for hepatotoxicity (odds ratio [OR], 14.05; P < 0.001) for drugs given at dosages ≥100 mg/day and octanol-water partition coeff. (logP) ≥3.  This defined the "rule-of-two.".  Similar results were obtained for an independent set of 179 oral medications with 85% of the rule-of-two positives being assocd. with hepatotoxicity (OR, 3.89; P < 0.01).  Using the World Health Organization's Anatomical Therapeutic Chem. classification system, the rule-of-two performed best in predicting DILI in seven therapeutic categories.  Among 15 rule-of-two positives, 14 were withdrawn from hepatotoxic drugs, and one was over-the-counter medication labeled for liver injury.  We addnl. examd. drug pairs that have similar chem. structures and act on the same mol. target but differ in their potential for DILI.  Again, the rule-of-two predicted hepatotoxicity reliably.  Finally, the rule-of-two was applied to clin. case studies to identify hepatotoxic drugs in complex comedication regimes to further demonstrate its use.  Conclusion: Apart from dose, lipophilicity contributes significantly to risk for hepatotoxicity.  Applying the rule-of-two is an appropriate means of estg. risk for DILI compared with dose alone. (HEPATOl. 2013).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EE02L_JCdLVg90H21EOLACvtfcHk0lhdva2X8X0rkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM&md5=a88e02ff29653bdeee53b59a4da46d06</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fhep.26208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DW.%26atitle%3DHigh%2520Lipophilicity%2520and%2520High%2520Daily%2520Dose%2520of%2520Oral%2520Medications%2520Are%2520Associated%2520with%2520Significant%2520Risk%2520for%2520Drug-Induced%2520Liver%2520Injury%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26issue%3D1%26spage%3D388%26epage%3D396%26doi%3D10.1002%2Fhep.26208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Limban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuţă, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiriţă, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negreş, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsene, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goumenou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakitsios, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsakis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarigiannis, D. A.</span></span> <span> </span><span class="NLM_article-title">The Use of Structural Alerts to Avoid the Toxicity of Pharmaceuticals</span>. <i>Toxicology Reports</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1016/j.toxrep.2018.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1016%2Fj.toxrep.2018.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=30258789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=943-953&author=C.+Limbanauthor=D.+C.+Nu%C5%A3%C4%83author=C.+Chiri%C5%A3%C4%83author=S.+Negre%C5%9Fauthor=A.+L.+Arseneauthor=M.+Goumenouauthor=S.+P.+Karakitsiosauthor=A.+M.+Tsatsakisauthor=D.+A.+Sarigiannis&title=The+Use+of+Structural+Alerts+to+Avoid+the+Toxicity+of+Pharmaceuticals&doi=10.1016%2Fj.toxrep.2018.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The use of structural alerts to avoid the toxicity of pharmaceuticals</span></div><div class="casAuthors">Limban, Carmen; Nuta, Diana C.; Chirita, Cornel; Negres, Simona; Arsene, Andreea L.; Goumenou, Marina; Karakitsios, Spyros P.; Tsatsakis, Aristidis M.; Sarigiannis, Dimosthenis A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">943-953</span>CODEN:
                <span class="NLM_cas:coden">TROEF9</span>;
        ISSN:<span class="NLM_cas:issn">2214-7500</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In order to identify compds. with potential toxicity problems, particular attention is paid to structural alerts, which are high chem. reactivity mol. fragments or fragments that can be transformed via bioactivation by human enzymes into fragments with high chem. reactivity.  The concept has been introduced in order to reduce the likelihood that future candidate substances as pharmaceuticals will have undesirable toxic effects.  A significant proportion (∼78-86%) of drugs characterized by residual toxicity contain structural alerts; there is also evidence indicating the formation of active metabolites as a causal factor for the toxicity of 62-69% of these mols.  On the other hand, the pharmacol. action of certain drugs depends on the formation of reactive metabolites.  Detailed assessment of the potential for the formation of active metabolites is recommended to characterize a biol. active compd.  Although many prescribed drugs frequently contain structural alerts and form reactive metabolites, the vast majority of these drugs are administered in low daily doses.  Avoiding structural alerts has become almost a norm in new drug design.  An in-depth review of the biochem. reactivity of these structural alerts for new drug candidates is crit. from a safety point of view and is currently being monitored in the discovery of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo166eMQmr1e7Vg90H21EOLACvtfcHk0lhdva2X8X0rkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrnN&md5=28743dd8412732377d245375a4da3dc6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.toxrep.2018.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxrep.2018.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DLimban%26aufirst%3DC.%26aulast%3DNu%25C5%25A3%25C4%2583%26aufirst%3DD.%2BC.%26aulast%3DChiri%25C5%25A3%25C4%2583%26aufirst%3DC.%26aulast%3DNegre%25C5%259F%26aufirst%3DS.%26aulast%3DArsene%26aufirst%3DA.%2BL.%26aulast%3DGoumenou%26aufirst%3DM.%26aulast%3DKarakitsios%26aufirst%3DS.%2BP.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26aulast%3DSarigiannis%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Use%2520of%2520Structural%2520Alerts%2520to%2520Avoid%2520the%2520Toxicity%2520of%2520Pharmaceuticals%26jtitle%3DToxicology%2520Reports%26date%3D2018%26volume%3D5%26spage%3D943%26epage%3D953%26doi%3D10.1016%2Fj.toxrep.2018.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claesson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minidis, A.</span></span> <span> </span><span class="NLM_article-title">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1Wkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=389-411&issue=6&author=A.+Claessonauthor=A.+Minidis&title=Systematic+Approach+to+Organizing+Structural+Alerts+for+Reactive+Metabolite+Formation+from+Potential+Drugs&doi=10.1021%2Facs.chemrestox.8b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs</span></div><div class="casAuthors">Claesson, Alf; Minidis, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">389-411</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Reactive metabolites are widely accepted as playing a pivotal role in causing idiosyncratic adverse drug reactions (IDR).  However, much is unknown about the biol. mechanisms of IDR although the initiating event in most cases is an attachment of a reactive intermediate to macromols. leading to immune mediated responses.  Reactive metabolites are also involved in many mutagenesis/ carcinogenesis events by reacting with DNA.  Drug designers thus have all reasons to make large efforts to avoid making test compds. having a liability to generate reactive metabolites.  In this Perspective the authors argue for using structural alerts (SA) as the most straightforward way to link forecasting about chem. hazards of planned test compds. to the accumulated knowledge base.  Although many SAs have been widely recognized and reviewed previously, there are also a lot of observations that have no readily discernable chem. interpretation.  For drug designers to benefit from all published data, the knowledge has to be organized in a way that is readily searchable starting with a query structure.  The authors propose that an increased no. of structural alerts with more details should be applied to obtain improved decision support.  The assocn. of selected SAs with ref. drugs, whose proposed or hypothesized activation mechanisms build the knowledge base, should be readily available in a format comprising of small summaries with included hyperlinks for quick access to the original literature, as outlined in the TOC illustration.  Since some structural alerts are present in drugs that do not cause idiosyncratic adverse reactions or drug-drug interactions, it is important to elaborate on the reasons for this discrepancy as much as possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TRDGoBo8FLVg90H21EOLACvtfcHk0lhdva2X8X0rkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1Wkurw%253D&md5=8822e32efecbf62c90d62ba5dacfda63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00046%26sid%3Dliteratum%253Aachs%26aulast%3DClaesson%26aufirst%3DA.%26aulast%3DMinidis%26aufirst%3DA.%26atitle%3DSystematic%2520Approach%2520to%2520Organizing%2520Structural%2520Alerts%2520for%2520Reactive%2520Metabolite%2520Formation%2520from%2520Potential%2520Drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D6%26spage%3D389%26epage%3D411%26doi%3D10.1021%2Facs.chemrestox.8b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallqvist, A.</span></span> <span> </span><span class="NLM_article-title">Data-Driven Identification of Structural Alerts for Mitigating the Risk of Drug-Induced Human Liver Injuries</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/s13321-015-0053-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1186%2Fs13321-015-0053-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVakur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=4&issue=1&author=R.+Liuauthor=X.+Yuauthor=A.+Wallqvist&title=Data-Driven+Identification+of+Structural+Alerts+for+Mitigating+the+Risk+of+Drug-Induced+Human+Liver+Injuries&doi=10.1186%2Fs13321-015-0053-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries</span></div><div class="casAuthors">Liu, Ruifeng; Yu, Xueping; Wallqvist, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4/1-4/8</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: The use of structural alerts to de-prioritize compds. with undesirable features as drug candidates has been gaining in popularity.  Hundreds of mol. structural moieties have been proposed as structural alerts.  An emerging issue is that strict application of these alerts will result in a significant redn. of the chem. space for new drug discovery, as more than half of the oral drugs on the market match at least one of the alerts.  To mitigate this issue, we propose to apply a rigorous statistical anal. to derive/validate structural alerts before use.  Method: To derive human liver toxicity structural alerts, we retrieved all small-mol. entries from LiverTox, a U.S.  National Institutes of Health online resource for information on human liver injuries induced by prescription and over-the-counter drugs and dietary supplements.  We classified the compds. into hepatotoxic, nonhepatotoxic, and possible hepatotoxic classes, and performed detailed statistical analyses to identify mol. structural fragments highly enriched in the hepatotoxic class beyond random distribution as structural alerts for human liver injuries.  Results: We identified 12 mol. fragments present in multiple marketed drugs that one can consider as common "drug-like" fragments, yet they are strongly assocd. with drug-induced human liver injuries.  Thus, these fragments may be considered as robust hepatotoxicity structural alerts suitable for use in drug discovery screening programs.  Conclusions: The use of structural alerts has contributed to the identification of many compds. with potential toxicity issues in modern drug discovery.  However, with a large no. of structural alerts published to date without proper validation, application of these alerts may restrict the chem. space and prevent discovery of valuable drugs.  To mitigate this issue, we showed how to use statistical analyses to develop a small, robust, and broadly applicable set of structural alerts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGSOZp-sLIIbVg90H21EOLACvtfcHk0lg422dv6itB5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVakur0%253D&md5=468b141b02779bfdb9a74e8a203ca24f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13321-015-0053-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-015-0053-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWallqvist%26aufirst%3DA.%26atitle%3DData-Driven%2520Identification%2520of%2520Structural%2520Alerts%2520for%2520Mitigating%2520the%2520Risk%2520of%2520Drug-Induced%2520Human%2520Liver%2520Injuries%26jtitle%3DJ.%2520Cheminf.%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D4%26doi%3D10.1186%2Fs13321-015-0053-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkata, K. C. N.</span></span> <span> </span><span class="NLM_article-title">Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice</span>. <i>Pharmacy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">43</span>, <span class="refDoi"> DOI: 10.3390/pharmacy6020043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.3390%2Fpharmacy6020043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=43&issue=2&author=A.+V.+Fuentesauthor=M.+D.+Pinedaauthor=K.+C.+N.+Venkata&title=Comprehension+of+Top+200+Prescribed+Drugs+in+the+US+as+a+Resource+for+Pharmacy+Teaching%2C+Training+and+Practice&doi=10.3390%2Fpharmacy6020043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fpharmacy6020043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmacy6020043%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes%26aufirst%3DA.%2BV.%26aulast%3DPineda%26aufirst%3DM.%2BD.%26aulast%3DVenkata%26aufirst%3DK.%2BC.%2BN.%26atitle%3DComprehension%2520of%2520Top%2520200%2520Prescribed%2520Drugs%2520in%2520the%2520US%2520as%2520a%2520Resource%2520for%2520Pharmacy%2520Teaching%252C%2520Training%2520and%2520Practice%26jtitle%3DPharmacy%26date%3D2018%26volume%3D6%26issue%3D2%26spage%3D43%26doi%3D10.3390%2Fpharmacy6020043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlap, T.</span></span> <span> </span><span class="NLM_article-title">Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=13-37&issue=1&author=J.+L.+Boltonauthor=T.+Dunlap&title=Formation+and+Biological+Targets+of+Quinones%3A+Cytotoxic+versus+Cytoprotective+Effects&doi=10.1021%2Facs.chemrestox.6b00256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects</span></div><div class="casAuthors">Bolton, Judy L.; Dunlap, Tareisha</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-37</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Quinones represent a class of toxicol. intermediates, which can create a variety of hazardous effects in vivo including, acute cytotoxicity, immunotoxicity, and carcinogenesis.  In contrast, quinones can induce cytoprotection through induction of detoxification enzymes, anti-inflammatory activities, and modification of redox status.  The mechanisms by which quinones cause these effects can be quite complex.  The various biol. targets of quinones depend on their rate and site of formation and their reactivity.  Quinones are formed through a variety of mechanisms from simple oxidn. of catechols/hydroquinones catalyzed by a variety of oxidative enzymes and metal ions to more complex mechanisms involving initial P 450-catalyzed hydroxylation reactions followed by two-electron oxidn.  Quinones are Michael acceptors and modification of cellular processes could occur through alkylation of crucial cellular proteins and/or DNA.  Alternatively, quinones are highly redox active mols. which can redox cycle with their semiquinone radical anions leading to formation of reactive oxygen species (ROS) including superoxide, hydrogen peroxide, and ultimately the hydroxyl radical.  Prodn. of ROS can alter redox balance within cells through the formation of oxidized cellular macromols. including lipids, proteins, and DNA.  This perspective explores the varied biol. targets of quinones including GSH, NADPH, protein sulfhydryls [heat shock proteins, P 450, cyclooxygenase-2 (COX-2), glutathione S-transferase (GST), NAD(P)H:quinone oxidoreductase 1, (NQO1), kelch-like ECH-assocd. protein 1 (Keap1), IκB kinase (IKK), arylhydrocarbon receptor (AhR)], and DNA.  The evidence strongly suggests that the numerous mechanisms of quinone modulations (i.e., alkylation vs. oxidative stress) can be correlated with the known pathol./cytoprotection of the parent compd.(s) that is best described by an inverse U-shaped dose-response curve.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSxHXZNZr3cbVg90H21EOLACvtfcHk0lg422dv6itB5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtb7P&md5=a8dfdbd1e5b6d7bc016a97aca34e6c5a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00256%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DJ.%2BL.%26aulast%3DDunlap%26aufirst%3DT.%26atitle%3DFormation%2520and%2520Biological%2520Targets%2520of%2520Quinones%253A%2520Cytotoxic%2520versus%2520Cytoprotective%2520Effects%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26issue%3D1%26spage%3D13%26epage%3D37%26doi%3D10.1021%2Facs.chemrestox.6b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foitzik, R.</span></span> <span> </span><span class="NLM_article-title">Evidence for the <i>in Vitro</i> Bioactivation of Aminopyrazole Derivatives: Trapping Reactive Aminopyrazole Intermediates Using Glutathione Ethyl Ester in Human Liver Microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1747</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWitb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=1747-1752&issue=9&author=E.+Ryanauthor=B.+Morrowauthor=C.+Hemleyauthor=J.+Pinsonauthor=S.+Charmanauthor=F.+Chiuauthor=R.+Foitzik&title=Evidence+for+the+in+Vitro+Bioactivation+of+Aminopyrazole+Derivatives%3A+Trapping+Reactive+Aminopyrazole+Intermediates+Using+Glutathione+Ethyl+Ester+in+Human+Liver+Microsomes&doi=10.1021%2Facs.chemrestox.5b00202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the in Vitro Bioactivation of Aminopyrazole Derivatives: Trapping Reactive Aminopyrazole Intermediates Using Glutathione Ethyl Ester in Human Liver Microsomes</span></div><div class="casAuthors">Ryan, Eileen; Morrow, Benjamin J.; Hemley, Catherine F.; Pinson, Jo-Anne; Charman, Susan A.; Chiu, Francis C. K.; Foitzik, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1747-1752</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced toxicity is a leading cause of drug withdrawal from clin. development and clin. use and represents a major impediment to the development of new drugs.  The mechanisms underlying drug-induced toxicities are varied; however, metabolic bioactivation to form reactive metabolites has been identified as a major contributor.  These electrophilic species can covalently modify important biol. macromols. and thereby increase the risk of adverse drug reactions or idiosyncratic toxicity.  Consequently, screening compds. for their propensity to form reactive metabolites has become an integral part of drug discovery programs.  This screening process typically involves identification of structural alerts as well as the generation of reactive metabolites in vitro in subcellular hepatic fractions, followed by trapping the reactive species with nucleophiles and characterization via LC-MS.  This article presents evidence for the bioactivation of a series of aminopyrazole derivs. via LC-MS detection of glutathione Et ester-trapped reactive intermediates formed in human liver microsomal incubations.  These results indicate that the aminopyrazole motif, within specific contexts, may be considered a new structural alert for the potential formation of reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLgkp20tGk7Vg90H21EOLACvtfcHk0lg422dv6itB5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWitb7J&md5=fde6656778dfcd6dfb6d14cc5e3a2b9c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00202%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DMorrow%26aufirst%3DB.%26aulast%3DHemley%26aufirst%3DC.%26aulast%3DPinson%26aufirst%3DJ.%26aulast%3DCharman%26aufirst%3DS.%26aulast%3DChiu%26aufirst%3DF.%26aulast%3DFoitzik%26aufirst%3DR.%26atitle%3DEvidence%2520for%2520the%2520in%2520Vitro%2520Bioactivation%2520of%2520Aminopyrazole%2520Derivatives%253A%2520Trapping%2520Reactive%2520Aminopyrazole%2520Intermediates%2520Using%2520Glutathione%2520Ethyl%2520Ester%2520in%2520Human%2520Liver%2520Microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D9%26spage%3D1747%26epage%3D1752%26doi%3D10.1021%2Facs.chemrestox.5b00202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&issue=9&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+Necessary+Nitrogen+Atom%3A+A+Versatile+High-Impact+Design+Element+for+Multiparameter+Optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0ljl7Ja72TxyJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520Necessary%2520Nitrogen%2520Atom%253A%2520A%2520Versatile%2520High-Impact%2520Design%2520Element%2520for%2520Multiparameter%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lame, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soglia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendsch, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.C. A.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of the Nontricyclic Antidepressant Nefazodone to a Reactive Quinone-Imine Species in Human Liver Microsomes and Recombinant Cytochrome P450 3A4</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.104.001735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15523046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=243-253&issue=2&author=A.+S.+Kalgutkarauthor=A.+D.+N.+Vazauthor=M.+E.+Lameauthor=K.+R.+Henneauthor=J.+Sogliaauthor=S.+X.+Zhaoauthor=Y.+A.+Abramovauthor=F.+Lombardoauthor=C.+Collinauthor=Z.+S.+Hendschauthor=C.+E.C.+A.+Hop&title=Bioactivation+of+the+Nontricyclic+Antidepressant+Nefazodone+to+a+Reactive+Quinone-Imine+Species+in+Human+Liver+Microsomes+and+Recombinant+Cytochrome+P450+3A4&doi=10.1124%2Fdmd.104.001735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4</span></div><div class="casAuthors">Kalgutkar, Amit S.; Vaz, Alfin D. N.; Lame, Mary E.; Henne, Kirk R.; Soglia, John; Zhao, Sabrina X.; Abramov, Yuri A.; Lombardo, Franco; Collin, Claire; Hendsch, Zachary S.; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The therapeutic benefits of the antidepressant nefazodone have been hampered by several cases of acute hepatotoxicity/liver failure.  Although the mechanism of hepatotoxicity remains unknown, it is possible that reactive metabolites of nefazodone play a causative role.  Studies were initiated to det. whether nefazodone undergoes bioactivation in human liver microsomes to electrophilic intermediates.  Following incubation of nefazodone with microsomes or recombinant P 4503A4 in the presence of sulfhydryl nucleophiles, conjugates derived from the addn. of thiol to a monohydroxylated nefazodone metabolite were obsd.  Product ion spectra suggested that hydroxylation and sulfhydryl conjugation occurred on the 3-chlorophenylpiperazine-ring, consistent with a bioactivation pathway involving initial formation of p-hydroxynefazodone, followed by its two-electron oxidn. to the reactive quinone-imine intermediate.  The formation of novel N-dearylated nefazodone metabolites was also discernible in these incubations, and 2-chloro-1,4-benzoquinone, a byproduct of N-dearylation, was trapped with glutathione to afford the corresponding hydroquinone-sulfhydryl adduct.  Nefazodone also displayed NADPH-, time-, and concn.-dependent inactivation of P 450 3A4 activity, suggesting that reactive metabolites derived from nefazodone bioactivation are capable of covalently modifying P 4503A4.  A causative role for 2-chloro-1,4-benzoquinone and/or the quinone-imine intermediate(s) in nefazodone hepatotoxicity is speculated.  Although the antianxiety agent buspirone, which contains a pyrimidine ring in place of the 3-chlorophenyl-ring, also generated p-hydroxybuspirone in liver microsomes, no sulfhydryl conjugates of this metabolite were obsd.  This finding is consistent with the proposal that two-electron oxidn. of p-hydroxybuspirone to the corresponding quinone-imine is less favorable due to differences in the protonation state at physiol. pH and due to weaker resonance stabilization of the oxidn. products as predicted from ab initio measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm8ZzhHTzKarVg90H21EOLACvtfcHk0ljl7Ja72TxyJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cjsbc%253D&md5=7f6d27921d2236e202256ad0035fedce</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001735%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DSoglia%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DCollin%26aufirst%3DC.%26aulast%3DHendsch%26aufirst%3DZ.%2BS.%26aulast%3DHop%26aufirst%3DC.%2BE.C.%2BA.%26atitle%3DBioactivation%2520of%2520the%2520Nontricyclic%2520Antidepressant%2520Nefazodone%2520to%2520a%2520Reactive%2520Quinone-Imine%2520Species%2520in%2520Human%2520Liver%2520Microsomes%2520and%2520Recombinant%2520Cytochrome%2520P450%25203A4%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26issue%3D2%26spage%3D243%26epage%3D253%26doi%3D10.1124%2Fdmd.104.001735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&issue=13&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0ljl7Ja72TxyJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagzoog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janero, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmowitch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczesniak, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, G. A.</span></span> <span> </span><span class="NLM_article-title">Application of Fluorine- And Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of CB1 Receptor Positive Allosteric Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01142</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1WktrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=542-568&author=S.+Garaiauthor=P.+M.+Kulkarniauthor=P.+C.+Schafferauthor=L.+Leoauthor=A.+L.+Brandtauthor=A.+Zagzoogauthor=T.+Blackauthor=X.+Linauthor=D.+P.+Hurstauthor=D.+R.+Janeroauthor=M.+E.+Aboodauthor=A.+Zimmowitchauthor=A.+Straikerauthor=R.+G.+Pertweeauthor=M.+Kellyauthor=A.+M.+Szczesniakauthor=E.+M.+Denovan-Wrightauthor=K.+Mackieauthor=A.+G.+Hohmannauthor=P.+H.+Reggioauthor=R.+B.+Laprairieauthor=G.+A.+Thakur&title=Application+of+Fluorine-+And+Nitrogen-Walk+Approaches%3A+Defining+the+Structural+and+Functional+Diversity+of+2-Phenylindole+Class+of+CB1+Receptor+Positive+Allosteric+Modulators&doi=10.1021%2Facs.jmedchem.9b01142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators</span></div><div class="casAuthors">Garai, Sumanta; Kulkarni, Pushkar M.; Schaffer, Peter C.; Leo, Luciana M.; Brandt, Asher L.; Zagzoog, Ayat; Black, Tallan; Lin, Xiaoyan; Hurst, Dow P.; Janero, David R.; Abood, Mary E.; Zimmowitch, Anaelle; Straiker, Alex; Pertwee, Roger G.; Kelly, Melanie; Szczesniak, Anna-Maria; Denovan-Wright, Eileen M.; Mackie, Ken; Hohmann, Andrea G.; Reggio, Patricia H.; Laprairie, Robert B.; Thakur, Ganesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">542-568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cannabinoid 1 receptor (CB1R) allosteric ligands hold far-reaching therapeutic promise.  We report application of fluoro- and nitrogen-walk approaches to enhance the drug-like properties of GAT211, a prototype CB1R allosteric agonist-pos. allosteric modulator (ago-PAM).  Several analogs exhibited improved functional potency (cAMP, arrestin2), metabolic stability, and aq. soly.  Two key analogs, GAT591 (6r) and GAT593 (6s), exhibited augmented allosteric-agonist and PAM activities in neuronal cultures, improved metabolic stability, and enhanced orthosteric agonist binding (CP55,940).  Both also exhibited good analgesic potency in the CFA inflammatory-pain model with longer duration of action over GAT211 while devoid of adverse cannabimimetic effects.  Another analog, GAT592 (9j), exhibited moderate ago-PAM potency and improved aq. soly. with therapeutic redn. of intraocular pressure in murine glaucoma models.  The SAR findings and the enhanced allosteric activity in this class of allosteric modulators were accounted for in our recently developed computational model for CB1R allosteric activation and pos. allosteric modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOfHY8Dr6ugbVg90H21EOLACvtfcHk0lhL9Alup7ndng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktrbF&md5=42e8edb208751b040c3f6d7481381834</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01142%26sid%3Dliteratum%253Aachs%26aulast%3DGarai%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DP.%2BM.%26aulast%3DSchaffer%26aufirst%3DP.%2BC.%26aulast%3DLeo%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DA.%2BL.%26aulast%3DZagzoog%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DZimmowitch%26aufirst%3DA.%26aulast%3DStraiker%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DSzczesniak%26aufirst%3DA.%2BM.%26aulast%3DDenovan-Wright%26aufirst%3DE.%2BM.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DThakur%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520Fluorine-%2520And%2520Nitrogen-Walk%2520Approaches%253A%2520Defining%2520the%2520Structural%2520and%2520Functional%2520Diversity%2520of%25202-Phenylindole%2520Class%2520of%2520CB1%2520Receptor%2520Positive%2520Allosteric%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D542%26epage%3D568%26doi%3D10.1021%2Facs.jmedchem.9b01142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamanda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span> <span> </span><span class="NLM_article-title">Overcoming Time Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10708</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2rtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10700-10708&issue=23&author=M.+Mandalauthor=K.+Mitraauthor=D.+Grotzauthor=X.+Linauthor=J.+Palamandaauthor=P.+Kumariauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Chenauthor=K.+Coxauthor=L.+Favreauauthor=L.+Hydeauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=E.+Parkerauthor=D.+Rindgenauthor=E.+Shererauthor=H.+Wangauthor=Z.+Zhuauthor=A.+W.+Stamfordauthor=J.+N.+Cumming&title=Overcoming+Time+Dependent+Inhibition+%28TDI%29+of+Cytochrome+P450+3A4+%28CYP3A4%29+Resulting+from+Bioactivation+of+a+Fluoropyrimidine+Moiety&doi=10.1021%2Facs.jmedchem.8b01326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety</span></div><div class="casAuthors">Mandal, Mihirbaran; Mitra, Kaushik; Grotz, Diane; Lin, Xinjie; Palamanda, Jairam; Kumari, Pramila; Buevich, Alexei; Caldwell, John P.; Chen, Xia; Cox, Kathleen; Favreau, Leonard; Hyde, Lynn; Kennedy, Matthew E.; Kuvelkar, Reshma; Liu, Xiaoxiang; Mazzola, Robert D.; Parker, Eric; Rindgen, Diane; Sherer, Edward; Wang, Hongwu; Zhu, Zhaoning; Stamford, Andrew W.; Cumming, Jared N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10700-10708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein the authors describe structure-activity relationship (SAR) and metabolite identification (Met-ID) studies that provided insight into the origin of time-dependent inhibition (TDI) of cytochrome P 450 3A4 (CYP3A4) by compd. I.  Collectively, these efforts revealed that bioactivation of the fluoropyrimidine moiety of I led to reactive metabolite formation via oxidative defluorination and was responsible for the obsd. TDI.  The authors discovered that substitution at both the 4- and 6-positions of the 5-fluoropyrimidine of I was necessary to ameliorate this TDI as exemplified by compd. II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1gkRc8EoJSLVg90H21EOLACvtfcHk0lhL9Alup7ndng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2rtbfM&md5=09c862a66c3b078e0886696a6c2cd489</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01326%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DKumari%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DSherer%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DOvercoming%2520Time%2520Dependent%2520Inhibition%2520%2528TDI%2529%2520of%2520Cytochrome%2520P450%25203A4%2520%2528CYP3A4%2529%2520Resulting%2520from%2520Bioactivation%2520of%2520a%2520Fluoropyrimidine%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D23%26spage%3D10700%26epage%3D10708%26doi%3D10.1021%2Facs.jmedchem.8b01326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.106.012633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=17093004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=246-255&issue=2&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnan&title=Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+Enzymes+and+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.106.012633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to use vitro inactivation kinetic parameters in scaling to in vivo drug-drug interactions (DDIs) for mechanism-based inactivators of human cytochrome P 450 (P 450) enzymes was examd. using eight human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, in vivo P 450 enzyme degrdn. rate consts. estd. from clin. pharmacokinetic data, and fraction of the affected drug cleared by the inhibited enzyme) to predict increases in exposure to drugs, and the predictions were compared with in vivo DDIs gathered from clin. studies reported in the scientific literature.  In general, the use of unbound systemic Cmax as the inactivator concn. in vivo yielded the most accurate predictions of DDI with a mean -fold error of 1.64.  Abbreviated in vitro approaches to identifying mechanism-based inactivators were developed.  Testing potential inactivators at a single concn. (IC25) in a 30-min preincubation with human liver microsomes in the absence and presence of NADPH followed by assessment of P 450 marker activities readily identified those compds. known to be mechanism-based inactivators and represents an approach that can be used with greater throughput.  Measurement of decreases in IC50 occurring with a 30-min preincubation with liver microsomes and NADPH was also useful in identifying mechanism-based inactivators, and the IC50 measured after such a preincubation was highly correlated with the kinact/K1 ratio measured after a full characterization of inactivation.  Overall, these findings support the conclusion that P 450 in vitro inactivation data are valuable in predicting clin. DDIs that can occur via this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPRf5ZGrW6LVg90H21EOLACvtfcHk0lhL9Alup7ndng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D&md5=71733cfafba3b2c9cc6b47a46e7b3f40</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012633%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26atitle%3DMechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520and%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D246%26epage%3D255%26doi%3D10.1124%2Fdmd.106.012633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuklish, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czeskis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luffer-Atlas, D.</span></span> <span> </span><span class="NLM_article-title">Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2051</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01806</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2041-2051&author=B.+H.+Normanauthor=M.+J.+Fisherauthor=M.+A.+Schifflerauthor=S.+L.+Kuklishauthor=N.+E.+Hughesauthor=B.+A.+Czeskisauthor=K.+C.+Cassidyauthor=T.+L.+Abrahamauthor=J.+J.+Albertsauthor=D.+Luffer-Atlas&title=Identification+and+Mitigation+of+Reactive+Metabolites+of+2-Aminoimidazole-Containing+Microsomal+Prostaglandin+E+Synthase-1+Inhibitors+Terminated+Due+to+Clinical+Drug-Induced+Liver+Injury&doi=10.1021%2Facs.jmedchem.7b01806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury</span></div><div class="casAuthors">Norman, Bryan H.; Fisher, Matthew J.; Schiffler, Matthew A.; Kuklish, Steven L.; Hughes, Norman E.; Czeskis, Boris A.; Cassidy, Kenneth C.; Abraham, Trent L.; Alberts, Jeffrey J.; Luffer-Atlas, Debra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2041-2051</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two 2-aminoimidazole-based inhibitors, LY3031207 (1) and LY3023703 (2), of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme were found to cause drug-induced liver injury (DILI) in humans.  We studied imidazole ring substitutions to successfully mitigate reactive metabolite (RM) formation.  These studies support the conclusion that RM formation may play a role in the observations of DILI and the consideration of 2-aminoimidazoles as structure alerts, due to the high likelihood of bioactivation to generate RMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYz_L4vs5v2LVg90H21EOLACvtfcHk0lghEVBwBNWIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gtbY%253D&md5=e4e9f4fac1cae1af730b997dcf663d21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01806%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DM.%2BJ.%26aulast%3DSchiffler%26aufirst%3DM.%2BA.%26aulast%3DKuklish%26aufirst%3DS.%2BL.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DCzeskis%26aufirst%3DB.%2BA.%26aulast%3DCassidy%26aufirst%3DK.%2BC.%26aulast%3DAbraham%26aufirst%3DT.%2BL.%26aulast%3DAlberts%26aufirst%3DJ.%2BJ.%26aulast%3DLuffer-Atlas%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520Mitigation%2520of%2520Reactive%2520Metabolites%2520of%25202-Aminoimidazole-Containing%2520Microsomal%2520Prostaglandin%2520E%2520Synthase-1%2520Inhibitors%2520Terminated%2520Due%2520to%2520Clinical%2520Drug-Induced%2520Liver%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2041%26epage%3D2051%26doi%3D10.1021%2Facs.jmedchem.7b01806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNearney, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landschulz, W.</span></span> <span> </span><span class="NLM_article-title">Dose-dependent Acute Liver Injury with Hypersensitivity Features in Humans Due to a Novel Microsomal Prostaglandin E Synthase 1 Inhibitor</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1111/bcp.13423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1111%2Fbcp.13423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=28865237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Shug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=179-188&issue=1&author=Y.+Jinauthor=A.+Regevauthor=J.+Kamauthor=K.+Phippsauthor=C.+Smithauthor=J.+Henckauthor=K.+Campanaleauthor=L.+Huauthor=D.+G.+Hallauthor=X.+Y.+Yangauthor=M.+Nakanoauthor=T.+A.+McNearneyauthor=J.+Uetrechtauthor=W.+Landschulz&title=Dose-dependent+Acute+Liver+Injury+with+Hypersensitivity+Features+in+Humans+Due+to+a+Novel+Microsomal+Prostaglandin+E+Synthase+1+Inhibitor&doi=10.1111%2Fbcp.13423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor</span></div><div class="casAuthors">Jin, Yan; Regev, Arie; Kam, Jeanelle; Phipps, Krista; Smith, Claire; Henck, Judith; Campanale, Kristina; Hu, Leijun; Hall, D. Greg; Yang, Xiao Yan; Nakano, Masako; McNearney, Terry Ann; Uetrecht, Jack; Landschulz, William</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : LY3031207, a novel microsomal prostaglandin E synthase 1 inhibitor, was evaluated in a multiple ascending dose study after nonclin. toxicol. studies and a single ascending dose study demonstrated an acceptable toxicity, safety and tolerability profile.  Methods : Healthy subjects were randomized to receive LY3031207 (25, 75 and 275 mg), placebo or celecoxib (400 mg) once daily for 28 days.  The safety, tolerability and pharmacokinetic and pharmacodynamic profiles of LY3031207 were evaluated.  Results : The study was terminated when two subjects experienced drug-induced liver injury (DILI) after they had received 225 mg LY3031207 for 19 days.  Liver biopsy from these subjects revealed acute liver injury with eosinophilic infiltration.  Four addnl. DILI cases were identified after LY3031207 dosing had been stopped.  All six DILI cases shared unique presentations of hepatocellular injury with hypersensitivity features and demonstrated a steep dose-dependent trend.  Prompt discontinuation of the study drug and supportive medical care resulted in full recovery.  Metabolites from metabolic activation of the imidazole ring were obsd. in plasma and urine samples from all subjects randomized to LY3031207 dosing.  Conclusions : This study emphasized the importance of careful safety monitoring and serious adverse events management in phase I trials.  Metabolic activation of the imidazole ring may be involved in the development of hepatotoxicity of LY3031207.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTg0xW88KU4LVg90H21EOLACvtfcHk0lghEVBwBNWIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Shug%253D%253D&md5=d57e0853ca828b7f02b613aea72497f1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13423%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DKam%26aufirst%3DJ.%26aulast%3DPhipps%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHenck%26aufirst%3DJ.%26aulast%3DCampanale%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DYang%26aufirst%3DX.%2BY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DMcNearney%26aufirst%3DT.%2BA.%26aulast%3DUetrecht%26aufirst%3DJ.%26aulast%3DLandschulz%26aufirst%3DW.%26atitle%3DDose-dependent%2520Acute%2520Liver%2520Injury%2520with%2520Hypersensitivity%2520Features%2520in%2520Humans%2520Due%2520to%2520a%2520Novel%2520Microsomal%2520Prostaglandin%2520E%2520Synthase%25201%2520Inhibitor%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26issue%3D1%26spage%3D179%26epage%3D188%26doi%3D10.1111%2Fbcp.13423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twomey, T. M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Sudoxicam by the Rat, Dog, and Monkey</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=13979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaE2sXhsFShtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=75-81&issue=1&author=D.+C.+Hobbsauthor=T.+M.+Twomey&title=Metabolism+of+Sudoxicam+by+the+Rat%2C+Dog%2C+and+Monkey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of sudoxicam by the rat, dog, and monkey</span></div><div class="casAuthors">Hobbs, Donald C.; Twomey, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">Sudoxicam (N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)(I) [34042-85-8] was prepd. in radiolabeled form and administered to rats, dogs, and monkeys.  Urine contained approx. 60,25, and 49% of the label given to rats, dogs, and monkeys, resp; the remainder was cleared via feces.  In addn. to some unchanged drug, urine from all species examd. contained 2 major metabolites.  These were identified from their mass spectra as the thiohydantoic acid and thiourea resulting from scission of the thiazole ring of sudoxicam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1k7yqZN80LVg90H21EOLACvtfcHk0lghEVBwBNWIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhsFShtbo%253D&md5=d7dad8fd060eed7a5c53a67d0e114de0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DD.%2BC.%26aulast%3DTwomey%26aufirst%3DT.%2BM.%26atitle%3DMetabolism%2520of%2520Sudoxicam%2520by%2520the%2520Rat%252C%2520Dog%252C%2520and%2520Monkey%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1977%26volume%3D5%26issue%3D1%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rettie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rettenmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howald, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450--Catalyzed Formation of Delta 4-VPA, a Toxic Metabolite of Valproic Acid</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>235</i></span> (<span class="NLM_issue">4791</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1126/science.3101178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1126%2Fscience.3101178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=3101178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=890-893&issue=4791&author=A.+Rettieauthor=A.+Rettenmeierauthor=W.+Howaldauthor=T.+Baillie&title=Cytochrome+P-450%2D%2DCatalyzed+Formation+of+Delta+4-VPA%2C+a+Toxic+Metabolite+of+Valproic+Acid&doi=10.1126%2Fscience.3101178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P-450-catalyzed formation of Δ4-VPA, a toxic metabolite of valproic acid</span></div><div class="casAuthors">Rettie, Allan E.; Rettenmeier, Albert W.; Howald, William N.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">4791</span>),
    <span class="NLM_cas:pages">890-3</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Liver damage induced by the antiepileptic drug valproic acid (VPA)  [99-66-1] is believed to be mediated by an unsatd. metabolite of the drug 2-n-propyl-4-pentenoic acid (Δ4-VPA)  [1575-72-0].  In studies of the biol. origin of this hepatotoxic compd., it was found that liver microsomes from phenobarbital-treated rats catalyzed the desatn. of VPA to Δ4-VPA.  Indirect evidence suggested that cytochrome P 450  [9035-51-2] was the responsible enzyme, a conclusion that was verified by studies with a purified and reconstituted form of the hemoprotein, which catalyzed the oxidn. of VPA to 4-  [60113-82-8] and 5-hydroxyvalproic acid  [53660-23-4] and to Δ4-VPA.  Desatn. of a nonactivated alkyl substituent represents a novel metabolic function of cytochrome P 450 and probably proceeds via the conversion of substrate to a transient free radical intermediate, which partitions between recombination (alc. formation) and elimination (olefin prodn.) pathways.  These findings have broad implications with resp. to the metabolic generation of olefins and may explain the increased hepatotoxic potential of VPA when it is administered in combination with potent enzyme-inducing anticonvulsants such as phenobarbital.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgCTIRwDQwlrVg90H21EOLACvtfcHk0lhUfRDeq4kwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyqsbo%253D&md5=fbbc8f1d52faf24d9d333b3c1d6b0ff6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.3101178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3101178%26sid%3Dliteratum%253Aachs%26aulast%3DRettie%26aufirst%3DA.%26aulast%3DRettenmeier%26aufirst%3DA.%26aulast%3DHowald%26aufirst%3DW.%26aulast%3DBaillie%26aufirst%3DT.%26atitle%3DCytochrome%2520P-450--Catalyzed%2520Formation%2520of%2520Delta%25204-VPA%252C%2520a%2520Toxic%2520Metabolite%2520of%2520Valproic%2520Acid%26jtitle%3DScience%26date%3D1987%26volume%3D235%26issue%3D4791%26spage%3D890%26epage%3D893%26doi%3D10.1126%2Fscience.3101178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawchuk, R. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Murine Cytochrome P4501A by Tacrine: In Vitro Studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.8.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.32.8.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15258105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFCjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=805-812&issue=8&author=J.+Z.+Pengauthor=R.+P.+Remmelauthor=R.+J.+Sawchuk&title=Inhibition+of+Murine+Cytochrome+P4501A+by+Tacrine%3A+In+Vitro+Studies&doi=10.1124%2Fdmd.32.8.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of murine cytochrome P4501A by tacrine: In vitro studies</span></div><div class="casAuthors">Peng, Joanna Z.; Remmel, Rory P.; Sawchuk, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Tacrine, a cholinesterase inhibitor, was approved for the treatment of Alzheimer's disease.  Oxidative metab. of tacrine occurs by CYP1A-catalyzed hydroxylation.  In rats, it was obsd. that the area under the curve (AUC) of the second oral dose was consistently higher than the AUC after the first oral dose, which was not due to the accumulation of the drug in the plasma from the first dose.  This finding suggested inhibition of the enzyme during metab. or inhibition by a metabolite.  The inhibitory mechanism was studied in liver and intestinal microsomes prepd. from 3-methylcholanthrene-treated rats and with recombinant CYP1A1 and CYP1A2.  Preincubation of CYP1A2 with tacrine and NADPH revealed a time-dependent inhibition of 7-ethoxyresorufin O-deethylation with a Ki of 1.94 μM and a kinact of 0.091 min-1.  No time-dependent inhibition was obsd. with CYP1A1 or with 1-hydroxytacrine or 2-hydroxytacrine.  Tacrine metab. catalyzed by CYP1A was also carried out, and the partition ratio was estd. to be 22.  A modified Michaelis-Menten equation involving mechanism-based inhibition was derived and used to analyze the data.  Reasonable parameter fits were obtained indicating that this equation is suitable to describe metab. data when the substrate is a mechanism-based inhibitor of the enzyme.  The probable inactivation mechanism involves either hydrogen atom abstraction to produce a carbon-centered radical intermediate at the benzylic position or insertion of OH+ into a C-H bond with subsequent loss of water to produce a carbocation.  Rapid rearrangement of the carbocation or radical and subsequent covalent binding of the tacrine moiety would result in enzyme inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3VeF_ZysNdLVg90H21EOLACvtfcHk0lhUfRDeq4kwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFCjt7g%253D&md5=b38e964963873741583ac7d72dc2f15f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.8.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.8.805%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%2BZ.%26aulast%3DRemmel%26aufirst%3DR.%2BP.%26aulast%3DSawchuk%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520Murine%2520Cytochrome%2520P4501A%2520by%2520Tacrine%253A%2520In%2520Vitro%2520Studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D8%26spage%3D805%26epage%3D812%26doi%3D10.1124%2Fdmd.32.8.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jushchyshyn, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahlstrom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienkers, L. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inactivation of Human Cytochrome P450 2B6 by Phencyclidine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.010579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.106.010579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=16782764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1523-1529&issue=9&author=M.+I.+Jushchyshynauthor=J.+L.+Wahlstromauthor=P.+F.+Hollenbergauthor=L.+C.+Wienkers&title=Mechanism+of+Inactivation+of+Human+Cytochrome+P450+2B6+by+Phencyclidine&doi=10.1124%2Fdmd.106.010579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine</span></div><div class="casAuthors">Jushchyshyn, Monica I.; Wahlstrom, Jan L.; Hollenberg, Paul F.; Wienkers, Larry C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1523-1529</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mechanism behind the obsd. inactivation of human P 450 2B6 by phencyclidine (PCP) has been evaluated over the past 2 decades.  The scope of the current investigation was to contribute to the fundamental knowledge of PCP oxidn. and perhaps the mechanism behind P 450 inactivation.  To study the chem. of PCP oxidn., we subjected PCP to the Fenton reagent.  Under Fenton chem. conditions, oxidn. on all three PCP rings was obsd. by liq. chromatog./tandem mass spectrometry (LC-MS/MS).  When PCP was incubated with the Fenton system in the presence of glutathione (GSH), three GSH-PCP conjugates were identified.  Subsequent LC-MS/MS anal. of these conjugates revealed two species that had GSH attached to the cyclohexane ring of PCP and a third conjugate in which GSH was adducted to the piperidine ring.  When PCP was incubated across a panel of P 450 enzymes, several enzymes, including P450s 2D6 and 3A4, were able to catalyze the formation of the PCP iminium ion, whereas P450s 2B6 and 2C19 were exclusively able to hydroxylate secondary carbons on the cyclohexane ring of PCP.  Subsequent mechanistic expts. revealed that only P450s 2B6 and 2C19 demonstrated loss of catalytic activity after preincubation with 10 μM PCP.  Finally, investigation of P 450 2B6 inactivation using structural analogs of PCP revealed that blocking the para-carbon atom on the cyclohexane ring of PCP from oxidn. protected the P 450 2B6 from inactivation, which suggests that a reactive intermediate generated during the hydroxylation of the cyclohexane ring may be linked to the mechanism of inactivation of P 450 2B6 by PCP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH7JJJ7v_R7LVg90H21EOLACvtfcHk0lhUfRDeq4kwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sks7c%253D&md5=567d10c98dc393cb65d8f365f1752ddd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.010579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.010579%26sid%3Dliteratum%253Aachs%26aulast%3DJushchyshyn%26aufirst%3DM.%2BI.%26aulast%3DWahlstrom%26aufirst%3DJ.%2BL.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26aulast%3DWienkers%26aufirst%3DL.%2BC.%26atitle%3DMechanism%2520of%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%25202B6%2520by%2520Phencyclidine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26issue%3D9%26spage%3D1523%26epage%3D1529%26doi%3D10.1124%2Fdmd.106.010579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jushchyshyn, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">The Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Phencyclidine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.1.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.31.1.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=12485952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtV2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=46-52&issue=1&author=M.+I.+Jushchyshynauthor=U.+M.+Kentauthor=P.+F.+Hollenberg&title=The+Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+2B6+by+Phencyclidine&doi=10.1124%2Fdmd.31.1.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine</span></div><div class="casAuthors">Jushchyshyn, Monica I.; Kent, Ute M.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phencyclidine (PCP) was analyzed for its ability to inactivate human cytochrome P 450 (P 450) 2B6.  PCP inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of P 450 2B6 in a concn.-, time-, and NADPH-dependent manner and exhibited pseudo-first order kinetics.  The K1 was 10 μM, kinact was 0.01 min-1, which corresponds to a t1/2 of 31 min.  The partition ratio was approx. 45.  Spectral anal. of the heme moiety demonstrated that the heme was not modified during inactivation.  Extensive dialysis of the PCP-inactivated P 450 2B6 did not cause a return in catalytic activity demonstrating PCP inactivation was irreversible.  Including 7-ethoxycoumarin, an alternate substrate, protected 2B6 from inactivation by PCP indicating competition of the two substrates for the active site.  Exogenous nucleophiles such as glutathione (GSH) and cyanide could not protect P 450 2B6 from PCP inactivation demonstrating that the reactive intermediate remained within the P 450 active site.  High performance liq. chromatog. anal. of P 450 2B6 inactivated in the presence of 3H-labeled PCP showed that PCP binding was specific for the P 450 and not to other proteins in the reaction mixt.  The stoichiometry of binding of PCP to P 450 2B6 was demonstrated using 3H-labeled PCP.  In the absence of GSH, the stoichiometry was 5.5:1 (PCP/P 450).  In the presence of GSH, the stoichiometry was 1:1.  This stoichiometry was further supported using electrospray ionization-liq. chromatog.-mass spectrometry to analyze PCP-inactivated P 450 2B1, 2B4, and 2B6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJuvzxADO6brVg90H21EOLACvtfcHk0lhUfRDeq4kwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtV2msw%253D%253D&md5=d31ba5b0d4f91c2b8df2f9410101d104</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.1.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.1.46%26sid%3Dliteratum%253Aachs%26aulast%3DJushchyshyn%26aufirst%3DM.%2BI.%26aulast%3DKent%26aufirst%3DU.%2BM.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DThe%2520Mechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%25202B6%2520by%2520Phencyclidine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D46%26epage%3D52%26doi%3D10.1124%2Fdmd.31.1.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Phencyclidine. The Role of Iminium Ion Formation in Covalent Binding to Rabbit Microsomal Protein</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=6130925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADyaL3sXms1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1982&pages=690-695&issue=6&author=D.+Wardauthor=A.+Trevorauthor=A.+Kalirauthor=J.+Adamsauthor=T.+Baillieauthor=N.+Castagnoli&title=Metabolism+of+Phencyclidine.+The+Role+of+Iminium+Ion+Formation+in+Covalent+Binding+to+Rabbit+Microsomal+Protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of phencyclidine.  The role of iminium ion formation in covalent binding to rabbit microsomal protein</span></div><div class="casAuthors">Ward, D. P.; Trevor, A. J.; Kalir, A.; Adams, J. D.; Baillie, T. A.; Castagnoli, N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">690-5</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">Incubation of phencyclidine (PCP)(I)  [77-10-1] with rabbit liver microsomes and Na14CN resulted in the metabolically dependent formation of a 14C-labeled cyano adduct of the drug.  After isolation by high-pressure liq. chromatog. (HPLC), this compd. was identified as the α-aminonitrile [1-(1-phenylcyclohexyl)-2-cyanopiperidine  [81262-67-1]] deriv. of PCP by use of chem.-ionization and gas-chromatog. coupled electron-impact mass spectrometry.  Synthetic α-aminonitrile exhibited identical chem. properties and comigrated in HPLC and gas liq. chromatog. with the metab.-derived cyano adduct.  Mol. identification of the adduct formed by cyanide trapping provided evidence for the formation of an iminium ion during PCP metab.  Quant. estn. by HPLC demonstrated that the α-aminonitrile accounted for ∼50% of the PCP metabolized in 30 min by hepatic microsomes in vitro.  Metab.-dependent covalent binding of [3H]PCP to rabbit liver microsomal proteins was inhibited by cyanide ion in a concn.-dependent manner with an IC50 of 57 μM.  The concns. of cyanide ion used in these expts. did not significantly inhibit the metab. of PCP.  Thus, iminium ion formation may represent an important intermediary step in the metab. of PCP and such a reactive electrophilic species may be capable of covalent interactions with nucleophilic groupings on microsomal macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUpdYxDdRr_LVg90H21EOLACvtfcHk0lj3eRdsXCWCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXms1Gkug%253D%253D&md5=323e11acbf22c1021b2bde6096f9c272</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DD.%26aulast%3DTrevor%26aufirst%3DA.%26aulast%3DKalir%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DT.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DMetabolism%2520of%2520Phencyclidine.%2520The%2520Role%2520of%2520Iminium%2520Ion%2520Formation%2520in%2520Covalent%2520Binding%2520to%2520Rabbit%2520Microsomal%2520Protein%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1982%26volume%3D10%26issue%3D6%26spage%3D690%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkowski, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of Phencyclidine in Rat and Human Liver Microsomes and Recombinant P450 2B Enzymes: Evidence for the Formation of a Novel Quinone Methide Intermediate</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1021/tx700145k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700145k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1488-1497&issue=10&author=J.+P.+Driscollauthor=K.+Korneckiauthor=J.+P.+Wolkowskiauthor=L.+Chupakauthor=A.+S.+Kalgutkarauthor=J.+P.+O%E2%80%99Donnell&title=Bioactivation+of+Phencyclidine+in+Rat+and+Human+Liver+Microsomes+and+Recombinant+P450+2B+Enzymes%3A+Evidence+for+the+Formation+of+a+Novel+Quinone+Methide+Intermediate&doi=10.1021%2Ftx700145k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of Phencyclidine in Rat and Human Liver Microsomes and Recombinant P450 2B Enzymes: Evidence for the Formation of a Novel Quinone Methide Intermediate</span></div><div class="casAuthors">Driscoll, James P.; Kornecki, Katherine; Wolkowski, Joanna P.; Chupak, Lou; Kalgutkar, Amit S.; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1488-1497</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypothesis that the psychol. side effects assocd. with the anesthetic phencyclidine (PCP) may be caused by irreversible binding of PCP or its reactive metabolite(s) to crit. macromols. in the brain has resulted in numerous in vitro studies aimed at characterizing pathways of PCP bioactivation.  The studies described herein extend the current knowledge of PCP metab. and provide details on a previously unknown metabolic activation pathway of PCP.  Following incubations with NADPH- and GSH-supplemented human and rat liver microsomes and recombinant P 450 2B enzymes, two sulfhydryl conjugates with MH+ ions at 547 and 482 Da, resp., were detected by LC/MS/MS.  Shebley et al. have also obsd. the GSH conjugate 1 with MH+ at 547 Da in PCP incubations with rat P 450 2B1 and rabbit P 450 2B4 isoforms fortified with NADPH and GSH.  The mol. wt. of 1 is consistent with a bioactivation pathway involving Michael addn. of the sulfhydryl nucleophile to the putative 2,3-dihydropyridinium metabolite of PCP obtained via a four-electron oxidn. of the piperidine ring in the parent compd.  The mass spectrum of the novel GSH adduct 2 with an MH+ ion at 482 Da was suggestive of a unique PCP bioactivation pathway involving initial ortho- or para-hydroxylation of the Ph ring in PCP followed by spontaneous decompn. to piperidine and an electrophilic quinone methide intermediate, which upon reaction with GSH yielded adduct 2.  The LC retention times and mass spectral properties of enzymically generated 2 were identical to those of a ref. std. obtained via reaction of GSH with synthetic p-hydroxyPCP in phosphate buffer (pH 7.4, 37°). 1H NMR and 13C-distortionless enhancement by polarization transfer (DEPT) NMR spectral studies on synthetically generated 2 suggested that the structural integrity of the p-hydroxyphenyl and cyclohexyl rings likely was preserved and that the site of GSH addn. was the benzylic carbon joining the two scaffolds.  The formation of 2 in human microsomes was reduced upon addn. of the dual P 450 2C19/P 450 2B6 inhibitor (+)-N-3-benzylnirvanol.  Consistent with this finding, both recombinant P 450 2B6 and P 450 2C19 catalyzed PCP bioactivation to 2.  In the absence of GSH, synthetic p-hydroxyPCP underwent rapid decompn. (t1/2 ∼ 5.2 min) to afford p-hydroxyphenylcyclohexanol and p-hydroxyphenylcyclohexene, presumably via the quinone methide intermediate.  Overall, our findings on the facile degrdn. of synthetic p-hydroxyPCP to yield an electrophilic quinone methide intermediate capable of reacting with nucleophiles, including GSH and water, suggest an inherent instability of the putative phenolic PCP metabolite.  Thus, if formed enzymically in vivo, p-hydroxyPCP may not require further metab. to liberate the quinone methide, which can then react with macromols.  To our knowledge, this is the first report of a quinone methide reactive intermediate obtained in human-liver microsomal metab. of PCP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSZWcMYbznCbVg90H21EOLACvtfcHk0lj3eRdsXCWCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsr3K&md5=379142481a787f68c038111370d0314b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx700145k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700145k%26sid%3Dliteratum%253Aachs%26aulast%3DDriscoll%26aufirst%3DJ.%2BP.%26aulast%3DKornecki%26aufirst%3DK.%26aulast%3DWolkowski%26aufirst%3DJ.%2BP.%26aulast%3DChupak%26aufirst%3DL.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBioactivation%2520of%2520Phencyclidine%2520in%2520Rat%2520and%2520Human%2520Liver%2520Microsomes%2520and%2520Recombinant%2520P450%25202B%2520Enzymes%253A%2520Evidence%2520for%2520the%2520Formation%2520of%2520a%2520Novel%2520Quinone%2520Methide%2520Intermediate%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26issue%3D10%26spage%3D1488%26epage%3D1497%26doi%3D10.1021%2Ftx700145k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “Cyclopropyl Fragment” Is a Versatile Player That Frequently Appears in Preclinical/Clinical Drug Molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&issue=19&author=T.+T.+Talele&title=The+%E2%80%9CCyclopropyl+Fragment%E2%80%9D+Is+a+Versatile+Player+That+Frequently+Appears+in+Preclinical%2FClinical+Drug+Molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lj3eRdsXCWCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259CCyclopropyl%2520Fragment%25E2%2580%259D%2520Is%2520a%2520Versatile%2520Player%2520That%2520Frequently%2520Appears%2520in%2520Preclinical%252FClinical%2520Drug%2520Molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S. P.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&issue=3&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+Comprehensive+Listing+of+Bioactivation+Pathways+of+Organic+Functional+Groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0livR4upyUFRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520Comprehensive%2520Listing%2520of%2520Bioactivation%2520Pathways%2520of%2520Organic%2520Functional%2520Groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26issue%3D3%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of Cyclopropyl Rings by P450: An Observation Encountered during the Optimisation of a Series of Hepatitis C Virus NS5B Inhibitors</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1080/00498254.2017.1409915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1080%2F00498254.2017.1409915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=29182424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKgsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=1215-1226&issue=12&author=X.+Zhuoauthor=Y.-Z.+Wangauthor=K.-S.+Yeungauthor=J.+Zhuauthor=X.+S.+Huangauthor=K.+E.+Parcellaauthor=K.+J.+Eastmanauthor=J.+F.+Kadowauthor=N.+A.+Meanwellauthor=Y.-Z.+Shuauthor=B.+M.+Johnson&title=Bioactivation+of+Cyclopropyl+Rings+by+P450%3A+An+Observation+Encountered+during+the+Optimisation+of+a+Series+of+Hepatitis+C+Virus+NS5B+Inhibitors&doi=10.1080%2F00498254.2017.1409915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimization of a series of hepatitis C virus NS5B inhibitors</span></div><div class="casAuthors">Zhuo, Xiaoliang; Wang, Ying-Zi; Yeung, Kap-Sun; Zhu, Juliang; Huang, Xiaohua Stella; Parcella, Kyle E.; Eastman, Kyle J.; Kadow, John F.; Meanwell, Nicholas A.; Shu, Yue-Zhong; Johnson, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Due to its unique C-C and C-H bonding properties, conformational preferences and relative hydrophilicity, the cyclopropyl ring has been used as a synthetic building block in drug discovery to modulate potency and drug-like properties.  During an effort to discover inhibitors of the hepatitis C virus non-structural protein 5B with improved potency and genotype-coverage profiles, the use of a pyrimidinylcyclopropylbenzamide moiety linked to a C6-substituted benzofuran or azabenzofuran core scaffold was explored in an effort to balance antiviral potency and metabolic stability.  In vitro metab. studies of two compds. from this C6-substituted series revealed an NADPH-dependent bioactivation pathway leading to the formation of multiple glutathione (GSH) conjugates.  Anal. of these conjugates by LC-MS and NMR demonstrated that the cyclopropyl group was the site of bioactivation.  Based on the putative structures and mol. wts. of the cyclopropyl-GSH conjugates, a multi-step mechanism was proposed to explain the formation of these metabolites by P 450.  This mechanism involves hydrogen atom abstraction to form a cyclopropyl radical, followed by a ring opening rearrangement and reaction with GSH.  These findings provided important information to the medicinal chem. team which responded by replacing the cyclopropyl ring with a gem-di-Me group.  Subsequent compds. bearing this feature were shown to avert the bioactivation pathways in question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrolyOdHK2ec7Vg90H21EOLACvtfcHk0livR4upyUFRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKgsr7K&md5=a24a2385788de07979dcec236988cb9f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F00498254.2017.1409915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2017.1409915%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-Z.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%2BS.%26aulast%3DParcella%26aufirst%3DK.%2BE.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26atitle%3DBioactivation%2520of%2520Cyclopropyl%2520Rings%2520by%2520P450%253A%2520An%2520Observation%2520Encountered%2520during%2520the%2520Optimisation%2520of%2520a%2520Series%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Inhibitors%26jtitle%3DXenobiotica%26date%3D2018%26volume%3D48%26issue%3D12%26spage%3D1215%26epage%3D1226%26doi%3D10.1080%2F00498254.2017.1409915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span> <span> </span><span class="NLM_article-title">Strategies toward Optimization of the Metabolism of a Series of Serotonin-4 Partial Agonists: Investigation of Azetidines as Piperidine Isosteres</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.3109/00498254.2016.1152522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.3109%2F00498254.2016.1152522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=26947511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslKhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=1112-1121&issue=12&author=R.+S.+Obachauthor=E.+A.+LaChapelleauthor=M.+A.+Brodneyauthor=M.+Vanase-Frawleyauthor=G.+W.+Kauffmanauthor=A.+Sawant-Basak&title=Strategies+toward+Optimization+of+the+Metabolism+of+a+Series+of+Serotonin-4+Partial+Agonists%3A+Investigation+of+Azetidines+as+Piperidine+Isosteres&doi=10.3109%2F00498254.2016.1152522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres</span></div><div class="casAuthors">Obach, Ronald Scott; LaChapelle, Erik A.; Brodney, Michael A.; Vanase-Frawley, Michelle; Kauffman, Gregory W.; Sawant-Basak, Aarti</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1112-1121</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The first generation 5HT-4 partial agonist, 4-{4-[4-Tetrahydrofuran-3-yloxy-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol, PF-4995274 (TBPT), was metabolized to N-dealkylated (M1) and an unusual, cyclized oxazolidine (M2) metabolites. and demonstrated pharmacol. activity at 5HT receptor subtypes warranting further investigation into their dispositional properties in humans; was a minor component in vitro but was the pre-dominant metabolite identified in human plasma.  To shift metab. away from the piperidine ring of TBPT, a series of heterocyclic replacements were designed, synthesized, and profiled.  Groups including azetidines, pyrrolidines, as well as functionalized piperidines were evaluated with the goal of identifying an alternative group that maintained the desired potency, functional activity, and reduced turnover in human hepatocytes.  Activities of 4-substituted piperidines or pyrrolidine analogs at the pharmacol. target were not significantly altered, but the same metabolic pathways of N-dealkylation and oxazolidine formation were still obsd.  Altering these to bridged ring systems lowered oxazolidine metabolite formation, but not N-dealkylation.  The effort concluded with identification of azetidines as second-generation 5HT4 partial agonists.  These were neither metabolized via N-dealkylation nor converted to cyclized oxazolidine metabolites rather oxidized on the isoxazole ring.  The use of azetidine as a replacement for aliph. aza-heterocyclic rings in drug design to alter drug metab. and pharmacol. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVnMRsLJZpj7Vg90H21EOLACvtfcHk0livR4upyUFRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslKhur4%253D&md5=109b5893fc34291b627e1127d9807fb4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498254.2016.1152522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2016.1152522%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DLaChapelle%26aufirst%3DE.%2BA.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSawant-Basak%26aufirst%3DA.%26atitle%3DStrategies%2520toward%2520Optimization%2520of%2520the%2520Metabolism%2520of%2520a%2520Series%2520of%2520Serotonin-4%2520Partial%2520Agonists%253A%2520Investigation%2520of%2520Azetidines%2520as%2520Piperidine%2520Isosteres%26jtitle%3DXenobiotica%26date%3D2016%26volume%3D46%26issue%3D12%26spage%3D1112%26epage%3D1121%26doi%3D10.3109%2F00498254.2016.1152522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloysius, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschirret-Guth, R. A.</span></span> <span> </span><span class="NLM_article-title">Metabolic Activation and Major Protein Target of a 1-Benzyl-3-Carboxyazetidine Sphingosine-1-Phosphate-1 Receptor Agonist</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1422</span>, <span class="refDoi"> DOI: 10.1021/tx300017s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300017s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2is78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1412-1422&issue=7&author=H.+Aloysiusauthor=V.+W.+Tongauthor=J.+Yabutauthor=S.+A.+Bradleyauthor=J.+Shangauthor=Y.+Zouauthor=R.+A.+Tschirret-Guth&title=Metabolic+Activation+and+Major+Protein+Target+of+a+1-Benzyl-3-Carboxyazetidine+Sphingosine-1-Phosphate-1+Receptor+Agonist&doi=10.1021%2Ftx300017s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Activation and Major Protein Target of a 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonist</span></div><div class="casAuthors">Aloysius, Herve; Tong, Vincent W.; Yabut, Jocelyn; Bradley, Scott A.; Shang, Jackie; Zou, Yan; Tschirret-Guth, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1412-1422</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-{4-[(4-Phenyl-5-trifluoromethyl-2-thienyl)methoxy]benzyl}azetidine-3-carboxylic acid (MRL-A) is a potent sphingosine-1-phosphate-1 receptor agonist, with potential application as an immunosuppressant in organ transplantation or for the treatment of autoimmune diseases.  When administered orally to rats, radiolabeled MRL-A was found to undergo metab. to several reactive intermediates, and in this study, we have investigated its potential for protein modification in vivo and in vitro.  MRL-A irreversibly modified liver and kidney proteins in vivo, in a dose- and time-dependent manner.  The binding was found to occur selectively to microsomal and mitochondrial subcellular fractions.  Following a nonspecific proteolytic digestion of liver and kidney proteins, a single major amino acid adduct was obsd.  This adduct was characterized with LC/MS/UV and NMR spectroscopy and was the product of an unprecedented metabolic activation of the azetidine moiety leading to the formation of a ring-opened α,β-unsatd. imine conjugated to the ε-amino group of a lysine residue.  The formation of this adduct was not inhibited when rats were pretreated with 1-aminobenzotriazole, indicating that P 450 enzymes were not involved in the metabolic activation of MRL-A.  Rather, our findings suggested that MRL-A underwent bioactivation via a β-oxidn. pathway.  Several other minor adducts were identified from protein hydrolyzates and included lysine, serine, and cysteine conjugates of MRL-A.  These minor adducts were also detected in microsomal incubations fortified with the cofactors for acyl-CoA synthesis and in hepatocytes.  Trypsin digestion of crude liver homogenates from rats treated with radiolabeled MRL-A led to the identification of a single radioactive peptide.  Its sequence, detd. by LC/MS anal., revealed that the target of the major reactive species of MRL-A in vivo is Lys676 of long chain acyl-CoA synthetase-1 (ACSL1).  This lysine residue has been crit. for ACSL1 activity, and its modification has the potential to lead to biol. consequences such as cardiac hypertrophy or thermogenesis dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprOkKn83jQ3bVg90H21EOLACvtfcHk0liy86ZXql-veA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2is78%253D&md5=225b32958c3d9be6da1d25b4fdbb89d6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Ftx300017s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300017s%26sid%3Dliteratum%253Aachs%26aulast%3DAloysius%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DV.%2BW.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DBradley%26aufirst%3DS.%2BA.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DTschirret-Guth%26aufirst%3DR.%2BA.%26atitle%3DMetabolic%2520Activation%2520and%2520Major%2520Protein%2520Target%2520of%2520a%25201-Benzyl-3-Carboxyazetidine%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonist%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D7%26spage%3D1412%26epage%3D1422%26doi%3D10.1021%2Ftx300017s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitholtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurva, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">886</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1021/tx500514z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500514z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvF2ht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=886-896&issue=5&author=M.+Darnellauthor=K.+Breitholtzauthor=E.+M.+Isinauthor=U.+Jurvaauthor=L.+Weidolf&title=Significantly+Different+Covalent+Binding+of+Oxidative+Metabolites%2C+Acyl+Glucuronides%2C+and+S-Acyl+CoA+Conjugates+Formed+from+Xenobiotic+Carboxylic+Acids+in+Human+Liver+Microsomes&doi=10.1021%2Ftx500514z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes</span></div><div class="casAuthors">Darnell, Malin; Breitholtz, Katarina; Isin, Emre M.; Jurva, Ulrik; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-896</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Xenobiotic carboxylic acids may be metabolized to oxidative metabolites, acyl glucuronides, and/or S-acyl-CoA thioesters (CoA conjugates) in vitro, e.g., in hepatocytes, and in vivo.  These metabolites can potentially be reactive species and bind covalently to tissue proteins and are generally considered to mediate adverse drug reactions in humans.  Acyl glucuronide metabolites have been the focus of reactive metabolite research for decades, whereas drug-CoA conjugates, which have been shown to be up to 40-70 times more reactive, have been given much less attention.  In an attempt to dissect the contribution of different pathways to covalent binding, we utilized human liver microsomes supplemented with NADPH, uridine 5'-diphosphoglucuronic acid (UDPGA), or CoA to evaluate the reactivity of each metabolite sep.  Seven carboxylic acid drugs were included in this study.  While ibuprofen and tolmetin are still on the market, ibufenac, fenclozic acid, tienilic acid, suprofen, and zomepirac were stopped before their launch or withdrawn.  The reactivities of the CoA conjugates of ibuprofen, ibufenac, fenclozic acid, and tolmetin were higher compared to those of their corresponding oxidative metabolites and acyl glucuronides, as measured by the level of covalent binding to human liver microsomal proteins.  The highest covalent binding was obsd. for ibuprofenyl-CoA and ibufenacyl-CoA, to levels of 1000 and 8600 pmol drug eq/mg protein, resp.  In contrast and in agreement with the proposed P 450-mediated toxicity for these drug mols., the reactivities of oxidative metabolites of suprofen and tienilic acid were higher compared to the reactivities of their conjugated metabolites, with NADPH-dependent covalent binding of 250 pmol drug eq/mg protein for both drugs.  The seven drugs all formed UDPGA-dependent acyl glucuronides, but none of these resulted in covalent binding.  This study shows that, unlike studies with hepatocytes or in vivo, human liver microsomes provide an opportunity to investigate the reactivity of individual metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWKWURekmygLVg90H21EOLACvtfcHk0liy86ZXql-veA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvF2ht7k%253D&md5=770a4825095e7651d8271b66c86568a1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx500514z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500514z%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DM.%26aulast%3DBreitholtz%26aufirst%3DK.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DSignificantly%2520Different%2520Covalent%2520Binding%2520of%2520Oxidative%2520Metabolites%252C%2520Acyl%2520Glucuronides%252C%2520and%2520S-Acyl%2520CoA%2520Conjugates%2520Formed%2520from%2520Xenobiotic%2520Carboxylic%2520Acids%2520in%2520Human%2520Liver%2520Microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26issue%3D5%26spage%3D886%26epage%3D896%26doi%3D10.1021%2Ftx500514z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grönberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Strained Rings: Glutathione S-transferase-Catalyzed Formation of a Glutathione-Conjugated Spiro-azetidine without Prior Bioactivation</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.088658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1124%2Fdmd.119.088658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=31492694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCntb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=1247-1256&issue=11&author=X.+Liauthor=G.+Gr%C3%B6nbergauthor=E.+Bangurauthor=M.+Hayesauthor=N.+Castagnoliauthor=L.+Weidolf&title=Metabolism+of+Strained+Rings%3A+Glutathione+S-transferase-Catalyzed+Formation+of+a+Glutathione-Conjugated+Spiro-azetidine+without+Prior+Bioactivation&doi=10.1124%2Fdmd.119.088658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of strained rings: glutathione S-transferase-catalyzed formation of a glutathione-conjugated spiro-azetidine without prior bioactivation</span></div><div class="casAuthors">Li, Xue-Qing; Groenberg, Gunnar; Bangur, Eva-Henriette; Hayes, Martin A.; Castagnoli, Neal; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1247-1256</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">AZD1979 [(3-(4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone] is a melanin-concg. hormone receptor 1 antagonist designed for the treatment of obesity.  In this study, metabolite profiles of AZD1979 in human hepatocytes revealed a series of glutathione-related metabolites, including the glutathionyl, cysteinyl, cysteinylglycinyl, and mercapturic acid conjugates.  The formation of these metabolites was not inhibited by coincubation with the cytochrome P 450 (P 450) inhibitor 1-aminobenzotriazole.  In efforts to identify the mechanistic features of this pathway, investigations were performed to characterize the structure of the glutathionyl conjugate M12 of AZD1979 and to identify the enzyme system catalyzing its formation.  Studies with various human liver subcellular fractions established that the formation of M12 was NAD(P)H-independent and proceeded in cytosol and S9 fractions but not in microsomal or mitochondrial fractions.  Metabolite M12 was purified from rat liver S9 incubations and its structure elucidated by NMR.  These results establish that M12 is the product of the GST-catalyzed glutathione attack on the carbon atom a to the nitrogen atom of the strained spiro-azetidinyl moiety to give, after ring opening, the corresponding amino-thioether conjugate product, a direct conjugation pathway that occurs without the prior substrate bioactivation by P 450.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrPA57-Kg_vrVg90H21EOLACvtfcHk0liy86ZXql-veA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCntb3O&md5=0c59a3f2baa40d89a84b8a11843e67c0</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.088658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.088658%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGr%25C3%25B6nberg%26aufirst%3DG.%26aulast%3DBangur%26aufirst%3DE.%26aulast%3DHayes%26aufirst%3DM.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DMetabolism%2520of%2520Strained%2520Rings%253A%2520Glutathione%2520S-transferase-Catalyzed%2520Formation%2520of%2520a%2520Glutathione-Conjugated%2520Spiro-azetidine%2520without%2520Prior%2520Bioactivation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26issue%3D11%26spage%3D1247%26epage%3D1256%26doi%3D10.1124%2Fdmd.119.088658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M. A.</span></span> <span> </span><span class="NLM_article-title">Interactive Mutagenicity of Sodium Nitrite, Dimethylamine, Methylurea and Ethylurea</span>. <i>Mutation Research/Environmental Mutagenesis and Related Subjects</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90073-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=10.1016%2F0165-1161%2875%2990073-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=109-114&issue=2&author=D.+B.+Couchauthor=M.+A.+Friedman&title=Interactive+Mutagenicity+of+Sodium+Nitrite%2C+Dimethylamine%2C+Methylurea+and+Ethylurea&doi=10.1016%2F0165-1161%2875%2990073-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990073-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990073-4%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DD.%2BB.%26aulast%3DFriedman%26aufirst%3DM.%2BA.%26atitle%3DInteractive%2520Mutagenicity%2520of%2520Sodium%2520Nitrite%252C%2520Dimethylamine%252C%2520Methylurea%2520and%2520Ethylurea%26jtitle%3DMutation%2520Research%252FEnvironmental%2520Mutagenesis%2520and%2520Related%2520Subjects%26date%3D1975%26volume%3D31%26issue%3D2%26spage%3D109%26epage%3D114%26doi%3D10.1016%2F0165-1161%2875%2990073-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiran, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzelka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8792</span>– <span class="NLM_lpage">8816</span>, <span class="refDoi"> DOI: 10.1021/jm500563g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&issue=21&author=A.-L.+Grillotauthor=A.+L.+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+Charifson&title=Second-Generation+Antibacterial+Benzimidazole+Ureas%3A+Discovery+of+a+Preclinical+Candidate+with+Reduced+Metabolic+Liability&doi=10.1021%2Fjm500563g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span></div><div class="casAuthors">Grillot, Anne-Laure; Tiran, Arnaud Le; Shannon, Dean; Krueger, Elaine; Liao, Yusheng; O'Dowd, Hardwin; Tang, Qing; Ronkin, Steve; Wang, Tiansheng; Waal, Nathan; Li, Pan; Lauffer, David; Sizensky, Emmanuelle; Tanoury, Jerry; Perola, Emanuele; Grossman, Trudy H.; Doyle, Tim; Hanzelka, Brian; Jones, Steven; Dixit, Vaishali; Ewing, Nigel; Liao, Shengkai; Boucher, Brian; Jacobs, Marc; Bennani, Youssef; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8792-8816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 3 is a potent aminobenzimidazole urea with broad-spectrum Gram-pos. antibacterial activity resulting from dual inhibition of bacterial gyrase (GyrB) and topoisomerase IV (ParE), and it demonstrates efficacy in rodent models of bacterial infection.  Preclin. in vitro and in vivo studies showed that compd. 3 covalently labels liver proteins, presumably via formation of a reactive metabolite, and hence presented a potential safety liability.  The urea moiety in compd. 3 was identified as being potentially responsible for reactive metabolite formation, but its replacement resulted in loss of antibacterial activity and/or oral exposure due to poor physicochem. parameters.  To identify second-generation aminobenzimidazole ureas devoid of reactive metabolite formation potential, we implemented a metabolic shift strategy, which focused on shifting metab. away from the urea moiety by introducing metabolic soft spots elsewhere in the mol.  Aminobenzimidazole urea 34, identified through this strategy, exhibits similar antibacterial activity as that of 3 and did not label liver proteins in vivo, indicating reduced/no potential for reactive metabolite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TXw5pd6rXbVg90H21EOLACvtfcHk0ljdaB1jhwMnKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtr3J&md5=493a19ab7eaa9997f836228e25fe3125</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DTiran%26aufirst%3DA.%2BL.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%26atitle%3DSecond-Generation%2520Antibacterial%2520Benzimidazole%2520Ureas%253A%2520Discovery%2520of%2520a%2520Preclinical%2520Candidate%2520with%2520Reduced%2520Metabolic%2520Liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D21%26spage%3D8792%26epage%3D8816%26doi%3D10.1021%2Fjm500563g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span> <span> </span><span class="NLM_article-title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2751</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01541</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1GksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2751-2788&issue=6&author=A.+K.+Ghoshauthor=M.+Brindisi&title=Urea+Derivatives+in+Modern+Drug+Discovery+and+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.9b01541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2751-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The urea functionality is inherent to numerous bioactive compds., including a variety of clin. approved therapies.  Urea-contg. compds. are increasingly used in medicinal chem. and drug design in order to establish key drug-target interactions and also to fine-tune crucial drug-like properties.  In this perspective, physicochem. and conformational properties of urea derivs. are highlighted.  Outlines of traditional reagents and chem. procedures for the prepn. of ureas are provided.  Also, newly developed methodologies mainly aimed at overcoming safety issues assocd. with traditional synthesis are discussed.  Finally, a broad overview of urea-based medicinally relevant compds., ranging from approved drugs to recent medicinal chem. developments is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgk8UhOqJ1gLVg90H21EOLACvtfcHk0liQceIxY4RxIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1GksbrF&md5=f888b6af362248abcb16573d8cb69e6d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26atitle%3DUrea%2520Derivatives%2520in%2520Modern%2520Drug%2520Discovery%2520and%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788%26doi%3D10.1021%2Facs.jmedchem.9b01541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+Set+of+Simple%2C+Interpretable+ADMET+Rules+of+Thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liQceIxY4RxIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520Set%2520of%2520Simple%252C%2520Interpretable%2520ADMET%2520Rules%2520of%2520Thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swamidass, S. J.</span></span> <span> </span><span class="NLM_article-title">Computationally Assessing the Bioactivation of Drugs by N-Dealkylation</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=68-80&issue=2&author=N.+L.+Dangauthor=T.+B.+Hughesauthor=G.+P.+Millerauthor=S.+J.+Swamidass&title=Computationally+Assessing+the+Bioactivation+of+Drugs+by+N-Dealkylation&doi=10.1021%2Facs.chemrestox.7b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Computationally Assessing the Bioactivation of Drugs by N-Dealkylation</span></div><div class="casAuthors">Dang, Na Le; Hughes, Tyler B.; Miller, Grover P.; Swamidass, S. Joshua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-80</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochromes P 450 (CYPs) oxidize alkylated amines commonly found in drugs and other biol. active mols., cleaving them into an amine and an aldehyde.  Metabolic studies usually neglect to report or investigate aldehydes, even though they can be toxic.  It is assumed that they are efficiently detoxified into carboxylic acids and alcs.  Nevertheless, some aldehydes are reactive and escape detoxification pathways to cause adverse events by forming DNA and protein adducts.  Herein, the authors modeled N-dealkylations that produce both amine and aldehyde metabolites and then predicted the reactivity of the aldehyde.  This model used a deep learning approach previously developed by the authors' group to predict other types of drug metab.  In this study, the authors trained the model to predict N-dealkylation by human liver microsomes (HLM), finding that including isoenzyme-specific metab. data alongside HLM data significantly improved results.  The final HLM model accurately predicted the site of N-dealkylation within metabolized substrates (97% top-two and 94% area under the ROC curve).  Next, the authors combined the metab., metabolite structure prediction, and previously published reactivity models into a bioactivation model.  This combined model predicted the structure of the most likely reactive metabolite of a small validation set of drug-like mols. known to be bioactivated by N-dealkylation.  Applying this model to approved and withdrawn medicines, the authors found that aldehyde metabolites produced from N-dealkylation may explain the hepatotoxicity of several drugs: indinavir, piperacillin, verapamil, and ziprasidone.  The authors' results suggest that N-dealkylation may be an under-appreciated bioactivation pathway, esp. in clin. contexts where aldehyde detoxification pathways are inhibited.  Moreover, this is the first report of a bioactivation model constructed by combining a metab. and reactivity model.  These results raise hope that more comprehensive models of bioactivation are possible.  The model developed in this study is available at http://swami.wustl.edu/xenosite/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo9E7gjFvsLVg90H21EOLACvtfcHk0liQceIxY4RxIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKns7Y%253D&md5=d26fb0370cf46674a1f828651b2490c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00191%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DN.%2BL.%26aulast%3DHughes%26aufirst%3DT.%2BB.%26aulast%3DMiller%26aufirst%3DG.%2BP.%26aulast%3DSwamidass%26aufirst%3DS.%2BJ.%26atitle%3DComputationally%2520Assessing%2520the%2520Bioactivation%2520of%2520Drugs%2520by%2520N-Dealkylation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26issue%3D2%26spage%3D68%26epage%3D80%26doi%3D10.1021%2Facs.chemrestox.7b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iverson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J. P.</span></span> <span> </span><span class="NLM_article-title">Identification of a Reactive Metabolite of Terbinafine: Insights into Terbinafine-Induced Hepatotoxicity</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1021/tx0002029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0002029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=175-181&issue=2&author=S.+L.+Iversonauthor=J.+P.+Uetrecht&title=Identification+of+a+Reactive+Metabolite+of+Terbinafine%3A+Insights+into+Terbinafine-Induced+Hepatotoxicity&doi=10.1021%2Ftx0002029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Reactive Metabolite of Terbinafine: Insights into Terbinafine-Induced Hepatotoxicity</span></div><div class="casAuthors">Iverson, Suzanne L.; Uetrecht, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral terbinafine treatment for superficial fungal infections of toe and fingernails is assocd. with a low incidence (1:45000) of hepatobiliary dysfunction.  Due to the rare and unpredictable nature of this adverse drug reaction, the mechanism of toxicity has been hypothesized to be either an uncommon immunol. or metabolically mediated effect. However, there is little evidence to support either mechanism, and toxic metabolites of terbinafine have not been identified.  The authors incubated terbinafine with both rat and human liver microsomal protein in the presence of GSH and were able to trap an allylic aldehyde, 7,7-dimethylhept-2-ene-4-ynal (TBF-A), which corresponds to the N-dealkylation product of terbinafine.  TBF-A was also prepd. synthetically and reacted with excess GSH to yield conjugates with HPLC retention times and mass spectra identical to those generated in the microsomal incubations.  The major GSH conjugate, characterized by 1H NMR, corresponds to addn. of GSH in a 1,6-Michael fashion.  There remains a second electrophilic site on this metabolite, which can bind either to a second mol. of GSH or to cellular proteins via a 1,4-Michael addn. mechanism.  Moreover, the authors demonstrated that the formation of the GSH conjugates was reversible.  The authors speculate that this allylic aldehyde metabolite, formed by liver enzymes and conjugated with GSH, would be transported across the canalicular membrane of hepatocytes and concd. in the bile.  The mono-GSH conjugate, which is still reactive, could bind to hepatobiliary proteins and lead to direct toxicity.  Alternatively, it could modify canalicular proteins and lead to an immune-mediated reaction causing cholestatic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGrZ61XgKfb7Vg90H21EOLACvtfcHk0lj_ZF7w5eE5KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKgtr4%253D&md5=a3c239dcafd228dd7bec404053c35dfc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx0002029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0002029%26sid%3Dliteratum%253Aachs%26aulast%3DIverson%26aufirst%3DS.%2BL.%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DIdentification%2520of%2520a%2520Reactive%2520Metabolite%2520of%2520Terbinafine%253A%2520Insights%2520into%2520Terbinafine-Induced%2520Hepatotoxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2001%26volume%3D14%26issue%3D2%26spage%3D175%26epage%3D181%26doi%3D10.1021%2Ftx0002029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoPachin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, T.</span></span> <span> </span><span class="NLM_article-title">Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/tx5001046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx5001046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVensrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=1081-1091&issue=7&author=R.+M.+LoPachinauthor=T.+Gavin&title=Molecular+Mechanisms+of+Aldehyde+Toxicity%3A+A+Chemical+Perspective&doi=10.1021%2Ftx5001046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective</span></div><div class="casAuthors">LoPachin, Richard M.; Gavin, Terrence</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1091</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehydes are electrophilic compds. to which humans are pervasively exposed.  Despite a significant health risk due to exposure, the mechanisms of aldehyde toxicity are poorly understood.  This ambiguity is likely due to the structural diversity of aldehyde derivs. and corresponding differences in chem. reactions and biol. targets.  To gain mechanistic insight, the authors have used parameters based on the hard and soft, acids and bases (HSAB) theory to profile the different aldehyde subclasses with respect to electronic character (softness, hardness), electrophilic reactivity (electrophilic index), and biol. nucleophilic targets.  The authors' analyses indicate that short chain aldehydes and longer chain satd. alkanals are hard electrophiles that cause toxicity by forming adducts with hard biol. nucleophiles, e.g., primary nitrogen groups on lysine residues.  In contrast, α,β-unsatd. carbonyl derivs., alkenals, and the α-oxoaldehydes are soft electrophiles that preferentially react with soft nucleophilic thiolate groups on cysteine residues.  The aldehydes can therefore be grouped into subclasses according to common electronic characteristics (softness/hardness) and mol. mechanisms of toxicity.  As the authors will discuss, the toxic potencies of these subgroups are generally related to corresponding electrophilicities.  For some aldehydes, however, predictions of toxicity based on electrophilicity are less accurate due to inherent physicochem. variables that limit target accessibility, e.g., steric hindrance and soly.  The unsatd. aldehydes are also members of the conjugated type-2 alkene chem. class that includes α,β-unsatd. amide, ketone, and ester derivs.  Type-2 alkenes are electrophiles of varying softness and electrophilicity that share a common mechanism of toxicity.  Therefore, exposure to an environmental mixt. of unsatd. carbonyl derivs. could cause "type-2 alkene toxicity" through additive interactions.  Finally, the authors propose that environmentally derived aldehydes can accelerate diseases by interacting with endogenous aldehydes generated during oxidative stress.  This review provides a basis for understanding aldehyde mechanisms and environmental toxicity through the context of electronic structure, electrophilicity, and nucleophile target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATFAViXVn7rVg90H21EOLACvtfcHk0lj_ZF7w5eE5KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVensrg%253D&md5=e72707796ea59ccaff0283848ebbdf76</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Ftx5001046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx5001046%26sid%3Dliteratum%253Aachs%26aulast%3DLoPachin%26aufirst%3DR.%2BM.%26aulast%3DGavin%26aufirst%3DT.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Aldehyde%2520Toxicity%253A%2520A%2520Chemical%2520Perspective%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26issue%3D7%26spage%3D1081%26epage%3D1091%26doi%3D10.1021%2Ftx5001046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Designing Around Structural Alerts in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+S.+Kalgutkar&title=Designing+Around+Structural+Alerts+in+Drug+Discovery&doi=10.1021%2Facs.jmedchem.9b00917"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00917%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DDesigning%2520Around%2520Structural%2520Alerts%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26doi%3D10.1021%2Facs.jmedchem.9b00917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1021/tx800407w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800407w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=332-340&issue=2&author=J.+N.+Baumanauthor=J.+M.+Kellyauthor=S.+Tripathyauthor=S.+X.+Zhaoauthor=W.+W.+Lamauthor=A.+S.+Kalgutkarauthor=R.+S.+Obach&title=Can+In+Vitro+Metabolism-Dependent+Covalent+Binding+Data+Distinguish+Hepatotoxic+from+Nonhepatotoxic+Drugs%3F+An+Analysis+Using+Human+Hepatocytes+and+Liver+S-9+Fraction&doi=10.1021%2Ftx800407w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction</span></div><div class="casAuthors">Bauman, Jonathon N.; Kelly, Joan M.; Tripathy, Sakambari; Zhao, Sabrina X.; Lam, Wing W.; Kalgutkar, Amit S.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-340</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro covalent binding studies in which xenobiotics are shown to undergo metab.-dependent covalent binding to macromols. have been commonly used to shed light on the biochem. mechanisms of xenobiotic-induced toxicity.  In this paper hepatotoxins and nonhepatotoxins were tested for their proclivity to demonstrate metab.-dependent covalent binding to macromols. in human liver S-9 fraction (9000 g supernatant) or human hepatocytes, as an extension to previous work that used human liver microsomes published in this journal [Obachet al. (2008) Chem. Res. Toxicol.21, 1814-1822].  In the S-9 fraction, seven out of the nine drugs in each category demonstrated some level of metab.-dependent covalent binding.  Inclusion of reduced glutathione, cofactors needed by conjugating enzymes, and other parameters (total daily dose and fraction of total intrinsic clearance comprised by covalent binding) improved the ability of the system to sep. hepatotoxins from nonhepatotoxins to a limited extent.  Covalent binding in human hepatocytes showed that six out of the nine hepatotoxins and four out of eight nonhepatotoxins demonstrated covalent binding.  Taking into account ests. of total daily body burden of covalent binding from the hepatocyte data showed an improvement over other in vitro systems for distinguishing hepatotoxins from nonhepatotoxins; however, this metab. system still displayed some false positives.  Combined with the previous study using liver microsomes, these findings identify the limitations of in vitro covalent binding data for prospective prediction of hepatotoxicity for new drug candidates and highlight the need for a better understanding of the link between drug bioactivation, covalent adduct formation, and toxicity outcomes.  Directly relating covalent binding to hepatotoxicity is likely an oversimplification of the process whereby adduct formation ultimately leads to toxicity.  Understanding underlying complexities (e.g., which macromols. are important covalent binding targets, interindividual differences in susceptibility, etc.) will be essential to any understanding of the problem of metab.-dependent hepatotoxicity and predicting toxicity from in vitro expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTemi_XkByprVg90H21EOLACvtfcHk0lj_ZF7w5eE5KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOnuw%253D%253D&md5=5904378a0deda8e27d73ab0218b03506</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Ftx800407w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800407w%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DTripathy%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DLam%26aufirst%3DW.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DCan%2520In%2520Vitro%2520Metabolism-Dependent%2520Covalent%2520Binding%2520Data%2520Distinguish%2520Hepatotoxic%2520from%2520Nonhepatotoxic%2520Drugs%253F%2520An%2520Analysis%2520Using%2520Human%2520Hepatocytes%2520and%2520Liver%2520S-9%2520Fraction%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26issue%3D2%26spage%3D332%26epage%3D340%26doi%3D10.1021%2Ftx800407w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&issue=8&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+Vitro+Approach+to+Assess+the+Potential+for+Risk+of+Idiosyncratic+Adverse+Reactions+Caused+by+Candidate+Drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0ljEFxUl9x7x-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520Vitro%2520Approach%2520to%2520Assess%2520the%2520Potential%2520for%2520Risk%2520of%2520Idiosyncratic%2520Adverse%2520Reactions%2520Caused%2520by%2520Candidate%2520Drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D8%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00026&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-12%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00026%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00026" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797e058bd2d19b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
